,pathway,pthwy_id,fold_enrichment,q-value,cohort
0,cochlear nucleus development,GO:0021747,9.996116504854369,0.00894936918670939,symptomatic
94,positive regulation of macrophage apoptotic process,GO:2000111,9.996116504854369,0.008923170799160475,symptomatic
119,positive regulation of viral translation,GO:1904973,9.996116504854369,0.008912734342085433,symptomatic
122,regulation of viral translation,GO:1904971,9.996116504854369,0.008907525262984273,symptomatic
123,sphingolipid translocation,GO:0099039,9.996116504854369,0.008902322269255894,symptomatic
88,regulation of mast cell apoptotic process,GO:0033025,9.996116504854369,0.00892839819857416,symptomatic
134,negative regulation of metalloendopeptidase activity,GO:1904684,9.996116504854369,0.008897125350242901,symptomatic
150,positive regulation of heparan sulfate proteoglycan biosynthetic process,GO:0010909,9.996116504854369,0.00889193449531277,symptomatic
83,viral penetration into host nucleus,GO:0075732,9.996116504854369,0.0012657282783194138,symptomatic
156,positive regulation of B cell apoptotic process,GO:0002904,9.996116504854369,0.008886749693857778,symptomatic
160,fungiform papilla formation,GO:0061198,9.996116504854369,0.008881570935294925,symptomatic
77,osteoblast fate commitment,GO:0002051,9.996116504854369,0.008933631726240381,symptomatic
169,regulation of cell proliferation involved in heart valve morphogenesis,GO:0003250,9.996116504854369,0.008876398209065864,symptomatic
172,positive regulation of calcidiol 1-monooxygenase activity,GO:0060559,9.996116504854369,0.00887123150463684,symptomatic
63,apoptotic process involved in embryonic digit morphogenesis,GO:1902263,9.996116504854369,0.008938871392941989,symptomatic
99,intrinsic apoptotic signaling pathway in response to hypoxia,GO:1990144,9.996116504854369,0.008917949517241714,symptomatic
15,negative regulation of primary miRNA processing,GO:2000635,9.996116504854369,0.0012667812968537894,symptomatic
13,central nervous system morphogenesis,GO:0021551,9.996116504854369,0.008944117209487143,symptomatic
16,regulation of primary miRNA processing,GO:2000634,8.33009708737864,0.0007402360967473025,symptomatic
180,cytoplasmic sequestering of NF-kappaB,GO:0007253,8.33009708737864,0.0007408917531660334,symptomatic
193,maintenance of DNA repeat elements,GO:0043570,8.33009708737864,0.0007395815997563676,symptomatic
209,regulation of protein localization to endoplasmic reticulum,GO:1905550,7.996893203883494,0.004676312075540983,symptomatic
314,regulation of termination of DNA-templated transcription,GO:0031554,7.996893203883494,0.0046700769927735955,symptomatic
338,cranial ganglion development,GO:0061550,7.996893203883494,0.004663858514753923,symptomatic
227,glial cell apoptotic process,GO:0034349,7.996893203883494,0.004654561786817537,symptomatic
213,hair follicle placode formation,GO:0060789,7.996893203883494,0.0046607554818099755,symptomatic
162,fungiform papilla morphogenesis,GO:0061197,7.996893203883494,0.004657656575239623,symptomatic
151,positive regulation of sulfur metabolic process,GO:0051176,7.996893203883494,0.004673192454409869,symptomatic
135,regulation of metalloendopeptidase activity,GO:1904683,7.996893203883494,0.004666965682318717,symptomatic
270,positive regulation of endodeoxyribonuclease activity,GO:0032079,7.497087378640777,0.027152185623523045,symptomatic
307,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,GO:1905005,7.497087378640777,0.02706098346451889,symptomatic
306,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,GO:1905007,7.497087378640777,0.027073974815197965,symptomatic
303,hepatocyte growth factor receptor signaling pathway,GO:0048012,7.497087378640777,0.000339522379999053,symptomatic
297,establishment or maintenance of microtubule cytoskeleton polarity,GO:0030951,7.497087378640777,0.027099994973597965,symptomatic
293,regulation of leukocyte adhesion to arterial endothelial cell,GO:1904997,7.497087378640777,0.02711302381733527,symptomatic
291,protein localization to lipid droplet,GO:1990044,7.497087378640777,0.027126065194832787,symptomatic
278,anterograde neuronal dense core vesicle transport,GO:1990048,7.497087378640777,0.02713911912418545,symptomatic
250,endoplasmic reticulum tubular network membrane organization,GO:1990809,7.497087378640777,0.027230849608912294,symptomatic
262,synaptic vesicle recycling via endosome,GO:0036466,7.497087378640777,0.02716526471101029,symptomatic
257,negative regulation of lysosome organization,GO:1905672,7.497087378640777,0.02717835640484692,symptomatic
254,positive regulation of fibroblast growth factor production,GO:0090271,7.497087378640777,0.027191460723267773,symptomatic
252,regulation of Schwann cell differentiation,GO:0014038,7.497087378640777,0.027217707306977493,symptomatic
248,neuropilin signaling pathway,GO:0038189,7.497087378640777,0.027244004608723362,symptomatic
245,regulation of ureteric bud formation,GO:0072106,7.497087378640777,0.02725717232482231,symptomatic
238,positive regulation of ureteric bud formation,GO:0072107,7.497087378640777,0.027270352775656367,symptomatic
228,negative regulation of epithelial cell differentiation involved in kidney development,GO:2000697,7.497087378640777,0.02728354597970845,symptomatic
155,regulation of heparan sulfate proteoglycan biosynthetic process,GO:0010908,7.497087378640777,0.027022084111191835,symptomatic
313,regulation of termination of RNA polymerase II transcription,GO:1904594,7.497087378640777,0.02704800457556708,symptomatic
301,negative regulation of myofibroblast differentiation,GO:1904761,7.497087378640777,0.027086978645560693,symptomatic
316,negative regulation of hyaluronan biosynthetic process,GO:1900126,7.497087378640777,0.027035038130420595,symptomatic
373,vasculogenesis involved in coronary vascular morphogenesis,GO:0060979,7.497087378640777,0.026931752406904184,symptomatic
331,negative regulation of triglyceride biosynthetic process,GO:0010868,7.497087378640777,0.02699621327910836,symptomatic
425,negative regulation of bicellular tight junction assembly,GO:1903347,7.497087378640777,0.02685480454288446,symptomatic
420,cardiac muscle tissue regeneration,GO:0061026,7.497087378640777,0.026867598637473733,symptomatic
401,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:1903378,7.497087378640777,0.02688040492853068,symptomatic
397,formation of radial glial scaffolds,GO:0021943,7.497087378640777,0.02689322343350375,symptomatic
390,actin modification,GO:0030047,7.497087378640777,0.026906054169874696,symptomatic
384,retinal cell programmed cell death,GO:0046666,7.497087378640777,0.026918897155158647,symptomatic
323,positive regulation of stress granule assembly,GO:0062029,7.497087378640777,0.027009142500027474,symptomatic
369,negative regulation of long-chain fatty acid import into cell,GO:0140213,7.497087378640777,0.027204577684542867,symptomatic
337,trigeminal ganglion development,GO:0061551,7.497087378640777,0.026983296430649457,symptomatic
348,Langerhans cell differentiation,GO:0061520,7.497087378640777,0.02695749978014214,symptomatic
359,negative regulation of long-chain fatty acid import across plasma membrane,GO:0010748,7.497087378640777,0.026944619942693437,symptomatic
340,negative regulation of dendrite extension,GO:1903860,7.497087378640777,0.02697039193689974,symptomatic
429,CRD-mediated mRNA stabilization,GO:0070934,7.269902912621359,2.4227316126345384e-05,symptomatic
541,corticosteroid receptor signaling pathway,GO:0031958,7.140083217753121,0.0020588375067446723,symptomatic
481,regulation of vitamin D biosynthetic process,GO:0060556,7.140083217753121,0.0020478444765789877,symptomatic
470,random inactivation of X chromosome,GO:0060816,7.140083217753121,0.0020494077166374448,symptomatic
465,glutathione transmembrane transport,GO:0034775,7.140083217753121,0.002050973345145189,symptomatic
460,negative regulation of hepatocyte apoptotic process,GO:1903944,7.140083217753121,0.0020525413675803153,symptomatic
457,post-embryonic camera-type eye development,GO:0031077,7.140083217753121,0.0020541117894376836,symptomatic
451,positive regulation of receptor binding,GO:1900122,7.140083217753121,0.0020556846162289835,symptomatic
448,negative regulation of hydrogen peroxide-mediated programmed cell death,GO:1901299,7.140083217753121,0.002057259853482799,symptomatic
444,odontoblast differentiation,GO:0071895,7.140083217753121,0.0020604175815771703,symptomatic
450,regulation of hydrogen peroxide-mediated programmed cell death,GO:1901298,6.997281553398058,0.00014722958148482665,symptomatic
540,glucocorticoid receptor signaling pathway,GO:0042921,6.6640776699029125,0.010872632315073046,symptomatic
568,intestinal epithelial cell maturation,GO:0060574,6.6640776699029125,0.010836085651829103,symptomatic
565,negative regulation of sequestering of triglyceride,GO:0010891,6.6640776699029125,0.010854328220266527,symptomatic
563,"negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",GO:1900152,6.6640776699029125,6.023336319707194e-05,symptomatic
555,pyrimidine deoxyribonucleoside triphosphate metabolic process,GO:0009211,6.6640776699029125,0.010860422733585036,symptomatic
509,positive regulation of cell proliferation in bone marrow,GO:0071864,6.6640776699029125,0.010909426333059757,symptomatic
512,negative regulation of cytoplasmic translation,GO:2000766,6.6640776699029125,0.0008417478399862092,symptomatic
499,activation-induced cell death of T cells,GO:0006924,6.6640776699029125,0.010915582894195796,symptomatic
496,negative regulation of cardiac muscle adaptation,GO:0010616,6.6640776699029125,0.010848240543194027,symptomatic
539,positive regulation of cell proliferation involved in heart morphogenesis,GO:2000138,6.6640776699029125,0.010878747406363864,symptomatic
536,hair follicle maturation,GO:0048820,6.6640776699029125,0.010884869380143472,symptomatic
486,negative regulation of cardiac muscle hypertrophy in response to stress,GO:1903243,6.6640776699029125,0.010921746407970044,symptomatic
163,fungiform papilla development,GO:0061196,6.6640776699029125,0.010842159690871609,symptomatic
532,interleukin-11-mediated signaling pathway,GO:0038154,6.6640776699029125,0.010890998248037697,symptomatic
518,response to indole-3-methanol,GO:0071680,6.6640776699029125,0.01090327671280437,symptomatic
302,regulation of myofibroblast differentiation,GO:1904760,6.6640776699029125,0.01086652409467132,symptomatic
525,modulation by host of viral RNA genome replication,GO:0044830,6.6640776699029125,0.010897134021698564,symptomatic
581,positive regulation of fibroblast migration,GO:0010763,6.426074895977809,2.4275758459809546e-05,symptomatic
578,interleukin-6-mediated signaling pathway,GO:0070102,6.426074895977809,2.4307041653701053e-05,symptomatic
35,negative regulation of miRNA-mediated gene silencing,GO:0060965,6.426074895977809,2.4244555685439612e-05,symptomatic
589,somatic stem cell division,GO:0048103,6.361165048543689,0.0003331628580409659,symptomatic
34,negative regulation of miRNA processing,GO:1903799,6.361165048543689,0.00033284343056441657,symptomatic
24,regulation of epithelial cell differentiation,GO:0030856,6.359235668789809,0.030364317973533873,asymptomatic
592,regulation of transforming growth factor beta2 production,GO:0032909,6.247572815533981,0.004473295461356313,symptomatic
277,regulation of endodeoxyribonuclease activity,GO:0032071,6.247572815533981,0.004455086660292447,symptomatic
330,regulation of stress granule assembly,GO:0062028,6.247572815533981,0.004446037736811827,symptomatic
631,necroptotic signaling pathway,GO:0097527,6.247572815533981,0.004443029592199639,symptomatic
634,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,GO:1902961,6.247572815533981,0.00444002551539626,symptomatic
594,negative regulation of stress-activated MAPK cascade,GO:0032873,6.247572815533981,0.004470250331702565,symptomatic
605,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,GO:0038089,6.247572815533981,0.004467209345082359,symptomatic
610,internal peptidyl-lysine acetylation,GO:0018393,6.247572815533981,0.004464172493046273,symptomatic
84,intracellular transport of virus,GO:0075733,6.247572815533981,0.004461139767167845,symptomatic
617,positive regulation of microtubule nucleation,GO:0090063,6.247572815533981,0.004458111159043494,symptomatic
461,regulation of hepatocyte apoptotic process,GO:1903943,6.247572815533981,0.004449049957500723,symptomatic
319,regulation of hyaluronan biosynthetic process,GO:1900125,6.247572815533981,0.004452066262556656,symptomatic
643,growth hormone receptor signaling pathway via JAK-STAT,GO:0060397,5.997669902912621,0.0017739201119937877,symptomatic
40,negative regulation of gene silencing by regulatory ncRNA,GO:0060967,5.997669902912621,5.058592194886931e-05,symptomatic
654,cellular response to X-ray,GO:0071481,5.997669902912621,0.0017725111206419262,symptomatic
757,foregut morphogenesis,GO:0007440,5.997669902912621,0.0017753313451775536,symptomatic
51,negative regulation of post-transcriptional gene silencing,GO:0060149,5.997669902912621,5.070536922619839e-05,symptomatic
39,negative regulation of post-transcriptional gene silencing by regulatory ncRNA,GO:1900369,5.997669902912621,5.064557515871467e-05,symptomatic
692,voluntary musculoskeletal movement,GO:0050882,5.712066574202497,0.021060651086552334,symptomatic
687,regulation of epithelial cell proliferation involved in lung morphogenesis,GO:2000794,5.712066574202497,0.021092723144044548,symptomatic
728,negative regulation of centriole replication,GO:0046600,5.712066574202497,0.020965017453969607,symptomatic
712,regulation of myosin-light-chain-phosphatase activity,GO:0035507,5.712066574202497,0.020996798683055967,symptomatic
690,regulation of mast cell proliferation,GO:0070666,5.712066574202497,0.021071330929902515,symptomatic
735,vascular endothelial growth factor production,GO:0010573,5.712066574202497,0.020954445080064426,symptomatic
696,positive regulation of pinocytosis,GO:0048549,5.712066574202497,0.021049982063712138,symptomatic
717,chaperone-mediated autophagy,GO:0061684,5.712066574202497,0.020986194239276647,symptomatic
689,dorsal root ganglion development,GO:1990791,5.712066574202497,0.021082021610232246,symptomatic
510,regulation of cell proliferation in bone marrow,GO:0071863,5.712066574202497,0.021103435547875957,symptomatic
271,positive regulation of nuclease activity,GO:0032075,5.712066574202497,0.0210393238449457,symptomatic
686,inflammatory cell apoptotic process,GO:0006925,5.712066574202497,0.021114158838296624,symptomatic
726,response to luteinizing hormone,GO:0034699,5.712066574202497,0.02097560050164955,symptomatic
662,positive regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045737,5.712066574202497,0.0002593574389322493,symptomatic
702,ribosomal large subunit export from nucleus,GO:0000055,5.712066574202497,0.02100741384922536,symptomatic
701,limb joint morphogenesis,GO:0036022,5.712066574202497,0.021018039754055518,symptomatic
700,post-embryonic eye morphogenesis,GO:0048050,5.712066574202497,0.02102867641385008,symptomatic
179,regulation of calcidiol 1-monooxygenase activity,GO:0060558,5.712066574202497,0.020943883363794234,symptomatic
574,intestinal epithelial cell development,GO:0060576,5.6228155339805825,9.901910211663434e-05,symptomatic
310,positive regulation of cardiac epithelial to mesenchymal transition,GO:0062043,5.553398058252427,0.00814652207034595,symptomatic
469,glutathione transport,GO:0034635,5.553398058252427,0.008136742331966183,symptomatic
635,positive regulation of aspartic-type peptidase activity,GO:1905247,5.553398058252427,0.008156325346002202,symptomatic
244,regulation of epithelial tube formation,GO:1905276,5.553398058252427,0.008161235836878784,symptomatic
759,positive regulation of vascular associated smooth muscle cell apoptotic process,GO:1905461,5.553398058252427,0.008171074578092621,symptomatic
755,cellular response to insulin-like growth factor stimulus,GO:1990314,5.553398058252427,0.008185877249429745,symptomatic
604,negative regulation of stress-activated protein kinase signaling cascade,GO:0070303,5.553398058252427,0.00817600284985263,symptomatic
466,tripeptide transmembrane transport,GO:0035443,5.553398058252427,0.008151420760706952,symptomatic
756,embryonic foregut morphogenesis,GO:0048617,5.553398058252427,0.008180937070039626,symptomatic
239,positive regulation of epithelial tube formation,GO:1905278,5.553398058252427,0.008166152244009434,symptomatic
497,negative regulation of muscle adaptation,GO:0014745,5.553398058252427,0.008117253128775844,symptomatic
746,negative regulation of synapse assembly,GO:0051964,5.553398058252427,0.00820073365097136,symptomatic
742,regulation of chronic inflammatory response,GO:0002676,5.553398058252427,0.00821066791341954,symptomatic
751,response to oxygen-glucose deprivation,GO:0090649,5.553398058252427,0.008195775529054207,symptomatic
770,mesenchymal-epithelial cell signaling,GO:0060638,5.553398058252427,0.008126986046196438,symptomatic
95,positive regulation of myeloid cell apoptotic process,GO:0033034,5.553398058252427,0.008190823398825172,symptomatic
639,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,GO:1902959,5.553398058252427,0.008122116671693026,symptomatic
830,regulation of attachment of mitotic spindle microtubules to kinetochore,GO:1902423,5.553398058252427,0.00820569777545742,symptomatic
765,coronary artery morphogenesis,GO:0060982,5.553398058252427,0.008141629264297694,symptomatic
768,regulation of branching involved in salivary gland morphogenesis,GO:0060693,5.553398058252427,0.00813186126278084,symptomatic
98,positive regulation of leukocyte apoptotic process,GO:2000108,5.5533980582524265,1.414291234285108e-07,symptomatic
772,fibroblast apoptotic process,GO:0044346,5.452427184466019,0.0032253513742210456,symptomatic
773,thymocyte apoptotic process,GO:0070242,5.452427184466019,0.003223037635789036,symptomatic
837,positive regulation of attachment of spindle microtubules to kinetochore,GO:0051987,5.452427184466019,0.003229988831265217,symptomatic
774,blood vessel endothelial cell differentiation,GO:0060837,5.452427184466019,0.003220727214544743,symptomatic
616,internal protein amino acid acetylation,GO:0006475,5.452427184466019,0.0032276684369898826,symptomatic
777,positive regulation of cytoplasmic translation,GO:2000767,5.33126213592233,0.0004707735494480454,symptomatic
159,positive regulation of lymphocyte apoptotic process,GO:0070230,5.292061679040548,0.00017843742414722088,symptomatic
780,regulation of establishment of endothelial barrier,GO:1903140,5.292061679040548,0.00017880609651116142,symptomatic
781,regulation of endothelial cell development,GO:1901550,5.292061679040548,0.00017862157009577322,symptomatic
784,negative regulation of anoikis,GO:2000811,5.2611139499233515,6.769400817978807e-05,symptomatic
785,regulation of anoikis,GO:2000209,5.197980582524273,3.550887969233144e-06,symptomatic
564,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",GO:1900151,5.183171521035598,1.330773374156969e-06,symptomatic
786,inflammatory response to wounding,GO:0090594,4.998058252427185,0.0020938497338833743,symptomatic
226,ectodermal placode development,GO:0071696,4.998058252427185,0.002095444440459066,symptomatic
471,dosage compensation by inactivation of X chromosome,GO:0009048,4.998058252427185,0.0020922574527169227,symptomatic
876,negative regulation of calcium ion-dependent exocytosis,GO:0045955,4.998058252427184,0.034664189970714965,symptomatic
879,epithelial to mesenchymal transition involved in endocardial cushion formation,GO:0003198,4.998058252427184,0.005337393408242153,symptomatic
889,T-helper 17 cell lineage commitment,GO:0072540,4.998058252427184,0.01344866699985592,symptomatic
224,ectodermal placode formation,GO:0060788,4.998058252427184,0.005340859248117635,symptomatic
225,ectodermal placode morphogenesis,GO:0071697,4.998058252427184,0.005354767735742941,symptomatic
364,regulation of long-chain fatty acid import into cell,GO:0140212,4.998058252427184,0.03485361177383363,symptomatic
875,endothelial cell activation,GO:0042118,4.998058252427184,0.013455940481197108,symptomatic
929,positive regulation of nucleocytoplasmic transport,GO:0046824,4.998058252427184,3.3728971008900144e-14,symptomatic
638,regulation of aspartic-type peptidase activity,GO:1905245,4.998058252427184,0.013477808206789519,symptomatic
919,type I pneumocyte differentiation,GO:0060509,4.998058252427184,0.03464849771631446,symptomatic
874,protein localization to cytoplasmic stress granule,GO:1903608,4.998058252427184,0.034679896445554435,symptomatic
860,anoikis,GO:0043276,4.998058252427184,0.005344329592008549,symptomatic
181,cytoplasmic sequestering of transcription factor,GO:0042994,4.998058252427184,0.01348511325188805,symptomatic
813,ubiquitin-dependent protein catabolic process via the C-end degron rule pathway,GO:0140627,4.998058252427184,0.005358256183779255,symptomatic
843,postsynaptic neurotransmitter receptor internalization,GO:0098884,4.998058252427184,0.03479024157060848,symptomatic
842,embryonic cleavage,GO:0040016,4.998058252427184,0.03480606250811216,symptomatic
840,cellular response to antibiotic,GO:0071236,4.998058252427184,0.005351283827001403,symptomatic
832,regulation of attachment of spindle microtubules to kinetochore,GO:0051988,4.998058252427184,4.4549937092961154e-05,symptomatic
873,renal system vasculature morphogenesis,GO:0061438,4.998058252427184,0.034695617160171645,symptomatic
829,positive regulation of attachment of mitotic spindle microtubules to kinetochore,GO:1902425,4.998058252427184,0.03488538352567851,symptomatic
821,glomerular mesangium development,GO:0072109,4.998058252427184,0.034901291133305354,symptomatic
807,positive regulation of cardiac muscle cell differentiation,GO:2000727,4.998058252427184,0.03491721325517274,symptomatic
274,regulation of deoxyribonuclease activity,GO:0032070,4.998058252427184,0.013499747124109307,symptomatic
802,I-kappaB phosphorylation,GO:0007252,4.998058252427184,0.03493314991115411,symptomatic
801,germinal center formation,GO:0002467,4.998058252427184,0.013521757581376876,symptomatic
797,clathrin coat disassembly,GO:0072318,4.998058252427184,0.0349491011211592,symptomatic
794,negative regulation of cell adhesion mediated by integrin,GO:0033629,4.998058252427184,0.005361749179987716,symptomatic
792,regulation of pro-B cell differentiation,GO:2000973,4.998058252427184,0.034965066905134144,symptomatic
308,regulation of cardiac epithelial to mesenchymal transition,GO:0062042,4.998058252427184,0.013470511071864349,symptomatic
790,regulation of germinal center formation,GO:0002634,4.998058252427184,0.034981047283061534,symptomatic
844,postsynaptic endocytosis,GO:0140239,4.998058252427184,0.03486949041245496,symptomatic
910,prostate glandular acinus development,GO:0060525,4.998058252427184,0.01344140137748971,symptomatic
764,regulation of vascular associated smooth muscle cell apoptotic process,GO:1905459,4.998058252427184,0.005347804448700363,symptomatic
263,synaptic vesicle endosomal processing,GO:0099532,4.998058252427184,0.03482189784137336,symptomatic
170,regulation of cell proliferation involved in heart morphogenesis,GO:2000136,4.998058252427184,0.0003082828141431143,symptomatic
863,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",GO:1900153,4.998058252427184,0.0008066013594230039,symptomatic
166,tongue morphogenesis,GO:0043587,4.998058252427184,0.013492426220028986,symptomatic
848,cellular response to leucine starvation,GO:1990253,4.998058252427184,0.013514412791816106,symptomatic
861,regulation of guanyl-nucleotide exchange factor activity,GO:1905097,4.998058252427184,0.034742864936604015,symptomatic
871,macrophage derived foam cell differentiation,GO:0010742,4.998058252427184,0.034727101386269804,symptomatic
869,regulation of dopaminergic neuron differentiation,GO:1904338,4.998058252427184,0.013463221834271349,symptomatic
370,negative regulation of fatty acid transport,GO:2000192,4.998058252427184,0.03483774759004945,symptomatic
872,kidney vasculature morphogenesis,GO:0061439,4.998058252427184,0.03471135213394043,symptomatic
859,negative regulation of gene expression via CpG island methylation,GO:0044027,4.998058252427184,0.03475864280442263,symptomatic
856,mitochondrial fragmentation involved in apoptotic process,GO:0043653,4.998058252427184,0.013507075977053992,symptomatic
855,regulation of cyclic-nucleotide phosphodiesterase activity,GO:0051342,4.998058252427184,0.034774435009240635,symptomatic
760,positive regulation of smooth muscle cell apoptotic process,GO:0034393,4.998058252427184,0.0008059011846318382,symptomatic
517,regulation of cytoplasmic translation,GO:2000765,4.846601941747573,5.40418343712644e-07,symptomatic
926,response to muscle stretch,GO:0035994,4.798135922330098,2.797395171566008e-05,symptomatic
928,positive regulation of protein import into nucleus,GO:0042307,4.760055478502081,1.652487353608492e-08,symptomatic
944,positive regulation of protein export from nucleus,GO:0046827,4.735002554931016,0.0005013417805638075,symptomatic
943,protein localization to cell-cell junction,GO:0150105,4.735002554931016,0.0005018025726415315,symptomatic
1222,response to hepatocyte growth factor,GO:0035728,4.70405482581382,0.0013243280342431932,symptomatic
685,positive regulation of cyclin-dependent protein kinase activity,GO:1904031,4.70405482581382,0.0013221390622857663,symptomatic
17,regulation of miRNA processing,GO:1903798,4.70405482581382,0.001323232642982446,symptomatic
502,leukocyte apoptotic process,GO:0071887,4.679033257591406,3.837113813154472e-09,symptomatic
569,columnar/cuboidal epithelial cell maturation,GO:0002069,4.664854368932039,0.0033571434123391927,symptomatic
903,T-helper cell lineage commitment,GO:0002295,4.664854368932039,0.0033619324899602184,symptomatic
946,positive regulation of MHC class II biosynthetic process,GO:0045348,4.664854368932039,0.0033595362444221143,symptomatic
948,regulation of hematopoietic stem cell proliferation,GO:1902033,4.664854368932039,0.0033547539864229366,symptomatic
950,"negative regulation of DNA damage response, signal transduction by p53 class mediator",GO:0043518,4.664854368932039,0.0033523679594055665,symptomatic
954,motor neuron apoptotic process,GO:0097049,4.664854368932039,0.0033499853240399617,symptomatic
985,regulation of nuclear-transcribed mRNA poly(A) tail shortening,GO:0060211,4.664854368932039,0.003364332156262831,symptomatic
956,positive regulation of mitotic metaphase/anaphase transition,GO:0045842,4.664854368932039,0.0033476060730995923,symptomatic
974,SMAD protein signal transduction,GO:0060395,4.641054091539528,1.7116572504691515e-05,symptomatic
984,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,GO:0060213,4.613592233009708,0.008323882813942453,symptomatic
1012,regulation of immature T cell proliferation in thymus,GO:0033084,4.613592233009708,0.008304111120797696,symptomatic
36,regulation of miRNA-mediated gene silencing,GO:0060964,4.613592233009708,4.511461636455813e-05,symptomatic
152,regulation of sulfur metabolic process,GO:0042762,4.613592233009708,0.008294260455173974,symptomatic
611,peptidyl-lysine acetylation,GO:0018394,4.613592233009708,0.008313985212499,symptomatic
976,positive regulation of cell size,GO:0045793,4.613592233009708,0.008328840457071662,symptomatic
980,stress granule assembly,GO:0034063,4.613592233009708,4.5168971324033506e-05,symptomatic
1021,primary miRNA processing,GO:0031053,4.613592233009708,0.008289343881104517,symptomatic
986,commissural neuron axon guidance,GO:0071679,4.613592233009708,0.00831893106925837,symptomatic
1013,regulation of immature T cell proliferation,GO:0033083,4.613592233009708,0.008299182864939655,symptomatic
1003,positive regulation of mitochondrial membrane permeability involved in apoptotic process,GO:1902110,4.613592233009708,0.008309045233168937,symptomatic
1027,positive regulation of vascular associated smooth muscle cell proliferation,GO:1904707,4.59281028601417,5.414480631718671e-07,symptomatic
1031,extrinsic apoptotic signaling pathway in absence of ligand,GO:0097192,4.54368932038835,3.8189632194566455e-06,symptomatic
1037,regulation of helicase activity,GO:0051095,4.543689320388349,0.02094512265452831,symptomatic
1038,epithelial cell differentiation involved in prostate gland development,GO:0060742,4.543689320388349,0.020924187999201444,symptomatic
1034,positive regulation of hepatocyte proliferation,GO:2000347,4.543689320388349,0.020955605698899947,symptomatic
1039,regulation of cardioblast proliferation,GO:0003264,4.543689320388349,0.020913736356844202,symptomatic
468,tripeptide transport,GO:0042939,4.543689320388349,0.020934650093201047,symptomatic
1053,negative regulation of miRNA metabolic process,GO:2000629,4.514375195740683,1.0223281673803294e-05,symptomatic
426,negative regulation of cell junction assembly,GO:1901889,4.514375195740683,1.0209372447036215e-05,symptomatic
1040,positive regulation of ubiquitin-protein transferase activity,GO:0051443,4.4982524271844655,0.0007893041068750992,symptomatic
1048,regulation of extracellular matrix assembly,GO:1901201,4.4982524271844655,0.0007886159603128714,symptomatic
761,positive regulation of muscle cell apoptotic process,GO:0010661,4.481017743555407,2.714627370142692e-05,symptomatic
1050,negative regulation of miRNA transcription,GO:1902894,4.481017743555407,2.711195477133662e-05,symptomatic
588,regulation of fibroblast migration,GO:0010762,4.471946857434849,8.680563282698316e-07,symptomatic
1030,positive regulation of smooth muscle cell proliferation,GO:0048661,4.46885208452313,8.06965093611801e-15,symptomatic
374,coronary vasculature morphogenesis,GO:0060977,4.442718446601942,0.0020272532581348673,symptomatic
1315,regulation of epidermal growth factor-activated receptor activity,GO:0007176,4.442718446601942,0.00203038657074404,symptomatic
18,regulation of regulatory ncRNA processing,GO:0070920,4.442718446601942,0.0020288187046662454,symptomatic
880,cardiac epithelial to mesenchymal transition,GO:0060317,4.442718446601941,6.985928154565426e-05,symptomatic
37,regulation of post-transcriptional gene silencing by regulatory ncRNA,GO:1900368,4.442718446601941,6.970051045123232e-05,symptomatic
1057,negative regulation of stem cell differentiation,GO:2000737,4.442718446601941,6.977980568496523e-05,symptomatic
606,vascular endothelial growth factor signaling pathway,GO:0038084,4.398291262135923,0.00018026157550127362,symptomatic
1059,positive regulation of cardiac muscle cell proliferation,GO:0060045,4.398291262135923,0.00018044683919654728,symptomatic
808,regulation of cardiac muscle cell differentiation,GO:2000725,4.373300970873787,0.00505101747739442,symptomatic
965,positive regulation of metaphase/anaphase transition of cell cycle,GO:1902101,4.373300970873787,0.005047687867982821,symptomatic
1069,myeloid cell apoptotic process,GO:0033028,4.373300970873787,0.005044362645408393,symptomatic
472,sex-chromosome dosage compensation,GO:0007549,4.373300970873787,0.005037725326138119,symptomatic
456,regulation of receptor binding,GO:1900120,4.373300970873787,0.005041041801007203,symptomatic
1176,positive regulation of blood vessel endothelial cell migration,GO:0043536,4.361941747572816,3.4726784507755926e-09,symptomatic
763,regulation of smooth muscle cell apoptotic process,GO:0034391,4.331650485436893,4.167150313153095e-05,symptomatic
500,T cell apoptotic process,GO:0070231,4.331650485436893,4.172207534406922e-05,symptomatic
501,lymphocyte apoptotic process,GO:0070227,4.322644975072159,3.5382207027576034e-06,symptomatic
573,columnar/cuboidal epithelial cell development,GO:0002066,4.316504854368931,2.939829745900262e-07,symptomatic
1104,intrinsic apoptotic signaling pathway in response to oxidative stress,GO:0008631,4.284049930651873,0.0012041691011724749,symptomatic
645,cellular response to growth hormone stimulus,GO:0071378,4.284049930651873,0.001205175090396512,symptomatic
1070,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",GO:0006977,4.284049930651873,0.0012071921198365063,symptomatic
1094,positive regulation of glial cell proliferation,GO:0060252,4.284049930651873,0.0012061827618767768,symptomatic
1102,cellular response to epidermal growth factor stimulus,GO:0071364,4.284049930651873,7.905040415019653e-07,symptomatic
1105,response to parathyroid hormone,GO:0071107,4.2840499306518725,0.012366846887348477,symptomatic
1111,lipoprotein catabolic process,GO:0042159,4.2840499306518725,0.012326032211152606,symptomatic
1109,regulation of RNA export from nucleus,GO:0046831,4.2840499306518725,0.01233281593829138,symptomatic
1107,positive regulation of T cell apoptotic process,GO:0070234,4.2840499306518725,0.01234640581811319,symptomatic
1106,regulation of DNA methylation,GO:0044030,4.2840499306518725,0.012353211995521191,symptomatic
1112,positive regulation of miRNA transcription,GO:1902895,4.2840499306518725,5.311274623791235e-09,symptomatic
1132,regulation of keratinocyte migration,GO:0051547,4.2840499306518725,0.012373675626656786,symptomatic
38,regulation of post-transcriptional gene silencing,GO:0060147,4.2840499306518725,0.0001073371862958215,symptomatic
1032,signal transduction in absence of ligand,GO:0038034,4.2840499306518725,9.334032126860138e-06,symptomatic
703,ribosomal subunit export from nucleus,GO:0000054,4.2840499306518725,0.012339607136495286,symptomatic
831,regulation of metaphase plate congression,GO:0090235,4.2840499306518725,0.012360025681122691,symptomatic
705,ribosome localization,GO:0033750,4.2840499306518725,0.012380511911533392,symptomatic
783,regulation of endothelial cell differentiation,GO:0045601,4.2840499306518725,9.34690665393167e-06,symptomatic
951,"regulation of DNA damage response, signal transduction by p53 class mediator",GO:0043516,4.248349514563106,2.0781982644497825e-06,symptomatic
1116,G1/S transition of mitotic cell cycle,GO:0000082,4.2407766990291265,2.546841428721995e-10,symptomatic
1010,positive regulation of mitochondrial membrane permeability,GO:0035794,4.229126213592233,0.0002732840691160409,symptomatic
920,lung epithelial cell differentiation,GO:0060487,4.229126213592233,0.0002740958039748014,symptomatic
570,epithelial cell maturation,GO:0002070,4.229126213592233,0.00027355411266259823,symptomatic
921,lung cell differentiation,GO:0060479,4.229126213592233,0.0002738246904199302,symptomatic
402,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,GO:1903376,4.208891159938681,0.0030094737470960408,symptomatic
966,positive regulation of mitotic sister chromatid separation,GO:1901970,4.208891159938681,0.0030182477230350966,symptomatic
157,regulation of B cell apoptotic process,GO:0002902,4.208891159938681,0.0030116624552757472,symptomatic
1344,regulation of nitric-oxide synthase biosynthetic process,GO:0051769,4.208891159938681,0.0030138543493480005,symptomatic
947,regulation of MHC class II biosynthetic process,GO:0045346,4.208891159938681,0.003016049436273964,symptomatic
1113,positive regulation of miRNA metabolic process,GO:2000630,4.191919824616348,1.7957017469007586e-09,symptomatic
1120,extrinsic apoptotic signaling pathway via death domain receptors,GO:0008625,4.184420862497178,1.1970560571600489e-06,symptomatic
484,regulation of vitamin metabolic process,GO:0030656,4.16504854368932,0.030823666045763354,symptomatic
1155,endocardium development,GO:0003157,4.16504854368932,0.030751748952796105,symptomatic
1134,engulfment of apoptotic cell,GO:0043652,4.16504854368932,0.030838089848311677,symptomatic
824,kidney vasculature development,GO:0061440,4.16504854368932,0.0006997615170726223,symptomatic
1124,positive regulation of myoblast proliferation,GO:2000288,4.16504854368932,0.030895920302785772,symptomatic
1147,neuronal stem cell population maintenance,GO:0097150,4.16504854368932,0.0006985163898180446,symptomatic
1122,positive regulation of cellular senescence,GO:2000774,4.16504854368932,0.030910411822627607,symptomatic
1129,positive regulation of keratinocyte migration,GO:0051549,4.16504854368932,0.030866977988684804,symptomatic
825,renal system vasculature development,GO:0061437,4.16504854368932,0.0006991383990698862,symptomatic
1125,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902043,4.16504854368932,0.030881442364499558,symptomatic
1150,endothelial tube morphogenesis,GO:0061154,4.16504854368932,0.030794858881234604,symptomatic
1121,response to sterol depletion,GO:0006991,4.16504854368932,0.030924916943145028,symptomatic
1133,progesterone receptor signaling pathway,GO:0050847,4.16504854368932,0.030852527156293098,symptomatic
1153,morphogenesis of an endothelium,GO:0003159,4.16504854368932,0.0307661055115976,symptomatic
1154,negative regulation of vasoconstriction,GO:0045906,4.16504854368932,0.030780475481476905,symptomatic
1139,trophoblast giant cell differentiation,GO:0060707,4.16504854368932,0.03080925572970643,symptomatic
1055,regulation of miRNA transcription,GO:1902893,4.154230235783634,1.789797007504474e-11,symptomatic
494,negative regulation of muscle hypertrophy,GO:0014741,4.136324070974222,0.00015876605722943952,symptomatic
1064,positive regulation of cardiac muscle tissue growth,GO:0055023,4.136324070974222,0.00015909995009427536,symptomatic
19,regulation of gene silencing by regulatory ncRNA,GO:0060966,4.136324070974222,0.00015893282829795784,symptomatic
1156,regulation of astrocyte differentiation,GO:0048710,4.136324070974222,0.00015926742372595354,symptomatic
1036,regulation of hepatocyte proliferation,GO:2000345,4.116047972587093,0.00739902391591178,symptomatic
1210,cellular response to reactive nitrogen species,GO:1902170,4.116047972587093,0.0073944253926576395,symptomatic
1119,cell cycle G1/S phase transition,GO:0044843,4.116047972587093,5.939009482543418e-10,symptomatic
1160,negative regulation of B cell proliferation,GO:0030889,4.116047972587093,0.007389832581854747,symptomatic
1157,Golgi to endosome transport,GO:0006895,4.116047972587093,0.007403628162281358,symptomatic
1251,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,GO:1902229,4.100970873786407,8.043436065448513e-06,symptomatic
1192,negative regulation of Rho protein signal transduction,GO:0035024,4.089320388349514,0.0017715742527548172,symptomatic
566,negative regulation of lipid storage,GO:0010888,4.089320388349514,0.0017729858657052195,symptomatic
907,"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment",GO:0043369,4.089320388349514,0.0017758158511253395,symptomatic
1172,positive regulation of cell migration involved in sprouting angiogenesis,GO:0090050,4.089320388349514,0.0017772342343930114,symptomatic
1171,release of cytochrome c from mitochondria,GO:0001836,4.089320388349514,0.0017786548852598324,symptomatic
1178,phosphatidylinositol-3-phosphate biosynthetic process,GO:0036092,4.089320388349514,0.0017743997300319382,symptomatic
663,regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0000079,4.077363311190598,7.132929894592408e-11,symptomatic
1342,facultative heterochromatin formation,GO:0140718,4.072491909385113,0.0004009370066640712,symptomatic
493,negative regulation of cardiac muscle hypertrophy,GO:0010614,4.072491909385113,0.00040055912070114557,symptomatic
412,positive regulation of neuron apoptotic process,GO:0043525,4.056395103419164,8.802980532543677e-10,symptomatic
607,cellular response to vascular endothelial growth factor stimulus,GO:0035924,3.9984466019417475,2.6237213221212405e-06,symptomatic
1196,negative regulation of cyclin-dependent protein serine/threonine kinase activity,GO:0045736,3.998446601941747,0.004340935990579425,symptomatic
632,necroptotic process,GO:0070266,3.998446601941747,0.004326028930172215,symptomatic
1009,mitochondrial outer membrane permeabilization involved in programmed cell death,GO:1902686,3.998446601941747,0.017769138372462377,symptomatic
1229,muscle hypertrophy in response to stress,GO:0003299,3.998446601941747,0.017695598223999007,symptomatic
1220,negative regulation by host of viral transcription,GO:0043922,3.998446601941747,0.01774148929823137,symptomatic
1224,retina vasculature development in camera-type eye,GO:0061298,3.998446601941747,0.004320094734108879,symptomatic
1223,response to laminar fluid shear stress,GO:0034616,3.998446601941747,0.01772310433522802,symptomatic
1221,cellular response to hepatocyte growth factor stimulus,GO:0035729,3.998446601941747,0.017732292051316784,symptomatic
1218,positive regulation of amyloid-beta formation,GO:1902004,3.998446601941747,0.004329002145931784,symptomatic
1216,cellular response to fluid shear stress,GO:0071498,3.998446601941747,0.004331979451396661,symptomatic
1211,estrous cycle,GO:0044849,3.998446601941747,0.01775069609080959,symptomatic
1231,cardiac muscle adaptation,GO:0014887,3.998446601941747,0.01770475743633027,symptomatic
1206,negative regulation of cyclin-dependent protein kinase activity,GO:1904030,3.998446601941747,0.0043230597956971486,symptomatic
1207,cellular response to nitric oxide,GO:0071732,3.998446601941747,0.01775991244392008,symptomatic
1225,cardiac muscle hypertrophy in response to stress,GO:0014898,3.998446601941747,0.01771392613515799,symptomatic
644,growth hormone receptor signaling pathway,GO:0060396,3.998446601941747,0.004337946365241561,symptomatic
905,alpha-beta T cell lineage commitment,GO:0002363,3.998446601941747,0.004334960855010836,symptomatic
1233,maintenance of blood-brain barrier,GO:0035633,3.945835462442514,3.0168142895337144e-05,symptomatic
1101,regulation of glial cell proliferation,GO:0060251,3.945835462442514,3.020590027067549e-05,symptomatic
1076,mitotic G1/S transition checkpoint signaling,GO:0044819,3.937864077669903,0.00013353596559817393,symptomatic
1075,mitotic G1 DNA damage checkpoint signaling,GO:0031571,3.937864077669903,0.00013339160239212185,symptomatic
1054,regulation of miRNA metabolic process,GO:2000628,3.9310570524708193,1.0584934582268186e-11,symptomatic
579,cellular response to interleukin-6,GO:0071354,3.9270457697642165,0.0005784338212433114,symptomatic
1236,positive regulation of G2/M transition of mitotic cell cycle,GO:0010971,3.9270457697642165,0.0005779089266686804,symptomatic
478,heterochromatin formation,GO:0031507,3.9225267297529802,2.3089811300586785e-10,symptomatic
664,regulation of cyclin-dependent protein kinase activity,GO:1904029,3.9225267297529802,2.3030301477647128e-10,symptomatic
1103,response to epidermal growth factor,GO:0070849,3.911523849725622,3.765347315221431e-06,symptomatic
389,programmed cell death involved in cell development,GO:0010623,3.911523849725622,0.002494115488514138,symptomatic
902,T-helper 17 type immune response,GO:0072538,3.8873786407766993,0.010175482440236177,symptomatic
904,"CD4-positive, alpha-beta T cell lineage commitment",GO:0043373,3.8873786407766993,0.010204655268333184,symptomatic
1273,negative regulation of nucleotide catabolic process,GO:0030812,3.8873786407766993,0.010198807328351331,symptomatic
1272,negative regulation of purine nucleotide catabolic process,GO:0033122,3.8873786407766993,0.010251681329477578,symptomatic
1271,negative regulation of glycolytic process,GO:0045820,3.8873786407766993,0.010181303654446838,symptomatic
1261,positive regulation of vascular endothelial cell proliferation,GO:1905564,3.8873786407766993,0.010222239395734103,symptomatic
1240,positive regulation of gluconeogenesis,GO:0045722,3.8873786407766993,0.010257590079523385,symptomatic
1245,negative regulation of cell-matrix adhesion,GO:0001953,3.8873786407766993,7.501011363813906e-05,symptomatic
1252,cellular response to prostaglandin E stimulus,GO:0071380,3.8873786407766993,0.010239884227832608,symptomatic
1270,muscle cell apoptotic process,GO:0010657,3.8873786407766993,0.010187131532898153,symptomatic
1260,positive regulation by host of viral transcription,GO:0043923,3.8873786407766993,0.010228114245961536,symptomatic
1259,cellular response to gonadotropin stimulus,GO:0071371,3.8873786407766993,0.010233995852773474,symptomatic
1265,"positive regulation of DNA damage response, signal transduction by p53 class mediator",GO:0043517,3.8873786407766993,0.010216371290455266,symptomatic
1267,clathrin coat assembly,GO:0048268,3.8873786407766993,0.01021050991851582,symptomatic
1269,ectopic germ cell programmed cell death,GO:0035234,3.8873786407766993,0.010192966087040706,symptomatic
945,regulation of protein export from nucleus,GO:0046825,3.8873786407766993,7.49253564475875e-05,symptomatic
1249,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:1902165,3.8873786407766993,0.010245779382828482,symptomatic
932,regulation of nucleocytoplasmic transport,GO:0046822,3.877803816538333,1.0013594478589016e-14,symptomatic
1286,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,GO:1902230,3.8694644534920135,0.0003298489710219551,symptomatic
1289,liver regeneration,GO:0097421,3.8694644534920135,0.0003295293499260036,symptomatic
1293,positive regulation of vascular endothelial growth factor production,GO:0010575,3.8694644534920135,0.00032921034765114786,symptomatic
1237,positive regulation of cell cycle G2/M phase transition,GO:1902751,3.8694644534920135,0.00033016921274139395,symptomatic
1173,regulation of cell migration involved in sprouting angiogenesis,GO:0090049,3.844660194174757,4.304599701846855e-05,symptomatic
467,oligopeptide transmembrane transport,GO:0035672,3.844660194174757,0.04294718113722755,symptomatic
1324,spindle elongation,GO:0051231,3.844660194174757,0.04296594355799523,symptomatic
575,intestinal epithelial cell differentiation,GO:0060575,3.844660194174757,0.0014440387617338575,symptomatic
1312,negative regulation of epidermal growth factor-activated receptor activity,GO:0007175,3.844660194174757,0.043022329310696016,symptomatic
1329,regulation of DNA catabolic process,GO:1903624,3.844660194174757,0.04290970541197692,symptomatic
1328,negative regulation of transcription by competitive promoter binding,GO:0010944,3.844660194174757,0.042928435095701045,symptomatic
1322,cellular response to cold,GO:0070417,3.844660194174757,0.042984722379480374,symptomatic
1320,cellular response to electrical stimulus,GO:0071257,3.844660194174757,0.043003517623196805,symptomatic
1330,establishment of blood-brain barrier,GO:0060856,3.844660194174757,0.04289099206465377,symptomatic
1295,toll-like receptor 3 signaling pathway,GO:0034138,3.844660194174757,0.043041157463567216,symptomatic
641,positive regulation of amyloid precursor protein catabolic process,GO:1902993,3.844660194174757,0.0014452224000631475,symptomatic
1028,regulation of vascular associated smooth muscle cell proliferation,GO:1904705,3.8318446601941742,1.4542322165006118e-07,symptomatic
1217,response to fluid shear stress,GO:0034405,3.822044545973729,0.00018598137791502574,symptomatic
1331,positive regulation of sprouting angiogenesis,GO:1903672,3.808044382801665,0.005934229732333978,symptomatic
1011,positive regulation of membrane permeability,GO:1905710,3.791630398393037,0.0008082957624113696,symptomatic
490,regulation of cardiac muscle hypertrophy,GO:0010611,3.7721194357941017,1.717640635818675e-06,symptomatic
1345,response to L-glutamate,GO:1902065,3.7485436893203885,0.024420136722376383,symptomatic
1351,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,GO:0042771,3.7485436893203885,0.000460648166051329,symptomatic
1350,response to leucine,GO:0043201,3.7485436893203885,0.024384504227158908,symptomatic
1349,response to follicle-stimulating hormone,GO:0032354,3.7485436893203885,0.02439637016595558,symptomatic
1348,replicative senescence,GO:0090399,3.7485436893203885,0.02440824765873355,symptomatic
1337,negative regulation of glial cell proliferation,GO:0060253,3.7485436893203885,0.024455873507823765,symptomatic
1343,positive regulation of nitric-oxide synthase biosynthetic process,GO:0051770,3.7485436893203885,0.024432037373800543,symptomatic
1341,DNA methylation-dependent heterochromatin formation,GO:0006346,3.7485436893203885,0.024443949629955494,symptomatic
491,regulation of muscle hypertrophy,GO:0014743,3.7485436893203885,9.612114654255805e-07,symptomatic
1354,negative regulation of endoplasmic reticulum unfolded protein response,GO:1900102,3.7485436893203885,0.024372649825492813,symptomatic
1357,cardiac left ventricle morphogenesis,GO:0003214,3.7485436893203885,0.024360806944139318,symptomatic
625,positive regulation of microtubule polymerization,GO:0031116,3.7485436893203885,0.0004602196561294208,symptomatic
90,regulation of myeloid cell apoptotic process,GO:0033032,3.7485436893203885,0.000461077474686978,symptomatic
590,stem cell division,GO:0017145,3.748543689320388,0.0034251880302507637,symptomatic
1381,response to amyloid-beta,GO:1904645,3.748543689320388,7.658136063146264e-06,symptomatic
1362,positive regulation of release of cytochrome c from mitochondria,GO:0090200,3.748543689320388,0.0034276035366190647,symptomatic
1056,regulation of ncRNA transcription,GO:0140747,3.735922330097087,1.3987904467025242e-11,symptomatic
1366,cellular response to mechanical stimulus,GO:0071260,3.7318834951456314,7.881118492581375e-09,symptomatic
1367,protein destabilization,GO:0031648,3.724043403769275,4.265411074215769e-06,symptomatic
1369,uterus development,GO:0060065,3.7022653721682843,0.0019800736933139823,symptomatic
1174,regulation of blood vessel endothelial cell migration,GO:0043535,3.69421696918531,1.671771949417437e-10,symptomatic
1403,post-transcriptional gene silencing,GO:0016441,3.69421696918531,1.9238134619156467e-05,symptomatic
182,cytoplasmic sequestering of protein,GO:0051220,3.6827797649463463,0.013828690545484947,symptomatic
1378,response to hydroperoxide,GO:0033194,3.6827797649463463,0.013836117339548043,symptomatic
1382,cardiac right ventricle morphogenesis,GO:0003215,3.6827797649463463,0.013821271720085009,symptomatic
1380,cellular response to amyloid-beta,GO:1904646,3.6827797649463463,0.00014819838794324658,symptomatic
1370,NLS-bearing protein import into nucleus,GO:0006607,3.6827797649463463,0.013843552115120073,symptomatic
235,negative regulation of epithelial cell differentiation,GO:0030857,3.672042797701605,1.0649655417208824e-05,symptomatic
1383,positive regulation of signaling receptor activity,GO:2000273,3.6652427184466014,0.0011262385934373022,symptomatic
1353,intrinsic apoptotic signaling pathway in response to DNA damage,GO:0008630,3.647231697717135,2.769674878103602e-08,symptomatic
1250,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,GO:1902253,3.63495145631068,0.0006380284302606637,symptomatic
1065,positive regulation of heart growth,GO:0060421,3.63495145631068,0.0006386047883729136,symptomatic
1005,regulation of mitochondrial membrane permeability,GO:0046902,3.6349514563106795,3.328033857964227e-06,symptomatic
1285,negative regulation of ATP metabolic process,GO:1903579,3.6349514563106795,0.008084030495416478,symptomatic
428,regulation of bicellular tight junction assembly,GO:2000810,3.6349514563106795,0.00811357019272007,symptomatic
1558,microautophagy,GO:0016237,3.6349514563106795,0.008088938832086433,symptomatic
1391,peptidyl-threonine phosphorylation,GO:0018107,3.6349514563106795,3.3329715936585362e-06,symptomatic
311,positive regulation of epithelial to mesenchymal transition,GO:0010718,3.6349514563106795,3.3231107309554046e-06,symptomatic
1384,stimulatory C-type lectin receptor signaling pathway,GO:0002223,3.6349514563106795,0.008108631927234544,symptomatic
1365,regulation of release of cytochrome c from mitochondria,GO:0090199,3.6349514563106795,4.707742270632258e-05,symptomatic
1386,response to lectin,GO:1990840,3.6349514563106795,0.00809385313271346,symptomatic
1385,cellular response to lectin,GO:1990858,3.6349514563106795,0.008098773408174076,symptomatic
823,glomerulus vasculature development,GO:0072012,3.6349514563106795,0.008103699669371262,symptomatic
1471,semi-lunar valve development,GO:1905314,3.615616608138814,2.657660876160884e-05,symptomatic
940,regulation of protein import into nucleus,GO:0042306,3.6051567722425593,1.041952675689434e-06,symptomatic
1393,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043154,3.598601941747573,1.4828627572522164e-05,symptomatic
1397,positive regulation of cardiac muscle hypertrophy,GO:0010613,3.598601941747573,0.00462529257194722,symptomatic
1278,negative regulation of purine nucleotide metabolic process,GO:1900543,3.598601941747573,0.0046283843450568105,symptomatic
762,regulation of muscle cell apoptotic process,GO:0010660,3.598601941747573,3.8200864056293124e-08,symptomatic
1029,regulation of smooth muscle cell proliferation,GO:0048660,3.595725361458406,8.466250145553368e-15,symptomatic
597,regulation of stress-activated protein kinase signaling cascade,GO:0070302,3.5883495145631064,0.00020018524740131696,symptomatic
1007,regulation of membrane permeability,GO:0090559,3.580698449500072,3.1645433190358224e-07,symptomatic
906,T cell lineage commitment,GO:0002360,3.5700416088765605,0.0026726175749136735,symptomatic
1401,miRNA-mediated post-transcriptional gene silencing,GO:0035195,3.5700416088765605,0.0026647337472590605,symptomatic
838,positive regulation of chromosome segregation,GO:0051984,3.5700416088765605,0.0026706422478073068,symptomatic
1399,glandular epithelial cell development,GO:0002068,3.5700416088765605,0.0026667003404304696,symptomatic
173,positive regulation of monooxygenase activity,GO:0032770,3.5700416088765605,0.002668669838466238,symptomatic
1472,heart valve development,GO:0003170,3.56026067296183,9.549829985403664e-08,symptomatic
1404,positive regulation of viral genome replication,GO:0045070,3.547009082367679,0.0015307863239159166,symptomatic
1407,negative regulation of protein processing,GO:0010955,3.547009082367679,0.0015295488248666716,symptomatic
1421,negative regulation of muscle cell differentiation,GO:0051148,3.547009082367679,1.4305794291693157e-06,symptomatic
1392,peptidyl-threonine modification,GO:0018210,3.5370873786407766,7.938572032508836e-07,symptomatic
881,epithelial to mesenchymal transition,GO:0001837,3.5280411193603656,9.069264473100593e-09,symptomatic
1432,branch elongation of an epithelium,GO:0060602,3.528041119360365,0.03274494334828547,symptomatic
1429,mammary gland epithelial cell differentiation,GO:0060644,3.528041119360365,0.032760054074334514,symptomatic
1294,regulation of vascular endothelial growth factor production,GO:0010574,3.528041119360365,0.0008535454985656345,symptomatic
229,regulation of epithelial cell differentiation involved in kidney development,GO:2000696,3.528041119360365,0.032896680805877154,symptomatic
1426,positive regulation of nitric-oxide synthase activity,GO:0051000,3.528041119360365,0.03280547004578692,symptomatic
1422,positive regulation of membrane protein ectodomain proteolysis,GO:0051044,3.528041119360365,0.03282063669860513,symptomatic
1110,regulation of nucleobase-containing compound transport,GO:0032239,3.528041119360365,0.032851012114337295,symptomatic
1419,negative regulation of smooth muscle cell differentiation,GO:0051151,3.528041119360365,0.03283581738162946,symptomatic
1418,regulation of pigmentation,GO:0120305,3.528041119360365,0.032866220916242084,symptomatic
1415,response to vitamin A,GO:0033189,3.528041119360365,0.03288144380689342,symptomatic
1411,positive regulation of homotypic cell-cell adhesion,GO:0034112,3.528041119360365,0.032911931932815434,symptomatic
339,ganglion development,GO:0061548,3.528041119360365,0.032775178753039196,symptomatic
1428,myelin maintenance,GO:0043217,3.528041119360365,0.03279031740373344,symptomatic
1095,positive regulation of gliogenesis,GO:0014015,3.5197593326952004,2.4029542509716974e-07,symptomatic
962,positive regulation of mitotic cell cycle phase transition,GO:1901992,3.5151178918169212,2.8310536342952692e-09,symptomatic
942,positive regulation of protein localization to nucleus,GO:1900182,3.5037934140726654,8.627648280381529e-10,symptomatic
1462,positive regulation of smooth muscle cell migration,GO:0014911,3.498640776699029,0.0002733646190977281,symptomatic
1438,regulation of skeletal muscle cell differentiation,GO:2001014,3.498640776699029,0.01858643482741238,symptomatic
85,transport of virus,GO:0046794,3.498640776699029,0.01851995294504555,symptomatic
1449,nuclear-transcribed mRNA poly(A) tail shortening,GO:0000289,3.498640776699029,0.018538899188467593,symptomatic
1447,mitochondrion distribution,GO:0048311,3.498640776699029,0.01854838685437776,symptomatic
1445,response to salt stress,GO:0009651,3.498640776699029,0.018557884236279642,symptomatic
1442,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,GO:0002433,3.498640776699029,0.01859597122291131,symptomatic
1439,Fc-gamma receptor signaling pathway involved in phagocytosis,GO:0038096,3.498640776699029,0.01857690820781863,symptomatic
1443,negative regulation of release of cytochrome c from mitochondria,GO:0090201,3.498640776699029,0.018567391349105608,symptomatic
1436,Golgi to vacuole transport,GO:0006896,3.498640776699029,0.01860551740937071,symptomatic
332,regulation of triglyceride biosynthetic process,GO:0010866,3.498640776699029,0.018529421223647313,symptomatic
1495,aortic valve development,GO:0003176,3.487017385414315,0.0001542171679695779,symptomatic
1464,positive regulation of DNA replication,GO:0045740,3.487017385414315,0.00015454424573833629,symptomatic
640,regulation of amyloid precursor protein catabolic process,GO:1902991,3.487017385414315,0.00015438053361361347,symptomatic
952,regulation of signal transduction by p53 class mediator,GO:1901796,3.484884653068496,7.74757836974557e-11,symptomatic
1179,phosphatidylinositol phosphate biosynthetic process,GO:0046854,3.483495145631068,1.0822345782336139e-06,symptomatic
1033,extrinsic apoptotic signaling pathway,GO:0097191,3.4807905686546468,4.296330040721972e-11,symptomatic
1643,positive regulation of glial cell differentiation,GO:0045687,3.4769100886449977,8.61651533909437e-05,symptomatic
1522,negative regulation of membrane permeability,GO:1905709,3.4769100886449977,0.010572939741483737,symptomatic
1466,negative regulation of stem cell proliferation,GO:2000647,3.4769100886449977,0.010578936871229332,symptomatic
1467,atrial septum development,GO:0003283,3.4769100886449977,0.010566949407352587,symptomatic
1470,pulmonary valve development,GO:0003177,3.4769100886449977,0.010560965857291797,symptomatic
1473,epidermal growth factor receptor signaling pathway,GO:0007173,3.4680404200515156,4.847200209556434e-05,symptomatic
1276,negative regulation of nucleotide metabolic process,GO:0045980,3.460194174757281,0.006123208457460635,symptomatic
1475,negative regulation of glial cell differentiation,GO:0045686,3.460194174757281,0.006146594358634896,symptomatic
1476,negative regulation of fat cell differentiation,GO:0045599,3.460194174757281,2.7368990158404666e-05,symptomatic
1478,cellular response to gamma radiation,GO:0071480,3.460194174757281,0.006138779235483421,symptomatic
1480,atrioventricular valve morphogenesis,GO:0003181,3.460194174757281,0.006115452651941369,symptomatic
1427,regulation of nitric-oxide synthase activity,GO:0050999,3.460194174757281,0.0061348791216108145,symptomatic
1398,positive regulation of muscle hypertrophy,GO:0014742,3.460194174757281,0.006119328097221433,symptomatic
811,regulation of cardiocyte differentiation,GO:1905207,3.460194174757281,0.006127093742014861,symptomatic
1264,regulation of vascular endothelial cell proliferation,GO:1905562,3.460194174757281,0.00613098396026376,symptomatic
1519,positive regulation of muscle tissue development,GO:1901863,3.460194174757281,0.006142684311332965,symptomatic
1563,prostate gland morphogenesis,GO:0060512,3.460194174757281,0.006111582112288242,symptomatic
1484,Golgi to plasma membrane protein transport,GO:0043001,3.4469367258118515,0.003520531620114176,symptomatic
1483,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,GO:1902176,3.4469367258118515,0.0035230004361170614,symptomatic
1130,positive regulation of epithelial cell migration,GO:0010634,3.4423712467048158,1.7413919134809235e-14,symptomatic
1481,heart valve morphogenesis,GO:0003179,3.4412860098678975,4.668585673834809e-06,symptomatic
1226,cardiac muscle hypertrophy,GO:0003300,3.4361650485436894,0.0020309436551354454,symptomatic
1493,insulin-like growth factor receptor signaling pathway,GO:0048009,3.4361650485436894,0.0020325168105615765,symptomatic
1410,negative regulation of protein maturation,GO:1903318,3.4361650485436894,0.0020293729330510403,symptomatic
580,response to interleukin-6,GO:0070741,3.4361650485436894,0.0020340924049883683,symptomatic
595,regulation of stress-activated MAPK cascade,GO:0032872,3.4272399445214976,0.001153505828871535,symptomatic
1060,regulation of cardiac muscle cell proliferation,GO:0060043,3.4197240674501788,0.0006508570913834376,symptomatic
1494,aortic valve morphogenesis,GO:0003180,3.4197240674501788,0.000649686485103971,symptomatic
1047,regulation of ubiquitin-protein transferase activity,GO:0051438,3.4197240674501788,0.000650271261418196,symptomatic
1496,positive regulation of nitric oxide biosynthetic process,GO:0045429,3.413308074828321,0.0003620043616791223,symptomatic
1177,positive regulation of endothelial cell migration,GO:0010595,3.3949074922146916,6.54441973438454e-10,symptomatic
1500,cellular response to hydrogen peroxide,GO:0070301,3.3833009708737865,3.4986052499637496e-06,symptomatic
1446,response to osmotic stress,GO:0006970,3.378968959387392,1.086512656184457e-06,symptomatic
1117,mitotic cell cycle phase transition,GO:0044772,3.377997991295614,2.5952862904669667e-13,symptomatic
253,regulation of glial cell differentiation,GO:0045685,3.3753120665742022,3.277727378003048e-07,symptomatic
1540,cellular response to acid chemical,GO:0071229,3.3694774735464166,3.020969210917376e-08,symptomatic
1118,cell cycle phase transition,GO:0044770,3.3531276883372247,3.179222975862293e-14,symptomatic
1520,negative regulation of phagocytosis,GO:0050765,3.3320388349514567,0.024469383417940645,symptomatic
164,tongue development,GO:0043586,3.3320388349514567,0.024457347321817702,symptomatic
403,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,GO:1902175,3.3320388349514567,0.00047870472984637376,symptomatic
1161,negative regulation of B cell activation,GO:0050869,3.3320388349514567,0.00265567164816841,symptomatic
1530,mammary gland lobule development,GO:0061377,3.3320388349514567,0.024397344016317657,symptomatic
1516,positive regulation of skeletal muscle tissue development,GO:0048643,3.3320388349514567,0.024481431366447752,symptomatic
1497,positive regulation of nitric oxide metabolic process,GO:1904407,3.3320388349514567,0.0004782631203169952,symptomatic
1004,regulation of mitochondrial membrane permeability involved in apoptotic process,GO:1902108,3.3320388349514567,0.02449349118485487,symptomatic
1529,mammary gland alveolus development,GO:0060749,3.3320388349514567,0.024373425051595777,symptomatic
1507,cell migration involved in sprouting angiogenesis,GO:0002042,3.3320388349514567,0.024505562890712363,symptomatic
1521,negative regulation of mitochondrial membrane permeability,GO:0035795,3.3320388349514567,0.024445323060597535,symptomatic
1506,ER-nucleus signaling pathway,GO:0006984,3.3320388349514567,0.0026576417309934607,symptomatic
1528,miRNA metabolic process,GO:0010586,3.3320388349514567,0.024385378668590186,symptomatic
1527,intracellular estrogen receptor signaling pathway,GO:0030520,3.3320388349514567,0.024409321112054683,symptomatic
1523,cellular response to platelet-derived growth factor stimulus,GO:0036120,3.3320388349514567,0.024433310616833116,symptomatic
1227,striated muscle hypertrophy,GO:0014897,3.3320388349514567,0.002653704483984582,symptomatic
1525,response to hyperoxia,GO:0055093,3.3320388349514567,0.024421309973111684,symptomatic
661,response to X-ray,GO:0010165,3.3320388349514563,0.008069201067858823,symptomatic
1549,"alternative mRNA splicing, via spliceosome",GO:0000380,3.3320388349514563,0.013756503849810973,symptomatic
1219,regulation of amyloid-beta formation,GO:1902003,3.3320388349514563,0.001525075649031543,symptomatic
967,positive regulation of chromosome separation,GO:1905820,3.3320388349514563,0.0046073978862921725,symptomatic
1557,piecemeal microautophagy of the nucleus,GO:0034727,3.3320388349514563,0.042764284126126234,symptomatic
1313,negative regulation of signaling receptor activity,GO:2000272,3.3320388349514563,0.008064274815680643,symptomatic
1402,regulatory ncRNA-mediated post-transcriptional gene silencing,GO:0035194,3.3320388349514563,0.0015213650026835344,symptomatic
1420,regulation of smooth muscle cell differentiation,GO:0051150,3.3320388349514563,0.0015238367573588937,symptomatic
633,programmed necrotic cell death,GO:0097300,3.3320388349514563,0.008049532082928027,symptomatic
1559,nucleophagy,GO:0044804,3.3320388349514563,0.04280179665606144,symptomatic
1561,negative regulation of organ growth,GO:0046621,3.3320388349514563,0.004601221749715373,symptomatic
1555,negative regulation of steroid biosynthetic process,GO:0010894,3.3320388349514563,0.013749099918783089,symptomatic
626,positive regulation of microtubule polymerization or depolymerization,GO:0031112,3.3320388349514563,0.0015225998768740243,symptomatic
1545,positive regulation of myelination,GO:0031643,3.3320388349514563,0.042783032168268335,symptomatic
1767,positive regulation of ERBB signaling pathway,GO:1901186,3.3320388349514563,0.0046043077468647465,symptomatic
1547,amyloid fibril formation,GO:1990000,3.3320388349514563,0.008054440334198104,symptomatic
1541,"mitochondrial electron transport, cytochrome c to oxygen",GO:0006123,3.3320388349514563,0.013763915759212812,symptomatic
925,lung epithelium development,GO:0060428,3.3320388349514563,0.000849125629478209,symptomatic
1538,B cell homeostasis,GO:0001782,3.3320388349514563,0.004610492176343409,symptomatic
1784,glial cell migration,GO:0008347,3.3320388349514563,0.0001533540383132305,symptomatic
1537,negative regulation of cellular senescence,GO:2000773,3.3320388349514563,0.013771335659891632,symptomatic
1534,specification of animal organ identity,GO:0010092,3.3320388349514563,0.04282057761115405,symptomatic
1539,cellular response to amino acid stimulus,GO:0071230,3.3320388349514563,2.419631386932331e-07,symptomatic
1562,prostate gland epithelium morphogenesis,GO:0060740,3.3320388349514563,0.013741703953253888,symptomatic
857,apoptotic mitochondrial changes,GO:0008637,3.3320388349514563,1.514689268392987e-05,symptomatic
320,regulation of polysaccharide biosynthetic process,GO:0032885,3.3320388349514563,0.0015263165568013002,symptomatic
841,response to antibiotic,GO:0046677,3.3320388349514563,0.0008476641395823773,symptomatic
1517,regulation of skeletal muscle tissue development,GO:0048641,3.3320388349514563,0.00805935457479249,symptomatic
1232,striated muscle adaptation,GO:0014888,3.3320388349514563,0.004598139886520654,symptomatic
174,regulation of monooxygenase activity,GO:0032768,3.3320388349514563,0.0008483942551203465,symptomatic
1531,regulation of megakaryocyte differentiation,GO:0045652,3.3320388349514563,0.013778763564778305,symptomatic
1061,regulation of cardiac muscle tissue growth,GO:0055021,3.3320388349514563,4.8326721162403345e-05,symptomatic
933,positive regulation of intracellular protein transport,GO:0090316,3.2976879191272146,1.633225623274631e-08,symptomatic
1619,ventricular septum development,GO:0003281,3.2863944673493815,1.920253896472895e-06,symptomatic
480,"negative regulation of gene expression, epigenetic",GO:0045814,3.273064696279749,1.1384708861459287e-09,symptomatic
1692,cell cycle G2/M phase transition,GO:0044839,3.2714563106796115,6.334080897993293e-05,symptomatic
1579,cellular response to glucocorticoid stimulus,GO:0071385,3.2714563106796115,6.326741290927252e-05,symptomatic
452,positive regulation of protein binding,GO:0032092,3.2714563106796115,6.319418673692382e-05,symptomatic
805,canonical NF-kappaB signal transduction,GO:0007249,3.2640380424014266,0.0001978543155893485,symptomatic
1071,"DNA damage response, signal transduction by p53 class mediator",GO:0030330,3.254549559720027,0.0006320021042619151,symptomatic
176,positive regulation of oxidoreductase activity,GO:0051353,3.254549559720027,0.0006325745699360654,symptomatic
1565,phosphatidylinositol 3-kinase/protein kinase B signal transduction,GO:0043491,3.251748742542987,4.2482100273059747e-07,symptomatic
949,regulation of stem cell proliferation,GO:0072091,3.251748742542987,4.255422607997496e-07,symptomatic
1566,negative regulation of striated muscle cell differentiation,GO:0051154,3.2419837313041198,0.0019636310901896014,symptomatic
1287,negative regulation of intrinsic apoptotic signaling pathway,GO:2001243,3.239482200647249,4.886307530658323e-09,symptomatic
646,response to growth hormone,GO:0060416,3.2340376927470014,0.0034165174022151115,symptomatic
1022,miRNA processing,GO:0035196,3.2340376927470014,0.0034068594024915353,symptomatic
1567,protein export from nucleus,GO:0006611,3.2340376927470014,0.003414097772326857,symptomatic
1704,regulation of mesenchymal cell proliferation,GO:0010464,3.2340376927470014,0.0034044534283372333,symptomatic
953,negative regulation of signal transduction by p53 class mediator,GO:1901797,3.2340376927470014,0.0034116815672509005,symptomatic
1568,postreplication repair,GO:0006301,3.2340376927470014,0.00340926877972102,symptomatic
120,positive regulation of viral process,GO:0048524,3.2295145631067963,1.4593921685432807e-05,symptomatic
1570,transforming growth factor beta receptor signaling pathway,GO:0007179,3.227912621359223,5.1079408491683655e-08,symptomatic
1611,regulation of mitochondrial fission,GO:0090140,3.2245537112433444,0.005911078269448703,symptomatic
1574,placenta blood vessel development,GO:0060674,3.2245537112433444,0.005903519345830483,symptomatic
1266,positive regulation of signal transduction by p53 class mediator,GO:1901798,3.2245537112433444,0.005914864994797485,symptomatic
413,positive regulation of intrinsic apoptotic signaling pathway,GO:2001244,3.2245537112433444,2.6187534620635714e-05,symptomatic
1356,regulation of endoplasmic reticulum unfolded protein response,GO:1900101,3.2245537112433444,0.005907296389557821,symptomatic
1246,negative regulation of cell-substrate adhesion,GO:0010812,3.219088365970051,4.650666246624937e-05,symptomatic
1575,cellular response to dexamethasone stimulus,GO:0071549,3.2130374479889046,0.010250987282897755,symptomatic
1581,negative regulation of protein dephosphorylation,GO:0035308,3.2130374479889046,0.010245072114240573,symptomatic
1583,positive regulation of translational initiation,GO:0045948,3.2130374479889046,0.010239163768153928,symptomatic
1058,regulation of stem cell differentiation,GO:2000736,3.2086299892125134,1.0186181586801356e-06,symptomatic
1096,regulation of gliogenesis,GO:0014013,3.206301520424986,1.1490134918137446e-08,symptomatic
526,modulation by host of viral genome replication,GO:0044827,3.1987572815533984,0.017712447610511686,symptomatic
1589,"establishment of mitochondrion localization, microtubule-mediated",GO:0034643,3.1987572815533984,0.017675945915281367,symptomatic
1588,mitochondrion transport along microtubule,GO:0047497,3.1987572815533984,0.01768505722760883,symptomatic
1585,Rac protein signal transduction,GO:0016601,3.1987572815533984,0.01770330806066106,symptomatic
1587,regulation of cell fate specification,GO:0042659,3.1987572815533984,0.017694177937886094,symptomatic
1591,ventricular cardiac muscle tissue morphogenesis,GO:0055010,3.1902499483577773,0.00045836956443035773,symptomatic
713,regulation of phosphoprotein phosphatase activity,GO:0043666,3.1902499483577773,0.0004587975472169407,symptomatic
1601,insulin receptor signaling pathway,GO:0008286,3.1871675812579148,1.0498559935793173e-05,symptomatic
1633,regulation of fibroblast proliferation,GO:0048145,3.1855755894590847,2.230482706007916e-07,symptomatic
1440,Fc receptor mediated stimulatory signaling pathway,GO:0002431,3.1805825242718444,0.031084869228868335,symptomatic
1612,positive regulation of G1/S transition of mitotic cell cycle,GO:1900087,3.1805825242718444,0.0008063928977414698,symptomatic
1607,"negative regulation of DNA-templated transcription, elongation",GO:0032785,3.1805825242718444,0.03105592614764965,symptomatic
1610,positive regulation of mitochondrial fission,GO:0090141,3.1805825242718444,0.031041474809284063,symptomatic
1296,endolysosomal toll-like receptor signaling pathway,GO:0140894,3.1805825242718444,0.031099361009394616,symptomatic
1604,regulation of superoxide anion generation,GO:0032928,3.1805825242718444,0.031070390947904727,symptomatic
1609,negative regulation of reactive oxygen species metabolic process,GO:2000378,3.1805825242718444,0.0008070922844697798,symptomatic
513,negative regulation of translation,GO:0017148,3.1770602844885976,3.12519688399453e-10,symptomatic
1615,regulation of cell-substrate junction assembly,GO:0090109,3.173370319001387,3.358461106340135e-05,symptomatic
542,intracellular steroid hormone receptor signaling pathway,GO:0030518,3.173370319001387,3.354340295166712e-05,symptomatic
1614,regulation of focal adhesion assembly,GO:0051893,3.173370319001387,3.362592054810418e-05,symptomatic
1394,regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043281,3.169500355197727,7.126902859922424e-13,symptomatic
1617,ventricular septum morphogenesis,GO:0060412,3.169500355197727,0.0014448710960355006,symptomatic
1710,regulation of striated muscle cell apoptotic process,GO:0010662,3.169500355197727,0.0014436896805849401,symptomatic
1283,regulation of carbohydrate catabolic process,GO:0043470,3.1654368932038834,6.0055174268134774e-05,symptomatic
487,regulation of muscle adaptation,GO:0043502,3.1633280078653065,2.3819061013579506e-06,symptomatic
1505,response to hydrogen peroxide,GO:0042542,3.162036853576382,8.761504546742618e-08,symptomatic
1288,negative regulation of apoptotic signaling pathway,GO:2001234,3.161165048543689,3.6200385893582596e-18,symptomatic
1352,intrinsic apoptotic signaling pathway by p53 class mediator,GO:0072332,3.1566683699540112,0.0001065532216280454,symptomatic
1622,negative regulation of insulin receptor signaling pathway,GO:0046627,3.156668369954011,0.0025073047525271766,symptomatic
1620,cellular response to estradiol stimulus,GO:0071392,3.156668369954011,0.002509178672372115,symptomatic
479,heterochromatin organization,GO:0070828,3.1519286276567833,1.081899664922385e-08,symptomatic
963,positive regulation of cell cycle phase transition,GO:1901989,3.1519286276567833,1.084158328105939e-08,symptomatic
1085,negative regulation of G1/S transition of mitotic cell cycle,GO:2000134,3.149461364543157,7.626508636023284e-06,symptomatic
383,vasculogenesis,GO:0001570,3.149461364543157,7.637175081668071e-06,symptomatic
458,post-embryonic development,GO:0009791,3.1448456419766555,5.270789674959967e-07,symptomatic
1632,negative regulation of fibroblast proliferation,GO:0048147,3.1416366158113727,0.0043715830906743,symptomatic
1228,muscle hypertrophy,GO:0014896,3.1416366158113727,0.004368599074912747,symptomatic
1358,cardiac ventricle morphogenesis,GO:0003208,3.1416366158113727,1.3669118518679685e-05,symptomatic
1626,negative regulation of blood vessel endothelial cell migration,GO:0043537,3.1416366158113727,0.004374571185746531,symptomatic
1274,regulation of nucleotide catabolic process,GO:0030811,3.136036550542547,0.0003308301063044795,symptomatic
1479,response to gamma radiation,GO:0010332,3.136036550542547,0.0003305120004330329,symptomatic
888,endocardial cushion development,GO:0003197,3.136036550542547,0.0003301945057159983,symptomatic
1281,regulation of glycolytic process,GO:0006110,3.136036550542547,0.00033114882509668035,symptomatic
1280,regulation of purine nucleotide catabolic process,GO:0033121,3.136036550542547,0.00033146815858279096,symptomatic
404,regulation of intrinsic apoptotic signaling pathway,GO:2001242,3.1306518723994454,8.008336792274035e-14,symptomatic
1634,DNA methylation,GO:0006306,3.1237864077669903,0.007591347400538846,symptomatic
1400,glandular epithelial cell differentiation,GO:0002067,3.1237864077669903,4.3536241268627836e-05,symptomatic
1635,DNA alkylation,GO:0006305,3.1237864077669903,0.007586641047531692,symptomatic
1086,negative regulation of cell cycle G1/S phase transition,GO:1902807,3.12378640776699,3.067118919584377e-06,symptomatic
955,neuron apoptotic process,GO:0051402,3.1180546895876016,2.5048344091979716e-08,symptomatic
446,columnar/cuboidal epithelial cell differentiation,GO:0002065,3.1180546895876016,2.5097651855940305e-08,symptomatic
1740,outflow tract morphogenesis,GO:0003151,3.1156726768377254,5.454162591716885e-06,symptomatic
1571,cellular response to transforming growth factor beta stimulus,GO:0071560,3.1156726768377254,1.3563996467219234e-11,symptomatic
115,cellular response to decreased oxygen levels,GO:0036294,3.114731954411144,2.0939670167113198e-10,symptomatic
964,positive regulation of mitotic cell cycle,GO:0045931,3.113544485118574,3.1402822779382164e-09,symptomatic
100,intrinsic apoptotic signaling pathway,GO:0097193,3.112563223068426,1.5707875320386499e-12,symptomatic
970,positive regulation of mitotic nuclear division,GO:0045840,3.1099029126213593,0.001033126763126049,symptomatic
1066,positive regulation of organ growth,GO:0046622,3.1099029126213593,0.0010348689667738164,symptomatic
1637,macrophage differentiation,GO:0030225,3.1099029126213593,0.0010339971310815048,symptomatic
462,regulation of epithelial cell apoptotic process,GO:1904035,3.1055895937411635,8.143654998875325e-08,symptomatic
1572,response to transforming growth factor beta,GO:0071559,3.104384007718749,5.266133903366342e-12,symptomatic
1645,regulation of axon regeneration,GO:0048679,3.1022430532306666,0.01283257927915672,symptomatic
736,cytokine production,GO:0001816,3.1022430532306666,0.012860690077139539,symptomatic
1482,atrioventricular valve development,GO:0003171,3.1022430532306666,0.01282557077053894,symptomatic
1638,salivary gland morphogenesis,GO:0007435,3.1022430532306666,0.012867737030606466,symptomatic
1642,positive regulation of oligodendrocyte differentiation,GO:0048714,3.1022430532306666,0.012839595451534609,symptomatic
1641,regulation of protein deacetylation,GO:0090311,3.1022430532306666,0.01284661930024989,symptomatic
1640,regulation of platelet aggregation,GO:0090330,3.1022430532306666,0.012853650837907389,symptomatic
1799,negative regulation of extrinsic apoptotic signaling pathway,GO:2001237,3.0915824241817633,2.691765697256928e-07,symptomatic
1651,positive regulation of fibroblast proliferation,GO:0048146,3.0897087378640777,0.00023937567059324763,symptomatic
1041,positive regulation of protein ubiquitination,GO:0031398,3.0897087378640777,3.222972041888695e-08,symptomatic
1616,regulation of cell-substrate junction organization,GO:0150116,3.0870359794403197,3.1401858982470595e-05,symptomatic
1346,response to amino acid,GO:0043200,3.082135922330097,7.168729539024521e-09,symptomatic
1666,motor neuron axon guidance,GO:0008045,3.0757281553398057,0.022464402776387744,symptomatic
1624,negative regulation of cellular response to insulin stimulus,GO:1900077,3.0757281553398057,0.0031807026281603255,symptomatic
1656,positive regulation of response to endoplasmic reticulum stress,GO:1905898,3.0757281553398057,0.003182997507401422,symptomatic
1657,negative regulation of receptor signaling pathway via STAT,GO:1904893,3.0757281553398057,0.02252028437533398,symptomatic
1659,regulation of long-term neuronal synaptic plasticity,GO:0048169,3.0757281553398057,0.022509085825172203,symptomatic
1662,secondary palate development,GO:0062009,3.0757281553398057,0.02249789840677003,symptomatic
1255,response to prostaglandin E,GO:0034695,3.0757281553398057,0.022475556898918225,symptomatic
1335,positive regulation of vasculature development,GO:1904018,3.0757281553398057,2.6450043083339087e-12,symptomatic
1664,regulation of cardiac muscle contraction by calcium ion signaling,GO:0010882,3.0757281553398057,0.022486722103537655,symptomatic
1580,cellular response to corticosteroid stimulus,GO:0071384,3.0757281553398057,5.5469687424553316e-05,symptomatic
1652,endoplasmic reticulum calcium ion homeostasis,GO:0032469,3.0757281553398057,0.022531494073878198,symptomatic
317,negative regulation of carbohydrate metabolic process,GO:0045912,3.063326025681177,9.814328306850444e-05,symptomatic
795,regulation of cell adhesion mediated by integrin,GO:0033628,3.0600356647513376,0.000748473647233218,symptomatic
758,digestive tract morphogenesis,GO:0048546,3.0600356647513376,0.0007478147795860057,symptomatic
1412,regulation of homotypic cell-cell adhesion,GO:0034110,3.054368932038835,0.005420300818530845,symptomatic
1230,muscle adaptation,GO:0043500,3.054368932038835,0.005416801592695771,symptomatic
1468,cardiac septum development,GO:0003279,3.0543689320388347,7.467367308651636e-08,symptomatic
108,cellular response to hypoxia,GO:0071456,3.0522493144593494,2.0599525238479666e-09,symptomatic
158,regulation of lymphocyte apoptotic process,GO:0070228,3.0496626624979433,0.0001724951385737786,symptomatic
1592,ventricular cardiac muscle tissue development,GO:0003229,3.0496626624979433,0.00017231620170803818,symptomatic
1980,cytoplasmic translation,GO:0002181,3.045691747572816,3.6947636510267856e-09,symptomatic
1257,cellular response to prostaglandin stimulus,GO:0071379,3.042296327564373,0.03909682251288079,symptomatic
1128,regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902041,3.042296327564373,0.0013216322650749647,symptomatic
1671,negative regulation of vascular associated smooth muscle cell proliferation,GO:1904706,3.042296327564373,0.039044623817937024,symptomatic
1123,regulation of cellular senescence,GO:2000772,3.042296327564373,0.0013227227207392178,symptomatic
1670,relaxation of muscle,GO:0090075,3.042296327564373,0.03906200788909372,symptomatic
1674,embryonic hemopoiesis,GO:0035162,3.042296327564373,0.03899256431951311,symptomatic
1667,hyperosmotic response,GO:0006972,3.042296327564373,0.03911425310695697,symptomatic
1668,positive regulation of embryonic development,GO:0040019,3.042296327564373,0.039079407447173496,symptomatic
1800,regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001239,3.042296327564373,0.001323814977321166,symptomatic
1673,phosphatidylinositol-mediated signaling,GO:0048015,3.042296327564373,0.039009902053759225,symptomatic
1524,response to platelet-derived growth factor,GO:0036119,3.042296327564373,0.03902725521303581,symptomatic
1675,rhythmic behavior,GO:0007622,3.042296327564373,0.03897524198973989,symptomatic
1074,signal transduction by p53 class mediator,GO:0072331,3.042296327564373,1.1290992965044542e-06,symptomatic
714,regulation of protein dephosphorylation,GO:0035304,3.0367948875506943,9.052668157355496e-06,symptomatic
886,mesenchyme morphogenesis,GO:0072132,3.0345353675450766,0.0003054913210886327,symptomatic
1677,neuroblast proliferation,GO:0007405,3.0345353675450766,0.00030579082238381763,symptomatic
1063,regulation of organ growth,GO:0046620,3.032529726191775,2.0259161530232807e-06,symptomatic
1197,negative regulation of protein serine/threonine kinase activity,GO:0071901,3.032529726191775,2.0290668779891026e-06,symptomatic
1248,regulation of cell-matrix adhesion,GO:0001952,3.031609103931243,1.1800459680660331e-08,symptomatic
116,cellular response to oxygen levels,GO:0071453,3.0310804885687443,6.839835538256348e-11,symptomatic
445,neuroepithelial cell differentiation,GO:0060563,3.029126213592233,0.009264729130384045,symptomatic
1590,establishment of mitochondrion localization,GO:0051654,3.029126213592233,0.009280851048824387,symptomatic
1681,regulation of mitophagy,GO:1901524,3.029126213592233,0.009275470845317824,symptomatic
1508,blood vessel endothelial cell migration,GO:0043534,3.029126213592233,0.009270096876114279,symptomatic
1680,non-canonical NF-kappaB signal transduction,GO:0038061,3.029126213592233,0.009286237497488824,symptomatic
514,negative regulation of amide metabolic process,GO:0034249,3.0251405212059272,1.2409361991018553e-10,symptomatic
1444,negative regulation of mitochondrion organization,GO:0010823,3.017695548635281,0.000535244909472716,symptomatic
1396,negative regulation of cysteine-type endopeptidase activity,GO:2000117,3.0147018030513175,0.00012494245574879998,symptomatic
1685,activation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0006919,3.012528261736933,2.8546246241252436e-05,symptomatic
1332,positive regulation of angiogenesis,GO:0045766,3.0108784653175804,1.8766992218969887e-11,symptomatic
779,positive regulation of amide metabolic process,GO:0034250,3.0108784653175804,1.871352500467083e-11,symptomatic
1688,thymus development,GO:0048538,2.998834951456311,0.0009372631941460813,symptomatic
941,regulation of protein localization to nucleus,GO:1900180,2.998834951456311,2.871911296107482e-10,symptomatic
1691,G2/M transition of mitotic cell cycle,GO:0000086,2.998834951456311,0.000936466878772975,symptomatic
1694,branching involved in blood vessel morphogenesis,GO:0001569,2.9988349514563106,0.016099882186603545,symptomatic
1693,positive regulation of extracellular matrix organization,GO:1903055,2.9988349514563106,0.01610835580880702,symptomatic
1499,regulation of nitric oxide biosynthetic process,GO:0045428,2.9988349514563106,0.0002172274033125644,symptomatic
1696,negative regulation of autophagy,GO:0010507,2.9988349514563106,2.5685309554348085e-06,symptomatic
1618,cardiac septum morphogenesis,GO:0060411,2.9988349514563106,5.034063084332437e-05,symptomatic
885,endocardial cushion morphogenesis,GO:0003203,2.9988349514563106,0.003984616781464501,symptomatic
1751,positive regulation of axonogenesis,GO:0050772,2.9988349514563106,1.1382986349657975e-05,symptomatic
1062,regulation of heart growth,GO:0060420,2.9988349514563106,0.00021744682493207205,symptomatic
1605,regulation of superoxide metabolic process,GO:0090322,2.9988349514563106,0.016091417474623206,symptomatic
1501,cellular response to reactive oxygen species,GO:0034614,2.9988349514563106,5.935942653688637e-09,symptomatic
1746,regulation of osteoblast differentiation,GO:0045667,2.9988349514563106,5.948735633545724e-09,symptomatic
778,positive regulation of translation,GO:0045727,2.9915385160513073,2.3804400553039405e-09,symptomatic
1088,regulation of G1/S transition of mitotic cell cycle,GO:2000045,2.986644565474781,4.333176785247327e-11,symptomatic
1697,epithelial cell apoptotic process,GO:1904019,2.981297904956566,0.0003823204474692565,symptomatic
1644,regulation of oligodendrocyte differentiation,GO:0048713,2.9775666184672587,0.0016678448465812352,symptomatic
1700,platelet-derived growth factor receptor signaling pathway,GO:0048008,2.97181842036211,0.006820664614414976,symptomatic
1698,protein localization to chromatin,GO:0071168,2.97181842036211,0.006824946262007202,symptomatic
1701,positive regulation of epithelial cell apoptotic process,GO:1904037,2.97181842036211,0.006816388335659857,symptomatic
1469,cardiac atrium development,GO:0003230,2.97181842036211,0.006812117415650045,symptomatic
1131,regulation of epithelial cell migration,GO:0010632,2.968279136812651,3.7906124413349095e-15,symptomatic
1702,T cell differentiation in thymus,GO:0033077,2.967597087378641,0.0001563923967808523,symptomatic
1708,positive regulation of cytokine production involved in inflammatory response,GO:1900017,2.9618122977346277,0.027876300207038806,symptomatic
1703,positive regulation of mesenchymal cell proliferation,GO:0002053,2.9618122977346277,0.02791602890092057,symptomatic
1705,negative regulation of peptidyl-serine phosphorylation,GO:0033137,2.9618122977346277,0.027902773426608643,symptomatic
769,regulation of morphogenesis of a branching structure,GO:0060688,2.9618122977346277,0.0006769264842013367,symptomatic
1707,regulation of vascular associated smooth muscle cell migration,GO:1904752,2.9618122977346277,0.0278895305346169,symptomatic
1712,regulation of necroptotic process,GO:0060544,2.9618122977346277,0.027849877173667204,symptomatic
1709,negative regulation of striated muscle cell apoptotic process,GO:0010664,2.9618122977346277,0.027863082426001804,symptomatic
1714,positive regulation of DNA biosynthetic process,GO:2000573,2.956597839463968,6.322132777499262e-05,symptomatic
810,regulation of muscle cell differentiation,GO:0051147,2.956597839463968,2.1362915984331176e-09,symptomatic
1686,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,GO:0043280,2.955373575348248,1.0982413523873047e-07,symptomatic
1716,cellular response to osmotic stress,GO:0071470,2.953398058252427,0.0028642182189844508,symptomatic
1026,regulatory ncRNA-mediated gene silencing,GO:0031047,2.95123439667129,5.089508608184572e-07,symptomatic
716,regulation of phosphatase activity,GO:0010921,2.949673722743912,0.0002732199294993897,symptomatic
463,negative regulation of epithelial cell apoptotic process,GO:1904036,2.949673722743912,0.00027295074730283853,symptomatic
1090,mitotic DNA damage checkpoint signaling,GO:0044773,2.940034266133638,1.0228869779926438e-05,symptomatic
1717,negative regulation of osteoclast differentiation,GO:0045671,2.9400342661336376,0.011495995745800812,symptomatic
1625,regulation of cellular response to insulin stimulus,GO:1900076,2.9400342661336376,0.00011152300389325072,symptomatic
72,apoptotic process involved in development,GO:1902742,2.9400342661336376,0.0115023966343007,symptomatic
1582,negative regulation of dephosphorylation,GO:0035305,2.9400342661336376,0.011483215316956119,symptomatic
1292,animal organ regeneration,GO:0031100,2.9400342661336376,0.00011164515395227948,symptomatic
1291,hepaticobiliary system development,GO:0061008,2.9400342661336376,6.77312308026452e-09,symptomatic
1733,nucleus localization,GO:0051647,2.9400342661336376,0.011489601977310377,symptomatic
1290,liver development,GO:0001889,2.931192057814439,1.2066331307431774e-08,symptomatic
1726,protein monoubiquitination,GO:0006513,2.9256926355671324,0.004887932536687259,symptomatic
1731,response to progesterone,GO:0032570,2.9256926355671324,0.004884695495272234,symptomatic
1725,myoblast differentiation,GO:0045445,2.9256926355671324,0.004891173871260659,symptomatic
1474,ERBB signaling pathway,GO:0038127,2.9219417475728156,0.0001936801425814758,symptomatic
642,positive regulation of endopeptidase activity,GO:0010950,2.9209431345353676,7.452993873556198e-10,symptomatic
411,regulation of neuron apoptotic process,GO:0043523,2.9206760158216474,2.0936086007899436e-15,symptomatic
93,regulation of leukocyte apoptotic process,GO:2000106,2.9202138104068944,7.262612997206778e-06,symptomatic
1363,positive regulation of mitochondrion organization,GO:0010822,2.9155339805825244,7.880840572070175e-05,symptomatic
1175,regulation of endothelial cell migration,GO:0010594,2.9155339805825244,1.127311214433544e-10,symptomatic
1738,protein deacylation,GO:0035601,2.915533980582524,0.04889554077255485,symptomatic
372,negative regulation of lipid localization,GO:1905953,2.915533980582524,0.002052326975863059,symptomatic
1732,nuclear migration,GO:0007097,2.915533980582524,0.04898006201848839,symptomatic
1734,"protein localization to chromosome, centromeric region",GO:0071459,2.915533980582524,0.04893776490102856,symptomatic
1735,cellular response to nerve growth factor stimulus,GO:1990090,2.915533980582524,0.0020507458302730258,symptomatic
371,negative regulation of organic acid transport,GO:0032891,2.915533980582524,0.048958904324311936,symptomatic
1737,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,GO:1901028,2.915533980582524,0.0489166437249815,symptomatic
556,pyrimidine nucleoside triphosphate metabolic process,GO:0009147,2.915533980582524,0.04887445602017341,symptomatic
1140,cell differentiation involved in embryonic placenta development,GO:0060706,2.915533980582524,0.04885338944430265,symptomatic
1739,outflow tract septum morphogenesis,GO:0003148,2.915533980582524,0.04883234102144857,symptomatic
1158,post-Golgi vesicle-mediated transport,GO:0006892,2.915533980582524,2.884259345901398e-06,symptomatic
1347,response to acid chemical,GO:0001101,2.909317490218809,1.511311729024035e-08,symptomatic
1043,positive regulation of post-translational protein modification,GO:1901875,2.909317490218809,1.5143835008309946e-08,symptomatic
833,regulation of mitotic sister chromatid segregation,GO:0033047,2.9079611650485435,0.0008360340071298048,symptomatic
1584,regulation of translational initiation,GO:0006446,2.905847821178596,1.2816686113743191e-05,symptomatic
1743,cellular response to interleukin-4,GO:0071353,2.90209834011901,0.02005569962949699,symptomatic
1934,regulation of substrate adhesion-dependent cell spreading,GO:1900024,2.90209834011901,0.0003389155324909065,symptomatic
1741,positive regulation of G protein-coupled receptor signaling pathway,GO:0045745,2.90209834011901,0.02006592691130703,symptomatic
1498,regulation of nitric oxide metabolic process,GO:0080164,2.90209834011901,0.0003385915214655806,symptomatic
309,regulation of epithelial to mesenchymal transition,GO:0010717,2.8988737864077674,2.04639213568427e-06,symptomatic
1745,positive regulation of osteoblast differentiation,GO:0045669,2.8974250738708314,0.00013904273179275704,symptomatic
1564,gland morphogenesis,GO:0022612,2.896071136920425,8.089753281874644e-07,symptomatic
1756,regulation of cardiac muscle cell apoptotic process,GO:0010665,2.8936126724578433,0.008303783280843637,symptomatic
1747,positive regulation of axon extension,GO:0045773,2.8936126724578433,0.008318655728510819,symptomatic
612,protein acetylation,GO:0006473,2.8936126724578433,0.008313692330104787,symptomatic
1754,glial cell activation,GO:0061900,2.8936126724578433,0.008308734851076699,symptomatic
891,"CD4-positive, alpha-beta T cell differentiation involved in immune response",GO:0002294,2.8877669902912624,0.003515712780797002,symptomatic
890,T-helper cell differentiation,GO:0042093,2.8877669902912624,0.003510774981947568,symptomatic
1711,negative regulation of muscle cell apoptotic process,GO:0010656,2.8877669902912624,0.003513242146376203,symptomatic
410,regulation of apoptotic signaling pathway,GO:2001233,2.886017888540631,1.9025954709546702e-23,symptomatic
1757,cellular response to leukemia inhibitory factor,GO:1990830,2.8854769292363125,3.5846052183256414e-06,symptomatic
1602,cellular response to insulin stimulus,GO:0032869,2.884785300058643,3.005589681171943e-09,symptomatic
1759,regulation of endothelial cell apoptotic process,GO:2000351,2.8834951456310676,0.0014755569955020363,symptomatic
550,cellular response to steroid hormone stimulus,GO:0071383,2.8834951456310676,1.1779886219996757e-09,symptomatic
1126,positive regulation of extrinsic apoptotic signaling pathway,GO:2001238,2.8834951456310676,0.0014767605493319726,symptomatic
608,cellular response to growth factor stimulus,GO:0071363,2.883090444557997,2.838398888641965e-29,symptomatic
1463,regulation of smooth muscle cell migration,GO:0014910,2.8776699029126216,0.0002417446400291863,symptomatic
1760,negative regulation of transforming growth factor beta receptor signaling pathway,GO:0030512,2.871224953522,6.39167297800201e-06,symptomatic
101,apoptotic signaling pathway,GO:0097190,2.8695476401947873,3.4047204341761186e-19,symptomatic
473,epigenetic regulation of gene expression,GO:0040029,2.8634708737864076,1.3103235109902228e-11,symptomatic
1776,positive regulation of protein tyrosine kinase activity,GO:0061098,2.8560332871012486,0.034401214270561524,symptomatic
1338,negative regulation of gliogenesis,GO:0014014,2.8560332871012486,0.0059925754301502,symptomatic
1867,endoderm development,GO:0007492,2.8560332871012486,2.827370753534005e-05,symptomatic
1526,response to increased oxygen levels,GO:0036296,2.8560332871012486,0.0344485119987062,symptomatic
1772,cellular response to UV,GO:0034644,2.8560332871012486,1.125140218086303e-05,symptomatic
727,response to gonadotropin,GO:0034698,2.8560332871012486,0.034432731645065016,symptomatic
1423,regulation of membrane protein ectodomain proteolysis,GO:0051043,2.8560332871012486,0.03446430682309808,symptomatic
279,vesicle transport along microtubule,GO:0047496,2.8560332871012486,0.005988756070411418,symptomatic
1783,telencephalon glial cell migration,GO:0022030,2.8560332871012486,0.0345117783200996,symptomatic
1718,negative regulation of myeloid leukocyte differentiation,GO:0002762,2.8560332871012486,0.001035000569243404,symptomatic
1556,negative regulation of steroid metabolic process,GO:0045939,2.8560332871012486,0.03441696574229713,symptomatic
1771,neurotrophin signaling pathway,GO:0038179,2.8560332871012486,0.034480116138154555,symptomatic
1778,cerebral cortex radial glia-guided migration,GO:0021801,2.8560332871012486,0.034385477210053486,symptomatic
1770,cell fate determination,GO:0001709,2.8560332871012486,0.005996399664630194,symptomatic
1768,response to iron ion,GO:0010039,2.8560332871012486,0.034495939963826036,symptomatic
1766,positive regulation of epidermal growth factor receptor signaling pathway,GO:0045742,2.8560332871012486,0.03452763122699905,symptomatic
375,coronary vasculature development,GO:0060976,2.856033287101248,0.002523702151254197,symptomatic
1042,positive regulation of protein modification by small protein conjugation or removal,GO:1903322,2.856033287101248,4.208575865404847e-08,symptomatic
504,lymphocyte homeostasis,GO:0002260,2.856033287101248,0.0001717324311498229,symptomatic
1603,response to insulin,GO:0032868,2.856033287101248,5.229380435864592e-13,symptomatic
1755,neuroinflammatory response,GO:0150076,2.856033287101248,0.00252558410662426,symptomatic
1786,ephrin receptor signaling pathway,GO:0048013,2.856033287101248,0.002527468870882935,symptomatic
609,response to growth factor,GO:0070848,2.844744617982271,3.9796407329656255e-30,symptomatic
543,intracellular receptor signaling pathway,GO:0030522,2.8410015329586105,2.9625254410511164e-11,symptomatic
1127,regulation of extrinsic apoptotic signaling pathway,GO:2001236,2.8376072658941434,3.283509876110797e-09,symptomatic
1787,negative regulation of neuron differentiation,GO:0045665,2.8367357648911047,0.0001226513879270101,symptomatic
81,osteoblast differentiation,GO:0001649,2.83577773187358,2.0685197832461833e-08,symptomatic
1395,regulation of cysteine-type endopeptidase activity,GO:2000116,2.83395055549995,2.043032808258125e-11,symptomatic
1758,response to leukemia inhibitory factor,GO:1990823,2.827184466019417,5.548332181751512e-06,symptomatic
1087,regulation of cell cycle G1/S phase transition,GO:1902806,2.8261271793829104,3.6718877418700785e-11,symptomatic
898,alpha-beta T cell activation involved in immune response,GO:0002287,2.8249894470240604,0.004340576696194376,symptomatic
1788,cellular response to glucose starvation,GO:0042149,2.8249894470240604,0.004337605733363305,symptomatic
892,alpha-beta T cell differentiation involved in immune response,GO:0002293,2.8249894470240604,0.004343551731626997,symptomatic
1502,response to reactive oxygen species,GO:0000302,2.8237617245351325,2.442158444497987e-10,symptomatic
1573,transforming growth factor beta receptor superfamily signaling pathway,GO:0141091,2.8224328954882925,6.34905569164567e-10,symptomatic
809,regulation of striated muscle cell differentiation,GO:0051153,2.8224328954882925,3.4731908588132516e-05,symptomatic
1791,chaperone cofactor-dependent protein refolding,GO:0051085,2.8114077669902913,0.02440563661503876,symptomatic
1794,negative regulation of DNA binding,GO:0043392,2.8114077669902913,0.024393719800285325,symptomatic
1646,regulation of neuron projection regeneration,GO:0070570,2.8114077669902913,0.024417565078682476,symptomatic
1639,salivary gland development,GO:0007431,2.8114077669902913,0.02445342053401094,symptomatic
1713,regulation of programmed necrotic cell death,GO:0062098,2.8114077669902913,0.02438181461736669,symptomatic
1789,neural tube patterning,GO:0021532,2.8114077669902913,0.024441457021029525,symptomatic
365,regulation of fatty acid transport,GO:2000191,2.8114077669902913,0.024429505208305304,symptomatic
1093,mitotic DNA integrity checkpoint signaling,GO:0044774,2.8078978946220134,2.4861445392816505e-05,symptomatic
414,positive regulation of apoptotic signaling pathway,GO:2001235,2.804665781937557,4.536606977586889e-08,symptomatic
1098,positive regulation of neurogenesis,GO:0050769,2.803788775751835,5.149093979080626e-14,symptomatic
715,regulation of dephosphorylation,GO:0035303,2.8026494873423466,2.7582654937677045e-06,symptomatic
1477,regulation of fat cell differentiation,GO:0045598,2.801941747572816,1.1676867567295932e-07,symptomatic
1797,response to nicotine,GO:0035094,2.7989126213592237,0.003100260114252448,symptomatic
1316,regulation of protein tyrosine kinase activity,GO:0061097,2.7989126213592237,0.003098013548952265,symptomatic
1736,response to nerve growth factor,GO:1990089,2.7989126213592237,0.0031025099401699023,symptomatic
1262,positive regulation of endothelial cell proliferation,GO:0001938,2.7946132164108985,1.7363156588290945e-05,symptomatic
766,artery morphogenesis,GO:0048844,2.793032552826956,0.0003665660821791648,symptomatic
1297,cytoplasmic pattern recognition receptor signaling pathway,GO:0002753,2.793032552826956,0.0003662179662416727,symptomatic
939,regulation of intracellular protein transport,GO:0033157,2.7911234396671287,8.88062842989272e-09,symptomatic
322,regulation of polysaccharide metabolic process,GO:0032881,2.789613908331452,0.0073900051396878896,symptomatic
649,cellular response to peptide hormone stimulus,GO:0071375,2.781177575947385,8.003910001685637e-14,symptomatic
1802,TOR signaling,GO:0031929,2.7766990291262137,0.01735709475360128,symptomatic
1798,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,GO:2001240,2.7766990291262137,0.017366153780090633,symptomatic
1803,striated muscle cell proliferation,GO:0014855,2.7766990291262137,0.017339005024832543,symptomatic
1801,negative regulation of signal transduction in absence of ligand,GO:1901099,2.7766990291262137,0.017348045173437774,symptomatic
1136,"phagocytosis, engulfment",GO:0006911,2.7766990291262137,0.017375222267704257,symptomatic
1282,regulation of ATP metabolic process,GO:1903578,2.7766990291262137,0.0002605397392617687,symptomatic
280,vesicle cytoskeletal trafficking,GO:0099518,2.7766990291262132,0.0021824921452705853,symptomatic
1805,morphogenesis of an epithelial sheet,GO:0002011,2.7766990291262132,0.0021841442967810098,symptomatic
1806,mitotic cytokinesis,GO:0000281,2.770008188092174,7.43790310275416e-05,symptomatic
516,regulation of translation,GO:0006417,2.7693726464636117,6.911035383588255e-21,symptomatic
1371,protein import into nucleus,GO:0006606,2.7667822468793344,2.387389741198179e-06,symptomatic
1809,platelet aggregation,GO:0070527,2.7648832885767405,0.005214004967139959,symptomatic
1814,negative regulation of MAP kinase activity,GO:0043407,2.7648832885767405,0.005210594891948892,symptomatic
914,prostate gland development,GO:0030850,2.7648832885767405,0.005207189274372455,symptomatic
729,negative regulation of organelle assembly,GO:1902116,2.7648832885767405,0.005217419508703246,symptomatic
674,regulation of protein serine/threonine kinase activity,GO:0071900,2.7640776699029126,1.8289219526449972e-14,symptomatic
658,cellular response to abiotic stimulus,GO:0071214,2.7629017668696862,1.3163311980176454e-17,symptomatic
659,cellular response to environmental stimulus,GO:0104004,2.7629017668696862,1.309941240745715e-17,symptomatic
12,tube development,GO:0035295,2.758011049723757,0.03144067559620494,asymptomatic
1816,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,GO:1902042,2.7575493806494813,0.04186029465642965,symptomatic
1817,phosphatidylinositol dephosphorylation,GO:0046856,2.7575493806494813,0.04184182959482558,symptomatic
1819,regulation of androgen receptor signaling pathway,GO:0060765,2.7575493806494813,0.04182338081634462,symptomatic
1195,negative regulation of small GTPase mediated signal transduction,GO:0051058,2.7575493806494813,0.0015734860990355183,symptomatic
1359,cardiac ventricle development,GO:0003231,2.75483525724333,4.584385160151842e-07,symptomatic
515,regulation of amide metabolic process,GO:0034248,2.752880843323325,4.9135392734607314e-24,symptomatic
1822,fibroblast proliferation,GO:0048144,2.748932038834951,0.012280871444916984,symptomatic
1989,establishment of protein localization to endoplasmic reticulum,GO:0072599,2.748932038834951,0.012274082682371425,symptomatic
544,steroid hormone mediated signaling pathway,GO:0043401,2.748932038834951,0.00013091735584366194,symptomatic
1821,cellular response to nutrient,GO:0031670,2.748932038834951,0.012287667721311516,symptomatic
798,protein depolymerization,GO:0051261,2.748932038834951,0.012294471524036494,symptomatic
1687,positive regulation of cysteine-type endopeptidase activity,GO:2001056,2.7470243830134145,3.1809864164132545e-07,symptomatic
230,regulation of epithelial cell differentiation,GO:0030856,2.737789870756292,1.648314346203176e-08,symptomatic
112,response to decreased oxygen levels,GO:0036293,2.735093766800544,2.4904595707503083e-16,symptomatic
2075,intracellular glucose homeostasis,GO:0001678,2.7347865909507236,7.330862004458224e-06,symptomatic
1823,canonical Wnt signaling pathway,GO:0060070,2.7347865909507236,7.341158158958868e-06,symptomatic
1364,regulation of mitochondrion organization,GO:0010821,2.7322718446601946,4.172418703491524e-08,symptomatic
882,mesenchymal cell differentiation,GO:0048762,2.73149695190788,3.2316256097853223e-09,symptomatic
975,transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0007178,2.73117937291103,8.801581578133747e-10,symptomatic
1623,regulation of insulin receptor signaling pathway,GO:0046626,2.7262135922330097,0.0007805625541331379,symptomatic
1834,positive regulation of ATP metabolic process,GO:1903580,2.7262135922330097,0.0295163110902563,symptomatic
1835,clathrin-dependent endocytosis,GO:0072583,2.7262135922330097,0.029502421061507942,symptomatic
1831,BMP signaling pathway,GO:0030509,2.7262135922330097,0.00022250670506751316,symptomatic
1829,hair follicle morphogenesis,GO:0031069,2.7262135922330097,0.02953021420428845,symptomatic
650,cellular response to peptide,GO:1901653,2.7262135922330097,3.082568662347548e-16,symptomatic
1828,regulation of fibroblast growth factor receptor signaling pathway,GO:0040036,2.7262135922330097,0.029558059762236858,symptomatic
1827,microtubule organizing center localization,GO:0061842,2.7262135922330097,0.029544130422103854,symptomatic
1826,centrosome localization,GO:0051642,2.7262135922330097,0.029572002243256783,symptomatic
1836,regulation of erythrocyte differentiation,GO:0045646,2.7262135922330093,0.008751589558800605,symptomatic
503,T cell homeostasis,GO:0043029,2.7262135922330093,0.008741281443890357,symptomatic
1804,muscle cell proliferation,GO:0033002,2.7262135922330093,0.008746432464187288,symptomatic
1078,negative regulation of mitotic cell cycle,GO:0045930,2.717838128047962,2.1160986509241344e-11,symptomatic
1861,regulation of TORC1 signaling,GO:1903432,2.716336006753904,4.541184948126e-05,symptomatic
655,cellular response to ionizing radiation,GO:0071479,2.7132316227461857,0.0005478553378296078,symptomatic
969,regulation of mitotic sister chromatid separation,GO:0010965,2.710811255553727,0.001905143761659179,symptomatic
1839,regulation of SMAD protein signal transduction,GO:0060390,2.710811255553727,0.0019081392707183916,symptomatic
1948,nucleoside diphosphate catabolic process,GO:0009134,2.710811255553727,0.0019066403396337738,symptomatic
453,positive regulation of binding,GO:0051099,2.710811255553727,2.5111866918775912e-06,symptomatic
1613,positive regulation of cell cycle G1/S phase transition,GO:1902808,2.710811255553727,0.0019036495312578778,symptomatic
1762,regulation of cellular response to transforming growth factor beta stimulus,GO:1903844,2.7072815533980585,1.3115655464291636e-07,symptomatic
1837,positive regulation of stem cell proliferation,GO:2000648,2.707281553398058,0.0062815910269421234,symptomatic
909,T cell selection,GO:0045058,2.707281553398058,0.006269701580203431,symptomatic
1518,regulation of muscle tissue development,GO:1901861,2.707281553398058,0.006277622870892254,symptomatic
527,modulation by host of viral process,GO:0044788,2.707281553398058,0.006273659725140429,symptomatic
1242,positive regulation of carbohydrate metabolic process,GO:0045913,2.7016531094201,0.0003841454075616131,symptomatic
1841,positive regulation of neuroblast proliferation,GO:0002052,2.7016531094201,0.02093170675796135,symptomatic
1850,response to activity,GO:0014823,2.7016531094201,0.0003845088374646988,symptomatic
1845,homeostasis of number of cells within a tissue,GO:0048873,2.7016531094201,0.020921172431460112,symptomatic
1838,positive regulation of SMAD protein signal transduction,GO:0060391,2.7016531094201,0.020942251698393574,symptomatic
1830,epidermis morphogenesis,GO:0048730,2.7016531094201,0.020910648702872858,symptomatic
1846,T cell proliferation,GO:0042098,2.7016531094201,0.00038487295568199494,symptomatic
1851,cardiac conduction system development,GO:0003161,2.7016531094201,0.020900135556214804,symptomatic
767,artery development,GO:0060840,2.69895145631068,2.2625083857172675e-05,symptomatic
430,mRNA stabilization,GO:0048255,2.697364771151179,0.0013451695862618505,symptomatic
111,response to hypoxia,GO:0001666,2.6951986480665364,5.614199170568476e-15,symptomatic
1761,regulation of transforming growth factor beta receptor signaling pathway,GO:0017015,2.6939888452799012,2.317897783453433e-07,symptomatic
1448,mitochondrion localization,GO:0051646,2.69126213592233,0.004498733807948992,symptomatic
1949,purine nucleoside diphosphate catabolic process,GO:0009137,2.69126213592233,0.004489639332595995,symptomatic
1138,membrane invagination,GO:0010324,2.69126213592233,0.004483596749375812,symptomatic
1860,positive regulation of TORC1 signaling,GO:1904263,2.69126213592233,0.0044866160064460986,symptomatic
1946,purine ribonucleoside diphosphate catabolic process,GO:0009181,2.69126213592233,0.00449266673605695,symptomatic
1852,positive regulation of stress fiber assembly,GO:0051496,2.69126213592233,0.004495698225082629,symptomatic
1775,response to UV,GO:0009411,2.69126213592233,4.3425682016446825e-08,symptomatic
1914,negative regulation of TOR signaling,GO:0032007,2.6855238371250545,0.0009364297202059181,symptomatic
113,response to oxygen levels,GO:0070482,2.6855238371250545,5.9980592144505e-17,symptomatic
593,regulation of transforming growth factor beta production,GO:0071634,2.681884915936538,0.014694695131758053,symptomatic
1198,negative regulation of protein kinase activity,GO:0006469,2.681884915936538,2.102822847493321e-08,symptomatic
793,regulation of hematopoietic progenitor cell differentiation,GO:1901532,2.681884915936538,0.014679087383344077,symptomatic
1241,positive regulation of glucose metabolic process,GO:0010907,2.681884915936538,0.014663512754820635,symptomatic
1108,regulation of T cell apoptotic process,GO:0070232,2.681884915936538,0.014671295935688373,symptomatic
1865,response to angiotensin,GO:1990776,2.681884915936538,0.014686887110965408,symptomatic
1864,regulation of activated T cell proliferation,GO:0046006,2.681884915936538,0.014702511458955797,symptomatic
1682,regulation of autophagy of mitochondrion,GO:1903146,2.681884915936538,0.014710336105820595,symptomatic
505,leukocyte homeostasis,GO:0001776,2.6793714342908617,3.862009159311683e-05,symptomatic
1870,somatic stem cell population maintenance,GO:0035019,2.6775312066574206,0.0032176644202352614,symptomatic
636,positive regulation of peptidase activity,GO:0010952,2.6775312066574206,1.4745416913674073e-08,symptomatic
1866,endoderm formation,GO:0001706,2.6775312066574206,0.0032199809532951857,symptomatic
930,positive regulation of intracellular transport,GO:0032388,2.675017092848352,2.828205103831521e-07,symptomatic
1719,negative regulation of myeloid cell differentiation,GO:0045638,2.673379995484308,0.0001357265849197906,symptomatic
1773,cellular response to light stimulus,GO:0071482,2.671375962504185,5.293767920474052e-06,symptomatic
424,regeneration,GO:0031099,2.669770246638124,3.6888897484425545e-08,symptomatic
1975,positive regulation of response to wounding,GO:1903036,2.6656310679611654,0.00046624330271718235,symptomatic
431,negative regulation of mRNA catabolic process,GO:1902373,2.6656310679611654,0.0004658111958564621,symptomatic
1872,embryonic cranial skeleton morphogenesis,GO:0048701,2.665631067961165,0.010484972529935589,symptomatic
1137,plasma membrane invagination,GO:0099024,2.665631067961165,0.01047900838173881,symptomatic
1871,semaphorin-plexin signaling pathway,GO:0071526,2.665631067961165,0.010490943471011862,symptomatic
1576,response to dexamethasone,GO:0071548,2.665631067961165,0.01049692121657939,symptomatic
1596,cardiac muscle tissue morphogenesis,GO:0055008,2.665631067961165,0.002261643436285226,symptomatic
648,response to peptide,GO:1901652,2.6613037447988908,7.383446299975632e-23,symptomatic
1504,cellular response to chemical stress,GO:0062197,2.6608367674792204,9.844468615005818e-14,symptomatic
1878,positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,GO:0051897,2.657926931926595,1.2432740057655949e-08,symptomatic
1723,regulation of myeloid leukocyte differentiation,GO:0002761,2.6552184466019417,1.8140418155708418e-06,symptomatic
1880,dendrite morphogenesis,GO:0048813,2.6552184466019417,0.0016279968803252936,symptomatic
1997,regulation of transcription by RNA polymerase I,GO:0006356,2.652030909451159,0.007613240262162499,symptomatic
1883,protein targeting to vacuole,GO:0006623,2.652030909451159,0.007617954342820184,symptomatic
1940,ADP catabolic process,GO:0046032,2.652030909451159,0.007622674264965674,symptomatic
1376,import into nucleus,GO:0051170,2.6485436893203884,6.4543087609566185e-06,symptomatic
1532,regulation of myeloid cell differentiation,GO:0045637,2.6460308395202743,5.622133206010925e-10,symptomatic
1858,regulation of actomyosin structure organization,GO:0110020,2.6460308395202743,3.286278660191714e-05,symptomatic
1890,organ growth,GO:0035265,2.6460308395202743,3.282211483632071e-05,symptomatic
1889,cardiac muscle tissue growth,GO:0055017,2.646030839520274,0.03505630959643564,symptomatic
1887,virion assembly,GO:0019068,2.646030839520274,0.03510374709250659,symptomatic
1888,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,GO:1902235,2.646030839520274,0.035087920335476606,symptomatic
1882,protein targeting to lysosome,GO:0006622,2.646030839520274,0.035119588133613315,symptomatic
1256,response to prostaglandin,GO:0034694,2.646030839520274,0.035040525575905944,symptomatic
1744,response to interleukin-4,GO:0070670,2.646030839520274,0.03507210784321185,symptomatic
656,cellular response to radiation,GO:0071478,2.642651489789086,1.5158651651966135e-08,symptomatic
528,modulation by host of symbiont process,GO:0051851,2.642651489789086,0.0001621386132584748,symptomatic
883,mesenchyme development,GO:0060485,2.641250295998106,6.256432881105137e-12,symptomatic
1891,mRNA transcription,GO:0009299,2.640483605055871,0.005337814515611241,symptomatic
1706,regulation of peptidyl-serine phosphorylation,GO:0033135,2.6389747572815536,3.1416869857463225e-06,symptomatic
1863,positive regulation of TOR signaling,GO:0032008,2.637864077669903,0.0007977233736521787,symptomatic
1748,positive regulation of cell growth,GO:0030307,2.6370123295014594,5.423478653038486e-08,symptomatic
647,response to peptide hormone,GO:0043434,2.630556974961676,3.700237296389777e-18,symptomatic
1899,endothelial cell proliferation,GO:0001935,2.6305569749616757,0.02494694059556951,symptomatic
1081,mitotic cell cycle process,GO:1903047,2.626430611079383,2.4910641723343087e-24,symptomatic
1046,regulation of protein ubiquitination,GO:0031396,2.6252427184466014,1.729668938510129e-09,symptomatic
1901,cellular response to virus,GO:0098586,2.6239805825242715,0.00039417007190268905,symptomatic
438,negative regulation of cellular catabolic process,GO:0031330,2.6234151913192463,1.5446378835649615e-10,symptomatic
1905,JNK cascade,GO:0007254,2.6219321979945884,0.0027188500798740424,symptomatic
1907,maintenance of protein localization in organelle,GO:0072595,2.6180305131761448,0.017731043589175356,symptomatic
1910,fat cell differentiation,GO:0045444,2.6180305131761443,3.7620698045342403e-06,symptomatic
241,regulation of morphogenesis of an epithelium,GO:1905330,2.614368932038835,0.0019374225037794082,symptomatic
927,response to mechanical stimulus,GO:0009612,2.611598005772763,1.87059851435547e-10,symptomatic
1913,negative regulation of TORC1 signaling,GO:1904262,2.6076825664837484,0.012451887810326792,symptomatic
1318,regulation of ERBB signaling pathway,GO:1901184,2.6076825664837484,0.001372363040198682,symptomatic
1911,blastocyst formation,GO:0001825,2.6076825664837484,0.012465571203524954,symptomatic
1669,regulation of embryonic development,GO:0045995,2.6076825664837484,0.00013775995607650287,symptomatic
1853,regulation of stress fiber assembly,GO:0051492,2.6076825664837484,0.00013790760876254414,symptomatic
1546,regulation of myelination,GO:0031641,2.6076825664837484,0.012458725749816263,symptomatic
175,regulation of oxidoreductase activity,GO:0051341,2.6076825664837484,0.0013734907008726331,symptomatic
1724,regulation of osteoclast differentiation,GO:0045670,2.6017289533182604,0.0009542773653775701,symptomatic
1503,cellular response to oxidative stress,GO:0034599,2.599886803953154,2.273759003440908e-10,symptomatic
1491,Golgi to plasma membrane transport,GO:0006893,2.5989902912621363,0.00889620747365903,symptomatic
1915,morphogenesis of a polarized epithelium,GO:0001738,2.5989902912621363,0.008885753645840395,symptomatic
893,T cell differentiation involved in immune response,GO:0002292,2.5989902912621363,0.008890977486902029,symptomatic
136,regulation of endopeptidase activity,GO:0052548,2.5982685499982474,8.122191358031677e-13,symptomatic
1843,regulation of neural precursor cell proliferation,GO:2000177,2.595145631067961,4.7568773197811145e-05,symptomatic
96,positive regulation of apoptotic process,GO:0043065,2.595145631067961,5.412992997607527e-24,symptomatic
1916,viral gene expression,GO:0019080,2.591585760517799,0.006361391285537152,symptomatic
961,regulation of mitotic cell cycle,GO:0007346,2.5893554801731193,7.719311106828429e-23,symptomatic
1917,nucleus organization,GO:0006997,2.586407766990291,1.0798811576966236e-06,symptomatic
1621,response to estradiol,GO:0032355,2.585202544358889,1.630023081944404e-05,symptomatic
1859,positive regulation of actin filament bundle assembly,GO:0032233,2.579642968994676,0.0032448352687857395,symptomatic
1247,regulation of cell-substrate adhesion,GO:0010810,2.579642968994676,6.981567343254108e-10,symptomatic
618,regulation of microtubule polymerization,GO:0031113,2.579642968994676,0.0032425125520579045,symptomatic
2016,regulation of chemokine production,GO:0032642,2.5763186868181362,0.0001156647899758147,symptomatic
1918,positive regulation of non-canonical NF-kappaB signal transduction,GO:1901224,2.5747572815533983,0.002285453890454478,symptomatic
960,regulation of mitotic cell cycle phase transition,GO:1901990,2.5738503575373524,5.255881884773525e-15,symptomatic
1204,negative regulation of kinase activity,GO:0033673,2.5704299583911236,5.553892915100756e-08,symptomatic
247,regulation of kidney development,GO:0090183,2.570429958391123,0.042076222750497876,symptomatic
1923,cellular response to retinoic acid,GO:0071300,2.570429958391123,0.0016428881939815798,symptomatic
1920,regulation of collagen biosynthetic process,GO:0032965,2.570429958391123,0.0421132779884992,symptomatic
1922,integrated stress response signaling,GO:0140467,2.570429958391123,0.04209474221473665,symptomatic
834,regulation of sister chromatid segregation,GO:0033045,2.570429958391123,5.6905988946689654e-05,symptomatic
908,positive T cell selection,GO:0043368,2.570429958391123,0.04205771957426634,symptomatic
1091,DNA damage checkpoint signaling,GO:0000077,2.5653750322192628,2.7952528640646113e-05,symptomatic
1927,negative regulation of ossification,GO:0030279,2.5631067961165046,0.02965869495852638,symptomatic
1925,negative regulation of actin filament depolymerization,GO:0030835,2.5631067961165046,0.029672645426521923,symptomatic
1336,regulation of sprouting angiogenesis,GO:1903670,2.5631067961165046,0.029644757601872938,symptomatic
1722,negative regulation of hemopoiesis,GO:1903707,2.5631067961165046,1.9612258262858637e-05,symptomatic
1929,oligodendrocyte differentiation,GO:0048709,2.559981056121241,0.000566699231875484,symptomatic
1089,negative regulation of mitotic cell cycle phase transition,GO:1901991,2.5585298196948685,1.4167757624179644e-07,symptomatic
1932,positive regulation of substrate adhesion-dependent cell spreading,GO:1900026,2.557146082637164,0.020965960050554365,symptomatic
1931,response to testosterone,GO:0033574,2.557146082637164,0.02098703136718809,symptomatic
1935,positive regulation of receptor signaling pathway via JAK-STAT,GO:0046427,2.557146082637164,0.020955440251231458,symptomatic
693,musculoskeletal movement,GO:0050881,2.557146082637164,0.020976490417229682,symptomatic
576,digestive tract development,GO:0048565,2.555398204248485,4.5484332905020184e-06,symptomatic
1938,positive regulation of peptidyl-serine phosphorylation,GO:0033138,2.552199958686222,0.000194716008475888,symptomatic
1955,axon extension,GO:0048675,2.552199958686222,0.014697569319218767,symptomatic
1939,glycolytic process,GO:0006096,2.552199958686222,0.014705362304011566,symptomatic
1936,positive regulation of receptor signaling pathway via STAT,GO:1904894,2.552199958686222,0.014689784589706469,symptomatic
97,positive regulation of programmed cell death,GO:0043068,2.549841178687436,9.404713571079941e-24,symptomatic
1958,mitotic spindle assembly,GO:0090307,2.5480296973158194,0.010497433846700766,symptomatic
1967,positive chemotaxis,GO:0050918,2.5480296973158194,0.010491469395651503,symptomatic
567,regulation of lipid storage,GO:0010883,2.5480296973158194,0.010479560803828971,symptomatic
1485,establishment of protein localization to plasma membrane,GO:0061951,2.5480296973158194,0.010485511718538697,symptomatic
1968,"regulation of alternative mRNA splicing, via spliceosome",GO:0000381,2.5444660194174755,0.007619431230898733,symptomatic
1947,ribonucleoside diphosphate catabolic process,GO:0009191,2.5444660194174755,0.007614722064501391,symptomatic
1360,cardiac chamber development,GO:0003205,2.5433905899925318,1.7003447547415038e-07,symptomatic
1972,"positive regulation of DNA-templated transcription, elongation",GO:0032786,2.541385552081619,0.005337877668157611,symptomatic
1973,aorta development,GO:0035904,2.541385552081619,0.005334420493502069,symptomatic
973,regulation of mitotic nuclear division,GO:0007088,2.541385552081619,2.3592929921329055e-05,symptomatic
1974,positive regulation of wound healing,GO:0090303,2.5386962552011094,0.0038485717024674478,symptomatic
1077,mitotic cell cycle checkpoint signaling,GO:0007093,2.5374757281553397,7.882428438174032e-06,symptomatic
1977,positive regulation of fat cell differentiation,GO:0045600,2.5363280683958846,0.0027191743322615017,symptomatic
1284,regulation of generation of precursor metabolites and energy,GO:0043467,2.5352469396369774,3.7855759710678507e-06,symptomatic
2019,embryonic heart tube morphogenesis,GO:0003143,2.5342267195405443,0.0019366960570652118,symptomatic
1597,muscle tissue morphogenesis,GO:0060415,2.5342267195405443,0.0019382079197170974,symptomatic
1072,signal transduction in response to DNA damage,GO:0042770,2.5332624019151484,1.8629742865271705e-06,symptomatic
1334,regulation of vasculature development,GO:1901342,2.5327997900813437,9.811899326657416e-13,symptomatic
1045,regulation of protein modification by small protein conjugation or removal,GO:1903320,2.5301373725979937,2.2752131673705628e-10,symptomatic
437,negative regulation of RNA catabolic process,GO:1902369,2.5277535989286912,0.0004708695471545646,symptomatic
1900,epithelial cell proliferation,GO:0050673,2.527108105159812,9.670505556508e-08,symptomatic
1239,regulation of G2/M transition of mitotic cell cycle,GO:0010389,2.523291544914695,0.00011530462099494087,symptomatic
1425,positive regulation of protein catabolic process,GO:0045732,2.5228294036061025,5.176667656007111e-09,symptomatic
1314,regulation of signaling receptor activity,GO:0010469,2.522384538608112,8.001749297216561e-05,symptomatic
1253,cellular response to ketone,GO:1901655,2.522384538608112,8.010719868177567e-05,symptomatic
666,regulation of protein kinase activity,GO:0045859,2.5205724807499164,1.4245774051474486e-19,symptomatic
1683,regulation of autophagy,GO:0010506,2.5200293709716894,6.108491365323542e-15,symptomatic
836,regulation of chromosome segregation,GO:0051983,2.518105684428963,9.431240478845978e-06,symptomatic
1862,regulation of TOR signaling,GO:0032006,2.516504854368932,3.1756644214776723e-06,symptomatic
1978,peptidyl-serine phosphorylation,GO:0018105,2.5143605932455775,5.138043529148571e-07,symptomatic
839,positive regulation of cell cycle process,GO:0090068,2.5088292404340375,1.7538340669104802e-10,symptomatic
582,positive regulation of cell migration,GO:0030335,2.5036313897977793,1.2946791844079948e-22,symptomatic
335,negative regulation of lipid biosynthetic process,GO:0051055,2.4990291262135926,0.008791431754698516,symptomatic
1720,negative regulation of leukocyte differentiation,GO:1902106,2.4990291262135926,6.68934801776116e-05,symptomatic
214,hair follicle development,GO:0001942,2.4990291262135926,0.0007962440396248143,symptomatic
324,positive regulation of organelle assembly,GO:1902117,2.4990291262135926,0.0007955510509045141,symptomatic
2103,regulation of stem cell population maintenance,GO:2000036,2.499029126213592,0.0022642540821456053,symptomatic
1987,translational initiation,GO:0006413,2.499029126213592,0.002265961664409667,symptomatic
2066,myeloid cell homeostasis,GO:0002262,2.499029126213592,5.405826334958812e-06,symptomatic
1992,skeletal muscle cell differentiation,GO:0035914,2.499029126213592,0.006292487776187381,symptomatic
1996,positive regulation of transcription by RNA polymerase I,GO:0045943,2.499029126213592,0.049969022402831874,symptomatic
1813,homotypic cell-cell adhesion,GO:0034109,2.499029126213592,0.004491827140403796,symptomatic
1842,positive regulation of neural precursor cell proliferation,GO:2000179,2.499029126213592,0.004488808439368578,symptomatic
2190,cardiocyte differentiation,GO:0035051,2.499029126213592,3.2983199767305256e-05,symptomatic
1959,mitotic spindle organization,GO:0007052,2.499029126213592,0.00027570789683453294,symptomatic
1510,epithelial cell migration,GO:0010631,2.499029126213592,0.0001370251382875529,symptomatic
1854,regulation of actin filament bundle assembly,GO:0032231,2.499029126213592,0.0001371723188872173,symptomatic
443,RNA stabilization,GO:0043489,2.499029126213592,0.00226254907154158,symptomatic
675,positive regulation of cell cycle,GO:0045787,2.499029126213592,2.6852261800386415e-13,symptomatic
1991,DNA synthesis involved in DNA repair,GO:0000731,2.499029126213592,0.034710763367697565,symptomatic
1921,regulation of collagen metabolic process,GO:0010712,2.499029126213592,0.034679379314019716,symptomatic
454,regulation of binding,GO:0051098,2.499029126213592,8.798629711082609e-10,symptomatic
1988,protein targeting to ER,GO:0045047,2.499029126213592,0.04999047754340844,symptomatic
1995,regulation of JUN kinase activity,GO:0043506,2.499029126213592,0.03469506424360543,symptomatic
1082,mitotic cell cycle,GO:0000278,2.4906148867313913,2.1902560534879067e-24,symptomatic
1213,rhythmic process,GO:0048511,2.4897390551124263,6.556023897275149e-11,symptomatic
25,regulation of multicellular organismal development,GO:2000026,2.488888888888889,0.008491719817591047,asymptomatic
924,respiratory tube development,GO:0030323,2.4860807887720715,5.43273641881846e-08,symptomatic
922,lung development,GO:0030324,2.48580674988442,7.894734446088506e-08,symptomatic
1606,regulation of reactive oxygen species metabolic process,GO:2000377,2.481794442584533,4.465140769964562e-06,symptomatic
577,digestive system development,GO:0055123,2.481794442584533,4.458706849546745e-06,symptomatic
1333,regulation of angiogenesis,GO:0045765,2.481794442584533,1.0882361403442585e-11,symptomatic
676,positive regulation of protein serine/threonine kinase activity,GO:0071902,2.479656807405735,1.9255869480549562e-05,symptomatic
455,regulation of protein binding,GO:0043393,2.479656807405735,1.9230698409333158e-05,symptomatic
1044,regulation of post-translational protein modification,GO:1901873,2.478711816244376,7.252688196262815e-10,symptomatic
1277,negative regulation of small molecule metabolic process,GO:0062014,2.4761022534960366,0.0001134189974849508,symptomatic
321,regulation of carbohydrate biosynthetic process,GO:0043255,2.473265939345411,0.00032811734443672367,symptomatic
1998,multicellular organism growth,GO:0035264,2.4721578452865645,0.00046425752556476547,symptomatic
1999,ureteric bud development,GO:0001657,2.470950147267372,0.0006645753004763385,symptomatic
2020,embryonic heart tube development,GO:0035050,2.4696287835522557,0.0009369540531029319,symptomatic
1795,regulation of DNA binding,GO:0051101,2.4681769147788564,0.0013461049009219927,symptomatic
1753,regulation of axonogenesis,GO:0050770,2.4673958461349392,1.8096562064409494e-06,symptomatic
2004,protein K48-linked ubiquitination,GO:0070936,2.4665742024965325,0.00190588840414122,symptomatic
2006,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032436,2.4665742024965325,0.0019043959308411877,symptomatic
1873,cranial skeletal system development,GO:1904888,2.464795850512036,0.00266357459269186,symptomatic
2015,positive regulation of chemokine production,GO:0032722,2.464795850512036,0.0026655359878263903,symptomatic
2014,stem cell proliferation,GO:0072089,2.464795850512036,0.0026675002737422534,symptomatic
2021,response to ischemia,GO:0002931,2.4605825242718447,0.005253718536565965,symptomatic
2017,heart looping,GO:0001947,2.4605825242718447,0.005257150096681293,symptomatic
1180,phosphatidylinositol biosynthetic process,GO:0006661,2.459361997226075,3.24594489932497e-05,symptomatic
1979,peptidyl-serine modification,GO:0018209,2.456188626907074,7.125441138232904e-07,symptomatic
2022,cellular response to heat,GO:0034605,2.455186509964231,0.010276326950720805,symptomatic
1067,positive regulation of developmental growth,GO:0048639,2.454136387419336,1.5148879914489838e-06,symptomatic
2024,cellular response to type II interferon,GO:0071346,2.453592233009709,0.00013453239586113454,symptomatic
2026,face development,GO:0060324,2.451877633266166,0.014402010926885131,symptomatic
1844,regulation of neuroblast proliferation,GO:1902692,2.451877633266166,0.01440969609813747,symptomatic
1191,phosphatidylinositol metabolic process,GO:0046488,2.451877633266166,3.178682140838146e-06,symptomatic
2027,ovarian follicle development,GO:0001541,2.451877633266166,0.014394333948779115,symptomatic
2034,non-canonical Wnt signaling pathway,GO:0035567,2.451877633266166,0.014386665150724358,symptomatic
1627,negative regulation of endothelial cell migration,GO:0010596,2.451877633266166,0.014379004519653684,symptomatic
464,negative regulation of apoptotic process,GO:0043066,2.4487131035381506,1.8821549697832866e-35,symptomatic
2035,ERK1 and ERK2 cascade,GO:0070371,2.44802853180107,0.0206486906659475,symptomatic
667,regulation of kinase activity,GO:0043549,2.4468672279434793,1.8020768068479133e-20,symptomatic
442,post-transcriptional regulation of gene expression,GO:0010608,2.4460631909759245,3.9306484207773355e-20,symptomatic
1833,response to BMP,GO:0071772,2.443495145631068,0.0007799930960327945,symptomatic
957,regulation of mitotic metaphase/anaphase transition,GO:0030071,2.443495145631068,0.000777268229321763,symptomatic
1832,cellular response to BMP stimulus,GO:0071773,2.443495145631068,0.0007806773005029988,symptomatic
2001,mesonephric epithelium development,GO:0072163,2.443495145631068,0.0007786282787169017,symptomatic
1279,regulation of purine nucleotide metabolic process,GO:1900542,2.443495145631068,0.0007779476595921491,symptomatic
695,multicellular organismal movement,GO:0050879,2.443495145631068,0.028905610642903763,symptomatic
1321,response to electrical stimulus,GO:0051602,2.443495145631068,0.028919271139426876,symptomatic
2000,mesonephric tubule development,GO:0072164,2.443495145631068,0.0007793100898191057,symptomatic
1960,microtubule cytoskeleton organization involved in mitosis,GO:1902850,2.4417994515674795,2.681643503260133e-05,symptomatic
1868,formation of primary germ layer,GO:0001704,2.4380771963059438,5.433129754683203e-05,symptomatic
2036,positive regulation of interleukin-10 production,GO:0032733,2.4380771963059438,0.040892549903272415,symptomatic
286,organelle transport along microtubule,GO:0072384,2.4380771963059438,0.001583696297214346,symptomatic
1792,'de novo' protein folding,GO:0006458,2.4380771963059438,0.04087448782292644,symptomatic
1598,muscle organ morphogenesis,GO:0048644,2.4349514563106793,0.0022051126014366006,symptomatic
345,negative regulation of cell growth,GO:0030308,2.4329172445677303,2.8036908023218556e-07,symptomatic
968,regulation of chromosome separation,GO:1905818,2.43148779847809,0.0031440023417528616,symptomatic
482,regulation of steroid biosynthetic process,GO:0050810,2.43148779847809,0.003141727376237845,symptomatic
1203,negative regulation of phosphorus metabolic process,GO:0010563,2.4307496418908165,8.814863606542342e-14,symptomatic
1512,epithelium migration,GO:0090132,2.428962889030034,0.00022198040023939074,symptomatic
1263,regulation of endothelial cell proliferation,GO:0001936,2.425528269560251,3.2066113557409204e-05,symptomatic
637,positive regulation of proteolysis,GO:0045862,2.425093353248693,1.2803663063206925e-12,symptomatic
734,negative regulation of cell cycle,GO:0045786,2.4233009708737865,1.410000789465824e-13,symptomatic
1782,pallium development,GO:0021543,2.421739565609048,2.188504502709927e-07,symptomatic
1431,mammary gland development,GO:0030879,2.4209344660194176,6.609354968010343e-05,symptomatic
671,regulation of transferase activity,GO:0051338,2.420934466019417,3.9203605275105894e-24,symptomatic
449,negative regulation of programmed cell death,GO:0043069,2.4203409126846083,2.663278461083761e-35,symptomatic
586,positive regulation of cell motility,GO:2000147,2.420112416964742,2.3294331320470804e-21,symptomatic
1049,regulation of extracellular matrix organization,GO:1903053,2.4184152834325086,0.008527772638283746,symptomatic
1514,sprouting angiogenesis,GO:0002040,2.4184152834325086,0.008522732583532987,symptomatic
971,positive regulation of nuclear division,GO:0051785,2.4184152834325086,0.008517698482774847,symptomatic
1319,regulation of epidermal growth factor receptor signaling pathway,GO:0042058,2.4184152834325086,0.008512670325465061,symptomatic
183,maintenance of protein location,GO:0045185,2.4166435506241335,0.0009095604133606195,symptomatic
1275,regulation of nucleotide metabolic process,GO:0006140,2.4166435506241335,0.0009087836751767078,symptomatic
2040,positive regulation of lipid biosynthetic process,GO:0046889,2.412855708068296,0.0013094050533389943,symptomatic
1238,regulation of cell cycle G2/M phase transition,GO:1902749,2.412855708068296,0.00019580934695332286,symptomatic
2037,negative regulation of BMP signaling pathway,GO:0030514,2.412855708068296,0.011956776522881896,symptomatic
900,"CD4-positive, alpha-beta T cell differentiation",GO:0043367,2.412855708068296,0.011963404447783715,symptomatic
1699,protein localization to chromosome,GO:0034502,2.412855708068296,0.0013083202107098816,symptomatic
651,cellular response to organonitrogen compound,GO:0071417,2.4122255551019682,2.699670874383493e-20,symptomatic
1202,negative regulation of phosphate metabolic process,GO:0045936,2.4100226093895465,1.7622306092769799e-13,symptomatic
1807,cytoskeleton-dependent cytokinesis,GO:0061640,2.4097780859916784,0.0002830879779542742,symptomatic
305,enzyme-linked receptor protein signaling pathway,GO:0007167,2.4094873659909557,7.575342111573988e-23,symptomatic
2044,positive regulation of dephosphorylation,GO:0035306,2.4064724919093847,0.016935062024199893,symptomatic
2043,lung alveolus development,GO:0048286,2.4064724919093847,0.016943928548819893,symptomatic
1441,Fc receptor signaling pathway,GO:0038093,2.4064724919093847,0.016961689480212785,symptomatic
2042,protein sumoylation,GO:0016925,2.4064724919093847,0.016952804362622313,symptomatic
1954,pyridine-containing compound catabolic process,GO:0072526,2.4064724919093847,0.016926204774187235,symptomatic
439,negative regulation of catabolic process,GO:0009895,2.4059420813976136,7.980033675046382e-13,symptomatic
1035,positive regulation of epithelial cell proliferation,GO:0050679,2.4010279840091378,1.3564957718488718e-07,symptomatic
1080,negative regulation of cell cycle phase transition,GO:1901988,2.400814007716115,1.694280996207751e-08,symptomatic
2045,negative regulation of osteoblast differentiation,GO:0045668,2.399067961165049,0.024031148063244658,symptomatic
2071,response to carbohydrate,GO:0009743,2.399067961165049,1.597641612783145e-06,symptomatic
137,regulation of peptidase activity,GO:0052547,2.399067961165049,7.05472158198445e-11,symptomatic
1672,negative regulation of smooth muscle cell proliferation,GO:0048662,2.399067961165049,0.024019280829633182,symptomatic
1361,cardiac chamber morphogenesis,GO:0003206,2.399067961165049,0.00010301252545972739,symptomatic
1840,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0090100,2.399067961165049,0.0005288322834819146,symptomatic
432,negative regulation of mRNA metabolic process,GO:1903312,2.399067961165049,0.0005283484479069083,symptomatic
2018,determination of heart left/right asymmetry,GO:0061371,2.393436346232736,0.005075095718536053,symptomatic
853,cellular response to external stimulus,GO:0071496,2.393009708737864,6.0626158238228516e-12,symptomatic
884,heart morphogenesis,GO:0003007,2.3928927540578027,1.7980856587666814e-09,symptomatic
2046,mammary gland morphogenesis,GO:0060443,2.390375685943436,0.03371435720983479,symptomatic
660,response to ionizing radiation,GO:0010212,2.390375685943436,3.807833874065719e-05,symptomatic
546,cellular response to hormone stimulus,GO:0032870,2.390375685943436,2.8741619950711645e-18,symptomatic
2051,autonomic nervous system development,GO:0048483,2.390375685943436,0.033683369749163986,symptomatic
2047,positive regulation of cytokinesis,GO:0032467,2.390375685943436,0.03369885635594521,symptomatic
218,molting cycle process,GO:0022404,2.385436893203883,0.0015231343314535434,symptomatic
215,hair cycle process,GO:0022405,2.385436893203883,0.001524368638043052,symptomatic
1205,negative regulation of transferase activity,GO:0051348,2.3822520642409946,8.612949127662103e-08,symptomatic
2068,cellular response to hexose stimulus,GO:0071331,2.3800277392510405,0.002120203384151294,symptomatic
1818,phospholipid dephosphorylation,GO:0046839,2.3800277392510405,0.04802676662820507,symptomatic
1459,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",GO:0000288,2.3800277392510405,0.04804759350011669,symptomatic
268,synaptic vesicle recycling,GO:0036465,2.38002773925104,0.009944173333798082,symptomatic
2052,positive regulation of protein localization to plasma membrane,GO:1903078,2.38002773925104,0.009949924735379227,symptomatic
441,regulation of RNA stability,GO:0043487,2.3774547362896876,1.0035226983023734e-06,symptomatic
1092,DNA integrity checkpoint signaling,GO:0031570,2.376126054432596,0.0001604853684901699,symptomatic
776,endothelium development,GO:0003158,2.3753148130347013,0.0008892455749463054,symptomatic
677,positive regulation of protein kinase activity,GO:0045860,2.372619092591893,4.872812767942963e-09,symptomatic
959,regulation of cell cycle phase transition,GO:1901987,2.3723502304147464,2.9540075121521965e-15,symptomatic
73,apoptotic process,GO:0006915,2.372284108329075,5.820852591190574e-38,symptomatic
1715,regulation of DNA biosynthetic process,GO:2000278,2.3719598486095115,0.00022880616831105397,symptomatic
915,gland development,GO:0048732,2.371171822081734,4.304140259679935e-15,symptomatic
2057,protein autophosphorylation,GO:0046777,2.370873786407767,1.116542880744041e-05,symptomatic
2070,cellular response to carbohydrate stimulus,GO:0071322,2.3702131918726854,0.0012922476914018456,symptomatic
931,regulation of intracellular transport,GO:0032386,2.3694498381877023,1.7645318210887233e-09,symptomatic
440,regulation of mRNA stability,GO:0043488,2.369021830630226,2.9796028880976452e-06,symptomatic
2058,regulation of circadian rhythm,GO:0042752,2.3675012774655086,0.00032885038244768165,symptomatic
1513,tissue migration,GO:0090130,2.3675012774655086,0.0003291681122857953,symptomatic
1808,cytokinesis,GO:0000910,2.3675012774655086,0.0003294864566883928,symptomatic
684,positive regulation of transferase activity,GO:0051347,2.3661020450320183,5.13733323160059e-13,symptomatic
958,regulation of metaphase/anaphase transition of cell cycle,GO:1902099,2.3646727215784527,0.0018389587014697624,symptomatic
246,regulation of animal organ morphogenesis,GO:2000027,2.3646727215784527,0.001837508418582168,symptomatic
1765,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0090101,2.3639464707425875,2.3472843486713755e-05,symptomatic
2093,development of primary male sexual characteristics,GO:0046546,2.3639464707425875,2.3442477583108694e-05,symptomatic
2011,positive regulation of proteasomal protein catabolic process,GO:1901800,2.3627184466019417,0.0004703847824475835,symptomatic
86,viral process,GO:0016032,2.3612873633514257,7.657292086855183e-09,symptomatic
901,"CD4-positive, alpha-beta T cell activation",GO:0035710,2.3601941747572814,0.00590932469175407,symptomatic
2062,regulation of cartilage development,GO:0061035,2.3601941747572814,0.005905524482949084,symptomatic
2059,mesoderm formation,GO:0001707,2.3601941747572814,0.005913129794581987,symptomatic
587,positive regulation of locomotion,GO:0040017,2.3580582524271843,2.3505379249475887e-20,symptomatic
435,regulation of cellular catabolic process,GO:0031329,2.3537367351546625,7.938940944635163e-24,symptomatic
688,regulation of epithelial cell proliferation,GO:0050678,2.3536562407551838,2.499804547613757e-12,symptomatic
2064,erythrocyte differentiation,GO:0030218,2.3520274129069105,0.0009545921596375535,symptomatic
1450,nuclear-transcribed mRNA catabolic process,GO:0000956,2.3520274129069105,0.0009562060094425197,symptomatic
2063,receptor signaling pathway via JAK-STAT,GO:0007259,2.3520274129069105,0.027543209265383378,symptomatic
1953,pyridine nucleotide catabolic process,GO:0019364,2.3520274129069105,0.027556312599953017,symptomatic
2007,positive regulation of ubiquitin-dependent protein catabolic process,GO:2000060,2.3520274129069105,0.0009553984030156257,symptomatic
1628,negative regulation of epithelial cell migration,GO:0010633,2.35202741290691,0.008175776442022957,symptomatic
812,positive regulation of muscle cell differentiation,GO:0051149,2.35202741290691,0.008180663337684657,symptomatic
1405,regulation of viral genome replication,GO:0045069,2.35202741290691,0.00366303902626974,symptomatic
1658,regulation of receptor signaling pathway via STAT,GO:1904892,2.35202741290691,0.0036604774605171037,symptomatic
547,cellular response to endogenous stimulus,GO:0071495,2.351003010723588,1.0647917196829666e-40,symptomatic
379,heart development,GO:0007507,2.3489107688085356,1.895444355917019e-19,symptomatic
1963,mitotic nuclear division,GO:0140014,2.348485202947713,7.072117256555236e-06,symptomatic
1099,positive regulation of nervous system development,GO:0051962,2.346027342976025,4.4640425588078234e-10,symptomatic
2078,negative regulation of neuron apoptotic process,GO:0043524,2.3447680690399135,1.012836266224544e-05,symptomatic
2067,cellular response to glucose stimulus,GO:0071333,2.3447680690399135,0.005153087354334818,symptomatic
52,negative regulation of gene expression,GO:0010629,2.3441306266548985,1.1429492164403014e-33,symptomatic
2079,regulation of lipid catabolic process,GO:0050994,2.3428398058252426,0.011391564328005241,symptomatic
918,urogenital system development,GO:0001655,2.3428398058252426,0.01139792122774185,symptomatic
2080,ribosome assembly,GO:0042255,2.3428398058252426,0.011385214515113375,symptomatic
1847,lymphocyte proliferation,GO:0046651,2.3428398058252426,0.0001386650707868236,symptomatic
591,cell division,GO:0051301,2.3419472954230236,8.023568496929291e-18,symptomatic
2065,erythrocyte homeostasis,GO:0034101,2.341432694830753,0.0005155513663157229,symptomatic
730,regulation of centrosome duplication,GO:0010824,2.339516628795703,0.03891849056265255,symptomatic
2089,cell differentiation involved in kidney development,GO:0061005,2.339516628795703,0.03890113173546136,symptomatic
2002,mesonephros development,GO:0001823,2.339516628795703,0.001964239555564579,symptomatic
2081,regulation of sodium ion transmembrane transporter activity,GO:2000649,2.339516628795703,0.03893586488879659,symptomatic
1100,positive regulation of cell development,GO:0010720,2.3390471291712207,3.840110798273871e-15,symptomatic
1097,regulation of neurogenesis,GO:0050767,2.3384231412384255,3.919188187192475e-13,symptomatic
934,positive regulation of protein transport,GO:0051222,2.3337236976313704,1.0716593156117543e-08,symptomatic
13,positive regulation of developmental process,GO:0051094,2.3335826477187736,0.0461810638855699,asymptomatic
598,regulation of cellular response to stress,GO:0080135,2.3278627477058116,4.7994567445195394e-17,symptomatic
1879,regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction,GO:0051896,2.3256271052110167,3.191228875579961e-08,symptomatic
1416,response to vitamin,GO:0033273,2.3246782569428763,0.003936546741849938,symptomatic
1068,positive regulation of growth,GO:0045927,2.3246782569428763,1.2068889383590859e-08,symptomatic
2069,cellular response to monosaccharide stimulus,GO:0071326,2.3246782569428763,0.003933803503702308,symptomatic
554,response to steroid hormone,GO:0048545,2.3230411595788323,1.7849972556316362e-09,symptomatic
75,cell death,GO:0008219,2.3215024669743753,2.9222193223756262e-37,symptomatic
304,transmembrane receptor protein tyrosine kinase signaling pathway,GO:0007169,2.3213730271936686,8.478667186459185e-14,symptomatic
74,programmed cell death,GO:0012501,2.3208533749844693,4.368878434851997e-37,symptomatic
1008,mitochondrial membrane organization,GO:0007006,2.320527045769764,0.0005721500758097039,symptomatic
1941,ADP metabolic process,GO:0046031,2.320527045769764,0.02266255226437974,symptomatic
1143,in utero embryonic development,GO:0001701,2.3200862998921252,2.176925911575156e-13,symptomatic
421,tissue regeneration,GO:0042246,2.317940059096665,0.014244206734738255,symptomatic
1212,ovulation cycle,GO:0042698,2.317940059096665,0.014251828033151705,symptomatic
2072,response to monosaccharide,GO:0034284,2.316980646820549,3.377376467872338e-05,symptomatic
2090,hippocampus development,GO:0021766,2.314890137966275,0.0021053587394014566,symptomatic
1372,protein localization to nucleus,GO:0034504,2.314890137966275,2.892094474900738e-06,symptomatic
1149,maintenance of cell number,GO:0098727,2.31315092674316,0.0003156655191756174,symptomatic
2092,male gonad development,GO:0008584,2.3120269467010104,4.847048491884201e-05,symptomatic
358,myeloid cell differentiation,GO:0030099,2.3120269467010104,1.6710838894410215e-09,symptomatic
1684,regulation of macroautophagy,GO:0016241,2.311240810370952,1.1620486810469745e-05,symptomatic
276,positive regulation of DNA metabolic process,GO:0051054,2.30933384600596,8.540171101267394e-10,symptomatic
1377,establishment of protein localization to organelle,GO:0072594,2.309044455799693,4.0110376018120685e-11,symptomatic
1170,regulation of B cell proliferation,GO:0030888,2.3067961165048545,0.020421183254547576,symptomatic
1781,cerebral cortex development,GO:0021987,2.3067961165048545,0.00017448442015301235,symptomatic
2095,midbrain development,GO:0030901,2.3067961165048545,0.0030146267347826,symptomatic
192,negative regulation of NF-kappaB transcription factor activity,GO:0032088,2.306796116504854,0.007770397483693875,symptomatic
849,cellular response to amino acid starvation,GO:0034198,2.306796116504854,0.03185352895006975,symptomatic
1148,stem cell population maintenance,GO:0019827,2.306796116504854,0.0004485292063987868,symptomatic
78,cell fate commitment,GO:0045165,2.3037924757281556,2.2568069726431794e-08,symptomatic
2105,response to tumor necrosis factor,GO:0034612,2.303026841804683,1.1543026098794774e-06,symptomatic
91,regulation of apoptotic process,GO:0042981,2.3026284631778355,5.725233547207384e-50,symptomatic
1079,cell cycle checkpoint signaling,GO:0000075,2.302135922330097,1.5405456729966895e-05,symptomatic
683,positive regulation of kinase activity,GO:0033674,2.3017373530914664,9.262144784697661e-10,symptomatic
1141,embryonic placenta development,GO:0001892,2.297957817207901,0.004260363399559016,symptomatic
236,negative regulation of cell differentiation,GO:0045596,2.2976148384292134,1.366496031963694e-21,symptomatic
1533,regulation of hemopoiesis,GO:1903706,2.297395969330833,4.890883785563769e-13,symptomatic
2060,mesoderm morphogenesis,GO:0048332,2.296405143007085,0.010732613565537286,symptomatic
1820,regulation of intracellular steroid hormone receptor signaling pathway,GO:0033143,2.296405143007085,0.010738687483797351,symptomatic
1317,regulation of peptidyl-tyrosine phosphorylation,GO:0050730,2.296405143007085,3.2889434592383667e-07,symptomatic
2096,regulation of tyrosine phosphorylation of STAT protein,GO:0042509,2.296405143007085,0.01072654651434139,symptomatic
1430,mammary gland epithelium development,GO:0061180,2.294190673245265,0.018519859032300547,symptomatic
2098,positive regulation of myeloid leukocyte differentiation,GO:0002763,2.294190673245265,0.01851034703485201,symptomatic
2097,response to cadmium ion,GO:0046686,2.294190673245265,0.018529380810723323,symptomatic
2073,response to hexose,GO:0009746,2.2907766990291263,7.836417310798861e-05,symptomatic
2102,positive regulation of stem cell population maintenance,GO:1902459,2.290776699029126,0.0448030112470121,symptomatic
733,negative regulation of cell cycle process,GO:0010948,2.2900194174757282,1.1109977233849952e-08,symptomatic
2104,cellular response to tumor necrosis factor,GO:0071356,2.289613277648207,9.329056527058752e-06,symptomatic
1433,morphogenesis of a branching epithelium,GO:0061138,2.2882676336413614,2.5710402038257804e-05,symptomatic
2159,regulation of DNA-templated transcription initiation,GO:2000142,2.2882676336413614,0.005909966957182143,symptomatic
2106,regulation of release of sequestered calcium ion into cytosol,GO:0051279,2.2882676336413614,0.005906178516824975,symptomatic
1199,negative regulation of protein phosphorylation,GO:0001933,2.28784356625188,5.788286516128946e-09,symptomatic
2109,regulation of postsynapse organization,GO:0099175,2.2848266296809987,0.001296509586110285,symptomatic
12,neural nucleus development,GO:0048857,2.2848266296809983,0.015022745308970577,symptomatic
2110,circadian regulation of gene expression,GO:0032922,2.2848266296809983,0.015030677064677532,symptomatic
1663,roof of mouth development,GO:0060021,2.2817222456732797,0.003273947090925296,symptomatic
1764,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,GO:0090092,2.2804828528184875,3.302589725768894e-08,symptomatic
1881,dendrite development,GO:0016358,2.2798160449667857,0.0007161563040638945,symptomatic
2120,regulation of canonical Wnt signaling pathway,GO:0060828,2.277107620796941,4.7490108921455974e-08,symptomatic
1340,negative regulation of cell development,GO:0010721,2.2766955740593584,9.162658804970036e-09,symptomatic
1608,regulation of DNA-templated transcription elongation,GO:0032784,2.276343362491589,0.0018314439006581378,symptomatic
652,cellular response to nitrogen compound,GO:1901699,2.274757281553398,1.8653628039158756e-19,symptomatic
1593,cardiac muscle tissue development,GO:0048738,2.274248728617661,5.397390260523875e-06,symptomatic
551,cellular response to organic cyclic compound,GO:0071407,2.2737947414475603,2.2289946224757727e-14,symptomatic
731,regulation of cell cycle process,GO:0010564,2.271844660194175,1.1900708526865498e-22,symptomatic
1848,mononuclear cell proliferation,GO:0032943,2.271844660194175,0.0002231613436296968,symptomatic
1990,protein localization to endoplasmic reticulum,GO:0070972,2.271844660194175,0.02130953969011273,symptomatic
2112,negative regulation of G2/M transition of mitotic cell cycle,GO:0010972,2.271844660194175,0.02129892208189643,symptomatic
357,myeloid leukocyte differentiation,GO:0002573,2.2718446601941746,7.375505543215197e-05,symptomatic
318,regulation of carbohydrate metabolic process,GO:0006109,2.2693886119128837,7.763474361722627e-06,symptomatic
1299,innate immune response-activating signaling pathway,GO:0002758,2.268622185498864,0.0001284813277393004,symptomatic
92,regulation of programmed cell death,GO:0043067,2.2673637042569084,3.858712168997447e-49,symptomatic
2029,development of primary female sexual characteristics,GO:0046545,2.26716044439996,0.0025613897451060696,symptomatic
870,regulation of neuron differentiation,GO:0045664,2.26716044439996,4.183086554188013e-06,symptomatic
1152,morphogenesis of an epithelium,GO:0002009,2.2669378682715093,3.581634920933259e-14,symptomatic
1869,gastrulation,GO:0007369,2.266561300519305,2.0948501665376798e-05,symptomatic
2114,activation of protein kinase activity,GO:0032147,2.2657864077669907,0.01147333526976293,symptomatic
1780,telencephalon development,GO:0021537,2.265306977718796,1.4628843556805746e-08,symptomatic
1465,regulation of DNA replication,GO:0006275,2.264745145631068,0.0003197801006696735,symptomatic
887,tissue morphogenesis,GO:0048729,2.263928825141233,1.4129179105922868e-17,symptomatic
2115,positive regulation of immunoglobulin production,GO:0002639,2.2632716614764607,0.036275601965416154,symptomatic
2123,positive regulation of neuron projection development,GO:0010976,2.2632716614764607,5.559610722001666e-05,symptomatic
2119,positive regulation of canonical Wnt signaling pathway,GO:0090263,2.2632716614764607,0.001444199063971852,symptomatic
1678,neural precursor cell proliferation,GO:0061351,2.2632716614764607,0.0014430201259604467,symptomatic
2111,circadian rhythm,GO:0007623,2.2618949755509883,0.0001792672989304706,symptomatic
1695,branching morphogenesis of an epithelial tube,GO:0048754,2.2618949755509883,0.00017945192024759773,symptomatic
775,endothelial cell differentiation,GO:0045446,2.2610263522884884,0.0063926396097960915,symptomatic
799,protein-containing complex disassembly,GO:0032984,2.2593961963026996,0.0001508023144896329,symptomatic
1434,morphogenesis of a branching structure,GO:0001763,2.2590093796281057,1.5975417791137903e-05,symptomatic
2028,female gonad development,GO:0008585,2.2571875978703413,0.003580873313486139,symptomatic
2041,positive regulation of lipid metabolic process,GO:0045834,2.2571875978703413,0.0004522257599059639,symptomatic
665,regulation of cell cycle,GO:0051726,2.2560042754075,1.0496791316901057e-33,symptomatic
814,proteasome-mediated ubiquitin-dependent protein catabolic process,GO:0043161,2.2550161812297733,4.877539877481434e-09,symptomatic
2101,positive regulation of myeloid cell differentiation,GO:0045639,2.2540262707024556,0.002031412051542977,symptomatic
549,response to hormone,GO:0009725,2.2539014284830867,9.118453241818742e-24,symptomatic
344,negative regulation of growth,GO:0045926,2.2532229826515997,2.2596218940304503e-07,symptomatic
2216,stem cell differentiation,GO:0048863,2.2518723994452152,1.2324201659793987e-05,symptomatic
436,regulation of catabolic process,GO:0009894,2.2496152603879693,2.555465723317264e-31,symptomatic
782,regulation of cell development,GO:0060284,2.247930505876341,2.635729422258745e-25,symptomatic
600,negative regulation of intracellular signal transduction,GO:1902532,2.2477556308904703,2.2986823425654647e-16,symptomatic
87,viral life cycle,GO:0019058,2.2463183156976108,1.770048377120553e-05,symptomatic
346,regulation of cell growth,GO:0001558,2.2449907043999175,1.470342627326173e-12,symptomatic
937,positive regulation of establishment of protein localization,GO:1904951,2.244636939712807,6.509671710577454e-10,symptomatic
1961,spindle assembly,GO:0051225,2.2440261541509807,0.0028467561152962302,symptomatic
523,response to organonitrogen compound,GO:0010243,2.2425150254276467,1.8209881656911724e-28,symptomatic
850,cellular response to starvation,GO:0009267,2.2405088717777035,2.5431886125660856e-05,symptomatic
828,glomerulus development,GO:0032835,2.2405088717777035,0.042452266700058465,symptomatic
2124,regulation of dendritic spine development,GO:0060998,2.2405088717777035,0.04243363093767916,symptomatic
1424,regulation of protein catabolic process,GO:0042176,2.2395670857870447,7.568316012438464e-11,symptomatic
571,epithelial cell development,GO:0002064,2.2387135922330095,7.6108249285335425e-06,symptomatic
2125,B cell differentiation,GO:0030183,2.2379365309375454,0.00042802653782959214,symptomatic
1408,regulation of protein processing,GO:0070613,2.2379365309375454,0.02288205060522165,symptomatic
868,positive regulation of catabolic process,GO:0009896,2.2362249159999257,2.2215142778582917e-15,symptomatic
1201,negative regulation of phosphorylation,GO:0042326,2.2359734287174247,6.9591625148232595e-09,symptomatic
619,regulation of microtubule cytoskeleton organization,GO:0070507,2.235156485557499,6.544908607929997e-05,symptomatic
1944,nucleoside diphosphate metabolic process,GO:0009132,2.234426042261565,0.007052986222032057,symptomatic
2127,glucose metabolic process,GO:0006006,2.2305383936451895,0.0007267736787194695,symptomatic
1305,activation of innate immune response,GO:0002218,2.22805006433501,5.075270334891803e-05,symptomatic
894,T cell differentiation,GO:0030217,2.2273955255382014,1.5507577424239922e-05,symptomatic
427,regulation of cell junction assembly,GO:1901888,2.226623107716376,3.7804872856289995e-06,symptomatic
548,response to endogenous stimulus,GO:0009719,2.2245078543758128,1.5664587000122442e-42,symptomatic
188,negative regulation of DNA-binding transcription factor activity,GO:0043433,2.221359223300971,0.00024220249807822275,symptomatic
1409,regulation of protein maturation,GO:1903317,2.221359223300971,0.017565889448246587,symptomatic
1952,pyruvate metabolic process,GO:0006090,2.221359223300971,0.01757503834900088,symptomatic
1966,sister chromatid segregation,GO:0000819,2.221359223300971,0.00024244421713818105,symptomatic
341,negative regulation of developmental growth,GO:0048640,2.2213592233009707,0.0018123862497433343,symptomatic
2091,limbic system development,GO:0021761,2.2213592233009707,0.0008533249128563178,symptomatic
923,respiratory system development,GO:0060541,2.2213592233009707,2.857853955800352e-06,symptomatic
2130,cellular senescence,GO:0090398,2.2213592233009707,0.03212702373641399,symptomatic
342,regulation of developmental growth,GO:0048638,2.2213592233009707,2.3694923385271474e-09,symptomatic
710,nucleocytoplasmic transport,GO:0006913,2.2168806764797995,3.328008349954915e-07,symptomatic
816,modification-dependent protein catabolic process,GO:0019941,2.2168806764797995,3.378023588264254e-14,symptomatic
434,regulation of mRNA catabolic process,GO:0061013,2.2156340706635973,9.724101377190175e-06,symptomatic
312,positive regulation of cell differentiation,GO:0045597,2.2149833357484425,3.956826924124821e-25,symptomatic
803,protein phosphorylation,GO:0006468,2.2145867866445657,4.87907847216197e-14,symptomatic
1962,mitotic sister chromatid segregation,GO:0000070,2.2134257975034672,0.0003412482822770613,symptomatic
1162,regulation of B cell activation,GO:0050864,2.212880752983028,0.0006470831289191277,symptomatic
2023,response to heat,GO:0009408,2.209667858967808,0.004435327842305402,symptomatic
2131,cellular response to fibroblast growth factor stimulus,GO:0044344,2.208444344095733,0.0077729920430901125,symptomatic
1355,regulation of response to endoplasmic reticulum stress,GO:1905897,2.208444344095733,0.007777769542809283,symptomatic
711,nuclear transport,GO:0051169,2.207977541232893,3.738981804428546e-07,symptomatic
1327,spindle organization,GO:0007051,2.207731252605873,7.943821902662108e-05,symptomatic
747,negative regulation of nervous system development,GO:0051961,2.206934812760055,0.00014526282061463175,symptomatic
368,regulation of organic acid transport,GO:0032890,2.206934812760055,0.013502547543755863,symptomatic
2133,regulation of tissue remodeling,GO:0034103,2.206934812760055,0.0135098383361661,symptomatic
1752,positive regulation of cell projection organization,GO:0031346,2.2058469382220536,5.10910194398209e-10,symptomatic
815,ubiquitin-dependent protein catabolic process,GO:0006511,2.2053287959163246,1.146123611506776e-13,symptomatic
2113,negative regulation of cell cycle G2/M phase transition,GO:1902750,2.2050256996002284,0.02448876430088634,symptomatic
2134,negative regulation of epithelial cell proliferation,GO:0050680,2.2050256996002284,0.00048510322654464233,symptomatic
1943,purine nucleoside diphosphate metabolic process,GO:0009135,2.2050256996002284,0.02446500033746966,symptomatic
1942,purine ribonucleoside diphosphate metabolic process,GO:0009179,2.2050256996002284,0.024476876551225716,symptomatic
820,proteasomal protein catabolic process,GO:0010498,2.204271844660194,5.7828433214939014e-11,symptomatic
1594,striated muscle tissue development,GO:0014706,2.204271844660194,1.586856147649529e-05,symptomatic
867,positive regulation of cellular catabolic process,GO:0031331,2.2041126454803117,4.243370262806566e-09,symptomatic
529,biological process involved in interaction with symbiont,GO:0051702,2.2025341451374034,0.001725632270680587,symptomatic
2135,regulation of tumor necrosis factor-mediated signaling pathway,GO:0010803,2.2025341451374034,0.045118100685332216,symptomatic
1721,regulation of leukocyte differentiation,GO:1902105,2.2009797808853655,3.3354900539945475e-09,symptomatic
1689,hematopoietic or lymphoid organ development,GO:0048534,2.1991456310679616,0.003515516769111425,symptomatic
2138,negative regulation of canonical Wnt signaling pathway,GO:0090090,2.1977277422020247,0.0003710296657076306,symptomatic
506,homeostasis of number of cells,GO:0048872,2.1977277422020247,7.027438679820507e-08,symptomatic
2217,neural crest cell differentiation,GO:0014033,2.196948682385576,0.006128910875431731,symptomatic
145,negative regulation of protein metabolic process,GO:0051248,2.1966774541531824,1.0916251684706518e-22,symptomatic
2140,endocrine system development,GO:0035270,2.196116504854369,0.0006914304414704584,symptomatic
2010,positive regulation of proteolysis involved in protein catabolic process,GO:1903052,2.196116504854369,0.0006920483417756152,symptomatic
552,cellular response to lipid,GO:0071396,2.196116504854369,1.1703757508960124e-14,symptomatic
2025,response to type II interferon,GO:0034341,2.196116504854369,0.0006908136435744099,symptomatic
897,lymphocyte differentiation,GO:0030098,2.195093151403831,2.8972236417789967e-08,symptomatic
1777,positive regulation of peptidyl-tyrosine phosphorylation,GO:0050731,2.194269476675349,8.860523299597914e-05,symptomatic
1763,regulation of cellular response to growth factor stimulus,GO:0090287,2.1935051891529964,6.787164676860733e-09,symptomatic
2141,endosome to lysosome transport,GO:0008333,2.1909296448995876,0.019032490499872722,symptomatic
2142,negative regulation of transcription by RNA polymerase II,GO:0000122,2.1906382978723404,3.118272943952603e-26,symptomatic
817,modification-dependent macromolecule catabolic process,GO:0043632,2.1884988797610156,6.693549372931515e-14,symptomatic
242,regulation of anatomical structure morphogenesis,GO:0022603,2.1884988797610156,2.35689987169757e-23,symptomatic
1379,response to oxidative stress,GO:0006979,2.1883390186302805,3.608992913255408e-10,symptomatic
851,cellular response to nutrient levels,GO:0031669,2.1879911662985956,1.5905300141885293e-06,symptomatic
2145,positive regulation of JNK cascade,GO:0046330,2.186650485436893,0.004878369585108839,symptomatic
2144,response to alkaloid,GO:0043279,2.186650485436893,0.004881598155317382,symptomatic
2148,response to endoplasmic reticulum stress,GO:0034976,2.182558188832832,2.263893673744818e-06,symptomatic
2003,kidney epithelium development,GO:0072073,2.182250786271024,0.0004058789494126673,symptomatic
2122,positive regulation of Wnt signaling pathway,GO:0030177,2.182250786271024,0.0004054974842346479,symptomatic
2149,tissue remodeling,GO:0048771,2.180970873786408,0.0033376812771862894,symptomatic
1971,regulation of RNA splicing,GO:0043484,2.1800041313778147,3.3676444095270385e-05,symptomatic
2061,mesoderm development,GO:0007498,2.1796043506825313,0.0007459821157404733,symptomatic
1815,regulation of MAP kinase activity,GO:0043405,2.1796043506825313,0.0007453237025756538,symptomatic
290,cytosolic transport,GO:0016482,2.1796043506825313,0.0007446664506333472,symptomatic
2150,autophagosome assembly,GO:0000045,2.178640776699029,0.014764435470057468,symptomatic
1945,ribonucleoside diphosphate metabolic process,GO:0009185,2.178640776699029,0.01475662359943839,symptomatic
1937,regulation of receptor signaling pathway via JAK-STAT,GO:0046425,2.178640776699029,0.014748819990977555,symptomatic
216,hair cycle,GO:0042633,2.1773719119484762,0.003960046041195473,symptomatic
2153,positive regulation of cold-induced thermogenesis,GO:0120162,2.1773719119484762,0.003962803733424718,symptomatic
217,molting cycle,GO:0042303,2.1773719119484762,0.003957292184421346,symptomatic
2094,male sex differentiation,GO:0046661,2.175625356938892,7.854663077022597e-05,symptomatic
354,leukocyte differentiation,GO:0002521,2.175080906148867,1.22937474194534e-11,symptomatic
334,regulation of lipid biosynthetic process,GO:0046890,2.170585298196949,8.96330462882127e-05,symptomatic
2085,regulation of sodium ion transport,GO:0002028,2.167832495028658,0.011711976436096349,symptomatic
219,skin epidermis development,GO:0098773,2.1658252427184466,0.001924489078587098,symptomatic
2155,positive regulation of interleukin-1 beta production,GO:0032731,2.1658252427184466,0.048796344408111154,symptomatic
1785,gliogenesis,GO:0042063,2.1652237916652064,1.9508519096190404e-07,symptomatic
1824,Wnt signaling pathway,GO:0016055,2.1622805205536046,1.5107501114948616e-07,symptomatic
1825,cell-cell signaling by wnt,GO:0198738,2.1622805205536046,1.5134478795511023e-07,symptomatic
2160,regulation of cytoplasmic pattern recognition receptor signaling pathway,GO:0039531,2.1613224875360797,0.0034882283994980383,symptomatic
2158,regulation of transcription initiation by RNA polymerase II,GO:0060260,2.1613224875360797,0.021064946026685127,symptomatic
822,connective tissue development,GO:0061448,2.1601777192693765,3.13901331203702e-06,symptomatic
1200,negative regulation of protein modification process,GO:0031400,2.159355264398153,7.568951007418226e-11,symptomatic
1906,MAPK cascade,GO:0000165,2.158785724053056,9.252175055666744e-06,symptomatic
2033,gonad development,GO:0008406,2.157752020871648,5.986058601430176e-06,symptomatic
2074,response to glucose,GO:0009749,2.1574352168750437,0.0006353139039846356,symptomatic
380,blood vessel morphogenesis,GO:0048514,2.1569346518595274,3.412057044598194e-11,symptomatic
2032,development of primary sexual characteristics,GO:0045137,2.1543354536324073,4.427053323474184e-06,symptomatic
1388,innate immune response activating cell surface receptor signaling pathway,GO:0002220,2.153009708737864,0.03712835464725298,symptomatic
2163,peptidyl-tyrosine phosphorylation,GO:0018108,2.153009708737864,0.03709510041111572,symptomatic
2162,positive regulation of interleukin-8 production,GO:0032757,2.153009708737864,0.037111720079758694,symptomatic
353,mononuclear cell differentiation,GO:1903131,2.1525560615173123,7.057279145152508e-09,symptomatic
422,developmental growth,GO:0048589,2.1519417475728155,3.666672989258494e-11,symptomatic
423,growth,GO:0040007,2.1519417475728155,3.676915092580445e-11,symptomatic
899,alpha-beta T cell differentiation,GO:0046632,2.1510630453484083,0.016410590823838823,symptomatic
2165,positive regulation of macroautophagy,GO:0016239,2.1510630453484083,0.016419214360793022,symptomatic
141,regulation of proteolysis,GO:0030162,2.150425063229175,1.9398793600778046e-15,symptomatic
376,blood vessel development,GO:0001568,2.1501080784026376,9.53404987241006e-14,symptomatic
2167,centrosome cycle,GO:0007098,2.14970247416223,0.007615159187207146,symptomatic
1511,ameboidal-type cell migration,GO:0001667,2.1491650485436895,2.3960643113316782e-05,symptomatic
2056,positive regulation of protein localization to membrane,GO:1905477,2.148697940295799,0.0048306442024304095,symptomatic
1368,regulation of protein stability,GO:0031647,2.1484190697000436,1.0112566415780239e-08,symptomatic
1298,pattern recognition receptor signaling pathway,GO:0002221,2.1479258605472196,0.0020543445077419904,symptomatic
360,negative regulation of transmembrane transport,GO:0034763,2.1479258605472196,0.0020527666701784402,symptomatic
1577,response to glucocorticoid,GO:0051384,2.1473139158576053,0.0008812959850921895,symptomatic
153,positive regulation of protein metabolic process,GO:0051247,2.147194776183521,4.5132991118984666e-33,symptomatic
669,regulation of phosphate metabolic process,GO:0019220,2.1469919797382864,2.27845126642186e-30,symptomatic
670,regulation of phosphorus metabolic process,GO:0051174,2.1451266522146217,2.4527122073062915e-30,symptomatic
2173,cellular response to biotic stimulus,GO:0071216,2.1450893787241134,4.694241912678208e-06,symptomatic
1151,epithelial tube morphogenesis,GO:0060562,2.1442773575081926,3.3469596428341575e-08,symptomatic
1461,RNA destabilization,GO:0050779,2.1420249653259367,0.012961855485265787,symptomatic
2169,cellular response to lipopolysaccharide,GO:0071222,2.1420249653259362,3.342745187712502e-05,symptomatic
2174,pancreas development,GO:0031016,2.1420249653259362,0.02907876759225168,symptomatic
977,regulation of cell size,GO:0008361,2.1420249653259362,3.338623430391032e-05,symptomatic
474,chromatin remodeling,GO:0006338,2.1408751934712256,7.384855184703903e-16,symptomatic
787,response to wounding,GO:0009611,2.1387039963874463,6.297961858246432e-11,symptomatic
1181,glycerophospholipid biosynthetic process,GO:0046474,2.138472685118099,2.6342717991842934e-05,symptomatic
673,regulation of protein modification process,GO:0031399,2.137381008761544,4.384884817815544e-32,symptomatic
381,tube morphogenesis,GO:0035239,2.133673990802248,2.442667574330123e-17,symptomatic
2005,protein polyubiquitination,GO:0000209,2.133558463486703,1.6567109327242017e-06,symptomatic
1665,regulation of cardiac muscle contraction,GO:0055117,2.1325048543689324,0.0229097809426589,symptomatic
2118,regulation of immunoglobulin production,GO:0002637,2.1325048543689324,0.022932475128832907,symptomatic
2175,regulation of mitochondrial membrane potential,GO:0051881,2.1325048543689324,0.02292112241837309,symptomatic
1928,regulation of ossification,GO:0030278,2.130319910870603,0.0022091029471193223,symptomatic
722,protein catabolic process,GO:0030163,2.1300916786110284,4.453411233102667e-18,symptomatic
1650,regulation of response to wounding,GO:1903034,2.129350261389096,0.00019947143716358178,symptomatic
2147,regulation of JNK cascade,GO:0046328,2.126833298905185,0.0007732546246698996,symptomatic
148,negative regulation of molecular function,GO:0044092,2.1262457758944375,3.7468536686088165e-18,symptomatic
275,regulation of DNA metabolic process,GO:0051052,2.1256109809173083,5.686145291971223e-13,symptomatic
672,regulation of protein phosphorylation,GO:0001932,2.1240378991694935,5.152089630024878e-23,symptomatic
1750,regulation of extent of cell growth,GO:0061387,2.1230689921814587,0.003992690544387618,symptomatic
377,vasculature development,GO:0001944,2.122587352210456,1.5994602865302463e-13,symptomatic
82,ossification,GO:0001503,2.1224630934964757,2.603286692974888e-07,symptomatic
2176,positive regulation of chemotaxis,GO:0050921,2.1224630934964757,0.000614506221006673,symptomatic
109,cellular response to stress,GO:0033554,2.121342104619598,2.014586528861438e-41,symptomatic
1595,muscle tissue development,GO:0060537,2.1212689094603747,1.539614598696536e-08,symptomatic
1908,maintenance of protein location in cell,GO:0032507,2.1203883495145632,0.04054643145109153,symptomatic
2178,astrocyte differentiation,GO:0048708,2.1203883495145632,0.040528490552219375,symptomatic
2179,positive regulation of response to cytokine stimulus,GO:0060760,2.1203883495145632,0.040492656343066216,symptomatic
847,regulation of postsynaptic membrane neurotransmitter receptor levels,GO:0099072,2.1203883495145632,0.040510565523226794,symptomatic
1168,negative regulation of leukocyte proliferation,GO:0070664,2.120388349514563,0.009121500521798344,symptomatic
938,positive regulation of protein localization,GO:1903829,2.120388349514563,4.0316401059028655e-12,symptomatic
524,response to nitrogen compound,GO:1901698,2.1169363538295576,2.2553295451926986e-26,symptomatic
2151,autophagosome organization,GO:1905037,2.1168246716162193,0.014343374345806053,symptomatic
2180,positive regulation of B cell activation,GO:0050871,2.1168246716162193,0.014351040499919258,symptomatic
530,biological process involved in symbiotic interaction,GO:0044403,2.1145631067961164,2.3009023533857615e-06,symptomatic
2184,negative regulation of angiogenesis,GO:0016525,2.1145631067961164,0.007132885555632763,symptomatic
1258,cellular response to alcohol,GO:0097306,2.1145631067961164,0.007128438619500822,symptomatic
653,cellular response to oxygen-containing compound,GO:1901701,2.112923204343625,2.7549418800652293e-26,symptomatic
2121,regulation of Wnt signaling pathway,GO:0030111,2.1122746185852983,3.1170907982427936e-08,symptomatic
2187,cardiac muscle cell differentiation,GO:0055007,2.1102912621359224,0.016803048073293556,symptomatic
1193,regulation of Rho protein signal transduction,GO:0035023,2.1102912621359224,0.01679423682627033,symptomatic
629,positive regulation of protein-containing complex assembly,GO:0031334,2.1097331316778067,6.60555381178144e-05,symptomatic
1930,glial cell differentiation,GO:0010001,2.1092722900151424,2.054679952665791e-05,symptomatic
682,positive regulation of protein modification process,GO:0031401,2.109272290015142,1.669817517018268e-18,symptomatic
343,regulation of growth,GO:0040008,2.1086815815393276,4.559069495124609e-15,symptomatic
2191,glial cell development,GO:0021782,2.1085558252427186,0.0019179530731900352,symptomatic
1339,negative regulation of neurogenesis,GO:0050768,2.1080245690509214,0.000953920400267922,symptomatic
972,regulation of nuclear division,GO:0051783,2.1080245690509214,0.0009547288073867932,symptomatic
2260,tube formation,GO:0035148,2.1080245690509214,0.0009531133610121963,symptomatic
2055,regulation of protein localization to membrane,GO:1905475,2.1072894253476777,0.00010267435318529439,symptomatic
818,proteolysis involved in protein catabolic process,GO:0051603,2.10531806984495,1.637765842137695e-14,symptomatic
1636,DNA modification,GO:0006304,2.1044455799693407,0.02515342824803289,symptomatic
2192,establishment of cell polarity,GO:0030010,2.1044455799693407,0.0015264316664126965,symptomatic
1912,blastocyst development,GO:0001824,2.1044455799693407,0.004328916021369997,symptomatic
1679,cell population proliferation,GO:0008283,2.103008117141493,1.1087052777218391e-17,symptomatic
668,regulation of phosphorylation,GO:0042325,2.1023177280179057,4.918277376905827e-24,symptomatic
142,regulation of protein metabolic process,GO:0051246,2.1017475728155337,5.419808884254789e-56,symptomatic
1578,response to corticosteroid,GO:0031960,2.101094551975759,0.0005520430266859008,symptomatic
378,circulatory system development,GO:0072359,2.100477067291597,1.864269438612775e-22,symptomatic
149,negative regulation of endopeptidase activity,GO:0010951,2.1000244758097413,0.0033504809064899654,symptomatic
852,cellular response to extracellular stimulus,GO:0031668,2.0984214036908027,2.584834141091372e-06,symptomatic
327,regulation of organelle assembly,GO:1902115,2.0973994452149793,1.707866569070992e-05,symptomatic
2008,regulation of ubiquitin-dependent protein catabolic process,GO:2000058,2.0949944770652866,0.00032988368312326255,symptomatic
2193,positive regulation of tumor necrosis factor production,GO:0032760,2.094424410540915,0.0076235811947530634,symptomatic
2039,regulation of BMP signaling pathway,GO:0030510,2.094424410540915,0.007614175172304263,symptomatic
2185,negative regulation of blood vessel morphogenesis,GO:2000181,2.094424410540915,0.0076188752804353145,symptomatic
336,negative regulation of lipid metabolic process,GO:0045833,2.094424410540915,0.007609480859620967,symptomatic
981,non-membrane-bounded organelle assembly,GO:0140694,2.092210431248589,3.196074896583247e-08,symptomatic
2166,positive regulation of autophagy,GO:0010508,2.0906910336950317,0.0007742655766836759,symptomatic
1084,cell cycle process,GO:0022402,2.090097087378641,5.76493813318297e-21,symptomatic
1924,response to retinoic acid,GO:0032526,2.090097087378641,0.005898828527132262,symptomatic
2197,symbiont entry into host cell,GO:0046718,2.090097087378641,0.005895042372750277,symptomatic
2053,regulation of protein localization to plasma membrane,GO:1903076,2.090097087378641,0.005902619548036589,symptomatic
748,regulation of nervous system development,GO:0051960,2.0897053900234352,7.508860084578826e-11,symptomatic
2164,peptidyl-tyrosine modification,GO:0018212,2.0887407622083756,0.04424840474329257,symptomatic
2232,response to topologically incorrect protein,GO:0035966,2.0887407622083756,0.0016840837268605735,symptomatic
1885,establishment of protein localization to vacuole,GO:0072666,2.0887407622083756,0.04422917466735024,symptomatic
545,hormone-mediated signaling pathway,GO:0009755,2.0887407622083756,0.0016854342350617448,symptomatic
237,negative regulation of developmental process,GO:0051093,2.088416070655102,7.491669328265311e-22,symptomatic
628,positive regulation of protein polymerization,GO:0032273,2.087101248266297,0.01756689986387733,symptomatic
1014,regulation of T cell proliferation,GO:0042129,2.087101248266297,0.0001588907956109505,symptomatic
2170,response to lipopolysaccharide,GO:0032496,2.0864168405770798,1.3893002213793719e-07,symptomatic
2200,positive regulation of transcription by RNA polymerase II,GO:0045944,2.0861460531869986,2.3685619962677724e-30,symptomatic
1169,negative regulation of cell population proliferation,GO:0008285,2.0836975249555585,1.8238505673600305e-16,symptomatic
678,positive regulation of protein phosphorylation,GO:0001934,2.0825242718446604,2.187577580303685e-13,symptomatic
2156,positive regulation of interleukin-1 production,GO:0032732,2.0825242718446604,0.03467788118451094,symptomatic
289,axo-dendritic transport,GO:0008088,2.0825242718446604,0.03466221818487927,symptomatic
864,positive regulation of mRNA catabolic process,GO:0061014,2.08252427184466,0.013369632136998679,symptomatic
1749,regulation of axon extension,GO:0030516,2.08252427184466,0.01337691407171382,symptomatic
231,regulation of cell differentiation,GO:0045595,2.0809284678049322,4.074538498319076e-38,symptomatic
2013,regulation of proteasomal ubiquitin-dependent protein catabolic process,GO:0032434,2.079192233009709,0.0029173743999380774,symptomatic
240,positive regulation of developmental process,GO:0051094,2.0784744864244686,5.568960377573072e-32,symptomatic
2201,segmentation,GO:0035282,2.078400461405364,0.01030657136351284,symptomatic
2202,cartilage development,GO:0051216,2.07784444202029,0.00022007125414597153,symptomatic
613,protein acylation,GO:0043543,2.077115117891817,0.027728170941480113,symptomatic
2077,carbohydrate homeostasis,GO:0033500,2.0764879696074297,6.0741675713683974e-05,symptomatic
2172,cellular response to molecule of bacterial origin,GO:0071219,2.0764879696074297,6.0671045858202946e-05,symptomatic
2186,negative regulation of vasculature development,GO:1901343,2.0746656896867557,0.008144673915952985,symptomatic
709,nuclear export,GO:0051168,2.0732686084142395,0.0025626448513139184,symptomatic
679,positive regulation of phosphorylation,GO:0042327,2.0731495645115974,2.926338268324774e-14,symptomatic
896,lymphocyte activation,GO:0046649,2.0731165646617895,4.788173353152348e-11,symptomatic
2203,positive regulation of MAP kinase activity,GO:0043406,2.072365616860052,0.03194792973297984,symptomatic
2255,negative regulation of cell projection organization,GO:0031345,2.069902912621359,0.00011032063246231143,symptomatic
2204,adult locomotory behavior,GO:0008344,2.068162035487111,0.02441236612671888,symptomatic
796,negative regulation of cell adhesion,GO:0007162,2.0681620354871106,1.2693055266408963e-06,symptomatic
2199,biological process involved in interaction with host,GO:0051701,2.0658640776699033,0.0011591288334953048,symptomatic
233,regulation of multicellular organismal development,GO:2000026,2.0647249190938513,5.8926255630235685e-33,symptomatic
2048,regulation of cytokinesis,GO:0032465,2.0644153651329673,0.018496150553837718,symptomatic
2257,embryonic epithelial tube formation,GO:0001838,2.0626907073509013,0.00462477938179262,symptomatic
2205,protein stabilization,GO:0050821,2.0619791893421566,4.655112726203538e-05,symptomatic
599,negative regulation of MAPK cascade,GO:0043409,2.0616990291262134,0.0006987937171838035,symptomatic
298,establishment or maintenance of cell polarity,GO:0007163,2.0580239862935468,9.162389380895372e-05,symptomatic
2206,cardiac cell development,GO:0055006,2.0580239862935463,0.0488598635314964,symptomatic
1779,forebrain development,GO:0030900,2.0573121135898824,4.237091328412029e-09,symptomatic
2168,microtubule organizing center organization,GO:0031023,2.0552762907177207,0.008679026293039824,symptomatic
1083,cell cycle,GO:0007049,2.0545377796538626,8.522868115614195e-29,symptomatic
2207,regulation of cilium assembly,GO:1902017,2.0539965420933632,0.038474505895147046,symptomatic
2210,regulation of alpha-beta T cell differentiation,GO:0046637,2.0539965420933632,0.03844010758858008,symptomatic
1509,endothelial cell migration,GO:0043542,2.0539965420933632,0.03845729904993454,symptomatic
2198,symbiont entry into host,GO:0044409,2.0527739251040225,0.006957618272114834,symptomatic
1969,"regulation of mRNA splicing, via spliceosome",GO:0048024,2.0527739251040225,0.00694892124927469,symptomatic
2030,female sex differentiation,GO:0046660,2.0527739251040225,0.006944580886220802,symptomatic
1956,developmental cell growth,GO:0048588,2.0527739251040225,0.006953267041175424,symptomatic
296,regulation of cell adhesion,GO:0030155,2.0524345675366384,1.4426590908195283e-17,symptomatic
1849,leukocyte proliferation,GO:0070661,2.052182858612486,0.0012534002001511875,symptomatic
916,reproductive structure development,GO:0048608,2.052182858612486,8.734707617858537e-07,symptomatic
433,regulation of mRNA metabolic process,GO:1903311,2.051320325100408,6.804909310040583e-07,symptomatic
2214,neural crest cell development,GO:0014032,2.0504854368932035,0.04387302606336024,symptomatic
1926,negative regulation of protein-containing complex disassembly,GO:0043242,2.0504854368932035,0.04385392592140841,symptomatic
2218,Ras protein signal transduction,GO:0007265,2.0473973564159547,0.03331236325982778,symptomatic
355,hemopoiesis,GO:0030097,2.044985207716988,3.157512848955625e-15,symptomatic
475,chromatin organization,GO:0006325,2.0434769417475724,8.176000878947006e-17,symptomatic
1774,response to light stimulus,GO:0009416,2.0432313610551383,6.079511152208158e-07,symptomatic
2227,regulation of canonical NF-kappaB signal transduction,GO:0043122,2.0422173504541186,3.7275765473347303e-06,symptomatic
583,regulation of cell migration,GO:0030334,2.0417599669489777,1.2771852312644642e-20,symptomatic
146,negative regulation of hydrolase activity,GO:0051346,2.0400237765008917,0.00017787777667978416,symptomatic
1244,regulation of glucose metabolic process,GO:0010906,2.0400237765008917,0.015115002414763126,symptomatic
1981,translation,GO:0006412,2.039509916607566,1.6341998103813835e-08,symptomatic
519,response to organic cyclic compound,GO:0014070,2.039302069976186,1.809584770859092e-18,symptomatic
2219,positive regulation of T cell proliferation,GO:0042102,2.0380431708926383,0.011900735295234574,symptomatic
2076,glucose homeostasis,GO:0042593,2.0380431708926383,0.00011001528225342562,symptomatic
2038,negative regulation of cellular response to growth factor stimulus,GO:0090288,2.0380431708926383,0.011907339476863451,symptomatic
351,cell activation,GO:0001775,2.037252005065428,7.412934079649276e-16,symptomatic
1790,neural tube development,GO:0021915,2.0362459546925566,0.000831288644782536,symptomatic
601,negative regulation of signal transduction,GO:0009968,2.036103669320836,9.686509268769472e-29,symptomatic
147,negative regulation of catalytic activity,GO:0043086,2.030813736877863,2.203892346625759e-09,symptomatic
1515,angiogenesis,GO:0001525,2.0286236436322103,3.6172135808581644e-07,symptomatic
681,positive regulation of phosphorus metabolic process,GO:0010562,2.0277836338418864,6.642875319649356e-15,symptomatic
680,positive regulation of phosphate metabolic process,GO:0045937,2.0277836338418864,6.616926587931976e-15,symptomatic
2225,positive regulation of inflammatory response,GO:0050729,2.0271844660194174,0.0023677363840391946,symptomatic
917,reproductive system development,GO:0061458,2.025356938892062,1.6838522090795714e-06,symptomatic
2215,stem cell development,GO:0048864,2.0230235783633845,0.0347037345947806,symptomatic
325,positive regulation of organelle organization,GO:0010638,2.023023578363384,1.29603151670175e-10,symptomatic
114,response to abiotic stimulus,GO:0009628,2.0225955158203535,1.0799444019008664e-23,symptomatic
189,regulation of DNA-binding transcription factor activity,GO:0051090,2.0210727359541623,9.523955361114599e-08,symptomatic
2132,response to fibroblast growth factor,GO:0071774,2.0204916339599257,0.020967996810526784,symptomatic
2050,positive regulation of cell division,GO:0051781,2.0204916339599257,0.020957486536436292,symptomatic
1874,embryonic skeletal system morphogenesis,GO:0048704,2.0204916339599257,0.02094698679368257,symptomatic
2126,B cell activation,GO:0042113,2.019940640877308,0.0002696457825429148,symptomatic
2235,chromosome localization,GO:0050000,2.0184466019417475,0.012870600610373442,symptomatic
1812,wound healing,GO:0042060,2.0178496050171866,8.179987758847579e-07,symptomatic
2196,positive regulation of tumor necrosis factor superfamily cytokine production,GO:1903557,2.017564799144919,0.010227101378551314,symptomatic
1796,negative regulation of binding,GO:0051100,2.017564799144919,0.010232945436481915,symptomatic
1073,DNA damage response,GO:0006974,2.0172111712880922,3.801254066664177e-16,symptomatic
2188,striated muscle cell differentiation,GO:0051146,2.01715355479124,7.996718317884952e-05,symptomatic
1957,cell growth,GO:0016049,2.016760347470618,0.011584633271201128,symptomatic
534,cellular response to organic substance,GO:0071310,2.016607851414099,7.505793354144493e-38,symptomatic
1051,negative regulation of DNA-templated transcription,GO:0045892,2.0164175592278557,3.282943933636585e-27,symptomatic
1414,positive regulation of cell adhesion,GO:0045785,2.0156778137360662,4.4576726368294914e-10,symptomatic
750,regulation of synapse structure or activity,GO:0050803,2.0153460695270904,3.265192440902161e-05,symptomatic
2259,epithelial tube formation,GO:0072175,2.0141428778437906,0.004203603454316129,symptomatic
1492,vesicle-mediated transport to the plasma membrane,GO:0098876,2.0141428778437906,0.004200696397985344,symptomatic
1970,regulation of mRNA processing,GO:0050684,2.0141428778437906,0.004197793359700627,symptomatic
1993,skeletal muscle tissue development,GO:0007519,2.013106796116505,0.00256183488589751,symptomatic
1135,phagocytosis,GO:0006909,2.011797032423521,0.0017739002113585252,symptomatic
139,regulation of catalytic activity,GO:0050790,2.009162621359223,6.96649079669697e-30,symptomatic
806,intracellular signaling cassette,GO:0141124,2.008846517822719,3.8279553017002196e-17,symptomatic
2226,positive regulation of canonical NF-kappaB signal transduction,GO:0043123,2.008788962698007,0.00018708838402043453,symptomatic
1649,regulation of cell projection organization,GO:0031344,2.0081484049930656,1.1350918050267726e-13,symptomatic
144,negative regulation of proteolysis,GO:0045861,2.008148404993065,8.623047959416872e-05,symptomatic
2228,positive regulation of DNA-binding transcription factor activity,GO:0051091,2.007953533726205,6.730345741455433e-05,symptomatic
2171,response to molecule of bacterial origin,GO:0002237,2.0051207148380445,5.977547634088176e-07,symptomatic
522,response to oxygen-containing compound,GO:1901700,2.00050980245155,1.0059651511442091e-32,symptomatic
1115,positive regulation of RNA biosynthetic process,GO:1902680,2.000389708964439,1.528219479462427e-36,symptomatic
2229,integrin-mediated signaling pathway,GO:0007229,1.999223300970874,0.017721300678216027,symptomatic
2212,regulation of lymphocyte differentiation,GO:0045619,1.999223300970874,0.00015489949118616665,symptomatic
2230,positive regulation of interleukin-6 production,GO:0032755,1.999223300970874,0.017712147113816124,symptomatic
854,response to starvation,GO:0042594,1.999223300970874,0.00015473592255767018,symptomatic
60,negative regulation of RNA metabolic process,GO:0051253,1.9992233009708738,2.381988713519143e-29,symptomatic
1166,negative regulation of lymphocyte proliferation,GO:0050672,1.9992233009708738,0.028812712364558665,symptomatic
725,macromolecule catabolic process,GO:0009057,1.9992233009708738,2.1617096272328427e-19,symptomatic
2231,response to unfolded protein,GO:0006986,1.9992233009708735,0.009266013817690025,symptomatic
1142,embryonic organ development,GO:0048568,1.9992233009708735,3.001106660490332e-09,symptomatic
1460,mRNA destabilization,GO:0061157,1.9992233009708735,0.04858042919527848,symptomatic
1114,positive regulation of DNA-templated transcription,GO:0045893,1.9980548478434799,2.3957194695866563e-36,symptomatic
1052,negative regulation of RNA biosynthetic process,GO:1902679,1.9930433216788466,1.4126672934826454e-26,symptomatic
1373,intracellular protein transport,GO:0006886,1.9921713669286485,3.401034686168793e-11,symptomatic
1187,phospholipid biosynthetic process,GO:0008654,1.9909277686017,6.529148453787718e-05,symptomatic
488,regulation of muscle system process,GO:0090257,1.9903771801701176,0.00010219771648116532,symptomatic
1309,regulation of innate immune response,GO:0045088,1.989967637540453,1.2224868620125706e-08,symptomatic
584,regulation of cell motility,GO:2000145,1.9892271844660196,4.7407685934624604e-20,symptomatic
603,negative regulation of signaling,GO:0023057,1.9877828242843452,1.347543610146982e-28,symptomatic
107,intracellular signal transduction,GO:0035556,1.9873388824049967,4.374173224978699e-31,symptomatic
1144,chordate embryonic development,GO:0043009,1.9871797871096033,4.076577616969805e-13,symptomatic
895,T cell activation,GO:0042110,1.986805764939999,2.1447720601608787e-06,symptomatic
826,renal system development,GO:0072001,1.9866099047502372,2.816273633658727e-06,symptomatic
827,kidney development,GO:0001822,1.9861990449384903,3.3943912910150703e-06,symptomatic
2154,regulation of cold-induced thermogenesis,GO:0120161,1.9859834115604706,0.003281181378664431,symptomatic
657,response to radiation,GO:0009314,1.9852100535341621,1.700057757906204e-08,symptomatic
1435,developmental growth involved in morphogenesis,GO:0060560,1.985044412311506,0.003807149205338309,symptomatic
1586,small GTPase-mediated signal transduction,GO:0007264,1.983962054398577,2.542973736963693e-05,symptomatic
419,positive regulation of intracellular signal transduction,GO:1902533,1.983888894060263,8.543184637662088e-21,symptomatic
315,regulation of protein-containing complex disassembly,GO:0043244,1.9833564493758669,0.007783184351492932,symptomatic
143,negative regulation of peptidase activity,GO:0010466,1.9833564493758669,0.007778397645249702,symptomatic
749,regulation of synapse organization,GO:0050807,1.9827007943512798,6.875241594474425e-05,symptomatic
20,positive regulation of biosynthetic process,GO:0009891,1.982415958625785,0.00879695978193596,asymptomatic
602,negative regulation of cell communication,GO:0010648,1.9820503019646816,3.592122397524323e-28,symptomatic
1647,regulation of neuron projection development,GO:0010975,1.9818008756900816,5.154461796433656e-09,symptomatic
2233,positive regulation of plasma membrane bounded cell projection assembly,GO:0120034,1.9812122802414065,0.016481895287247608,symptomatic
866,positive regulation of RNA metabolic process,GO:0051254,1.9808718991801046,2.098618178184998e-38,symptomatic
1254,response to ketone,GO:1901654,1.9807972797637687,0.00017878038785117752,symptomatic
21,positive regulation of cellular metabolic process,GO:0031325,1.9797665369649804,0.0028618181157779314,asymptomatic
350,leukocyte activation,GO:0045321,1.9795909935963643,6.772502678726887e-12,symptomatic
1630,negative regulation of cell motility,GO:2000146,1.9794290108622514,6.911395379299625e-06,symptomatic
53,negative regulation of macromolecule biosynthetic process,GO:0010558,1.9788527578751005,4.205986514598316e-43,symptomatic
1629,negative regulation of cell migration,GO:0030336,1.9783980582524272,1.0120147867680834e-05,symptomatic
1919,regulation of non-canonical NF-kappaB signal transduction,GO:1901222,1.978398058252427,0.024395645196000116,symptomatic
2234,establishment of chromosome localization,GO:0051303,1.978398058252427,0.02440759798639502,symptomatic
1167,negative regulation of mononuclear cell proliferation,GO:0032945,1.9772538141470182,0.030883952953420012,symptomatic
382,tube development,GO:0035295,1.9771324357667759,1.0513281656620316e-17,symptomatic
2236,pyrimidine-containing compound metabolic process,GO:0072527,1.975976518401445,0.039378966908114155,symptomatic
1690,immune system development,GO:0002520,1.9752805069472703,0.0016182045585113544,symptomatic
2161,regulation of pattern recognition receptor signaling pathway,GO:0062207,1.9745415318230852,0.0020546252800561007,symptomatic
2128,hexose metabolic process,GO:0019318,1.9745415318230852,0.002056206977731279,symptomatic
476,protein-DNA complex organization,GO:0071824,1.9735323473369024,1.3417759021050278e-16,symptomatic
1982,peptide biosynthetic process,GO:0043043,1.9710652263093122,3.7890941627935834e-08,symptomatic
553,response to lipid,GO:0033993,1.9710652263093122,1.8978332836246145e-16,symptomatic
865,positive regulation of mRNA metabolic process,GO:1903313,1.9689320388349516,0.00648894552902086,symptomatic
1933,positive regulation of cell-substrate adhesion,GO:0010811,1.9677394694595214,0.008173514091913959,symptomatic
1451,mRNA catabolic process,GO:0006402,1.9677394694595214,0.008178405482752926,symptomatic
935,regulation of protein transport,GO:0051223,1.9675613934894347,1.7980138888421158e-08,symptomatic
2237,Notch signaling pathway,GO:0007219,1.9650485436893204,0.01332867534862656,symptomatic
1325,nuclear chromosome segregation,GO:0098813,1.9650485436893204,0.00013249205483529278,symptomatic
62,negative regulation of nitrogen compound metabolic process,GO:0051172,1.9645018725262242,5.883752176872326e-45,symptomatic
2009,regulation of proteolysis involved in protein catabolic process,GO:1903050,1.9643023699495485,0.00017019799867185623,symptomatic
1452,RNA catabolic process,GO:0006401,1.9635228848821085,0.0017415094922211825,symptomatic
54,negative regulation of cellular biosynthetic process,GO:0031327,1.9632694507877722,4.581660889649709e-43,symptomatic
264,endosomal transport,GO:0016197,1.9615021066129326,4.264227160553265e-05,symptomatic
272,positive regulation of nucleobase-containing compound metabolic process,GO:0045935,1.9613555453915323,1.0712659541468284e-41,symptomatic
292,protein localization to organelle,GO:0033365,1.9613489759186515,6.422090333396161e-14,symptomatic
211,regulation of cellular localization,GO:0060341,1.961200034986443,6.475452959867966e-19,symptomatic
55,negative regulation of biosynthetic process,GO:0009890,1.95974639516891,4.726410079925729e-43,symptomatic
405,regulation of intracellular signal transduction,GO:1902531,1.9588122741123946,3.2452987242058536e-35,symptomatic
2280,negative regulation of cell-cell adhesion,GO:0022408,1.9580022019817835,0.0007210780037270341,symptomatic
1326,chromosome segregation,GO:0007059,1.9570710024564273,3.2879167250468823e-06,symptomatic
2012,regulation of proteasomal protein catabolic process,GO:0061136,1.956911696717522,0.0009252041920008436,symptomatic
2100,positive regulation of hemopoiesis,GO:1903708,1.956911696717522,0.0009259929423776559,symptomatic
2099,positive regulation of leukocyte differentiation,GO:1902107,1.956911696717522,0.0009267830387448724,symptomatic
23,positive regulation of nitrogen compound metabolic process,GO:0051173,1.9565043362241497,0.007791930964043715,asymptomatic
2279,negative regulation of leukocyte cell-cell adhesion,GO:1903038,1.9557619248628113,0.007846792899781695,symptomatic
2129,monosaccharide metabolic process,GO:0005996,1.955761924862811,0.0012190335708556317,symptomatic
1145,embryo development ending in birth or egg hatching,GO:0009792,1.9554446885408545,9.904437806646697e-13,symptomatic
2238,negative regulation of innate immune response,GO:0045824,1.9532641446267158,0.042278624996945735,symptomatic
2241,regulation of transcription elongation by RNA polymerase II,GO:0034243,1.9532641446267158,0.042260049151165,symptomatic
1600,muscle structure development,GO:0061061,1.952819665358397,1.7646249995072878e-09,symptomatic
1631,negative regulation of locomotion,GO:0040013,1.9519044062733382,2.6261495895654105e-06,symptomatic
1727,protein ubiquitination,GO:0016567,1.9512419417475728,1.3886128797681034e-11,symptomatic
1728,protein modification by small protein conjugation,GO:0032446,1.9508090614886733,5.136603459338596e-13,symptomatic
2244,response to interleukin-1,GO:0070555,1.9504617570447549,0.010992197203079701,symptomatic
1884,protein targeting,GO:0006605,1.9504617570447549,9.169727258240877e-05,symptomatic
2242,negative regulation of inflammatory response,GO:0050728,1.9504617570447549,0.0023398165903327946,symptomatic
1648,regulation of plasma membrane bounded cell projection organization,GO:0120035,1.9504617570447549,3.952695264221507e-12,symptomatic
328,regulation of cellular component biogenesis,GO:0044087,1.9499611251769304,5.050287987493571e-18,symptomatic
585,regulation of locomotion,GO:0040012,1.9474200100627994,2.080472469524797e-19,symptomatic
511,positive regulation of cell population proliferation,GO:0008284,1.9466121614716403,1.471211426492674e-17,symptomatic
18,positive regulation of metabolic process,GO:0009893,1.9463296585103522,0.002045130332628606,asymptomatic
177,positive regulation of catalytic activity,GO:0043085,1.9449457452884067,4.1360606517642583e-16,symptomatic
2139,negative regulation of Wnt signaling pathway,GO:0030178,1.942102635228849,0.0021326584221583104,symptomatic
258,negative regulation of organelle organization,GO:0010639,1.9412747994934567,2.310669448037503e-06,symptomatic
535,response to cytokine,GO:0034097,1.9409934960882271,5.505004259338537e-15,symptomatic
187,maintenance of location,GO:0051235,1.940422615648201,0.002811162073569108,symptomatic
1015,regulation of lymphocyte proliferation,GO:0050670,1.9401745114907214,0.00016034380529027253,symptomatic
1877,embryonic organ morphogenesis,GO:0048562,1.940035769034236,1.2368230893584377e-05,symptomatic
294,regulation of leukocyte cell-cell adhesion,GO:1903037,1.939947138408395,9.176198582288676e-07,symptomatic
1909,maintenance of location in cell,GO:0051651,1.938022587675847,0.039459383940729786,symptomatic
2245,DNA replication,GO:0006260,1.938022587675847,0.0008145111767665751,symptomatic
2243,cellular response to interleukin-1,GO:0071347,1.938022587675847,0.03947688255888532,symptomatic
483,regulation of steroid metabolic process,GO:0019218,1.938022587675847,0.03949439670376504,symptomatic
14,regulation of developmental process,GO:0050793,1.937254901960784,0.035549997317452516,asymptomatic
1417,response to nutrient,GO:0007584,1.936747572815534,0.0032055116066159036,symptomatic
2240,negative regulation of defense response,GO:0031348,1.936006753904601,0.00011002404081763324,symptomatic
167,sensory organ morphogenesis,GO:0090596,1.93586763298236,3.527951231100757e-05,symptomatic
8,regulation of multicellular organismal process,GO:0051239,1.9355360755225892,0.009098769452075514,asymptomatic
57,negative regulation of cellular metabolic process,GO:0031324,1.9354844554500295,3.901909123499388e-51,symptomatic
2247,regulation of calcium-mediated signaling,GO:0050848,1.9347322267460068,0.03560602954864506,symptomatic
2246,positive regulation of neuron differentiation,GO:0045666,1.9347322267460068,0.035622046655954386,symptomatic
154,positive regulation of nitrogen compound metabolic process,GO:0051173,1.9338717721199248,3.3622568079405246e-61,symptomatic
1730,post-translational protein modification,GO:0043687,1.9321197411003235,2.2600394745972858e-15,symptomatic
800,cellular component disassembly,GO:0022411,1.932022517744962,2.17617391936582e-06,symptomatic
621,regulation of microtubule-based process,GO:0032886,1.9310679611650488,6.95450584859014e-05,symptomatic
1964,nuclear division,GO:0000280,1.930714091280283,9.07357527653836e-06,symptomatic
42,positive regulation of gene expression,GO:0010628,1.9298175809541034,2.2325520735097897e-21,symptomatic
210,regulation of protein localization,GO:0032880,1.9296655879180151,6.257180011554864e-16,symptomatic
2137,regulation of response to cytokine stimulus,GO:0060759,1.9290751149718957,0.002916140218588322,symptomatic
61,negative regulation of nucleobase-containing compound metabolic process,GO:0045934,1.9288464702978443,3.985748631717808e-28,symptomatic
2054,regulation of protein localization to cell periphery,GO:1904375,1.9278224687933425,0.008309806003620959,symptomatic
1306,positive regulation of innate immune response,GO:0045089,1.9278224687933425,4.8522416259058486e-05,symptomatic
1182,glycerolipid biosynthetic process,GO:0045017,1.9275022856894073,0.00035798491030475935,symptomatic
259,negative regulation of cellular component organization,GO:0051129,1.9266258068015403,1.3342926617693136e-12,symptomatic
2248,mRNA transport,GO:0051028,1.9251779935275082,0.010733304551217368,symptomatic
3,hindbrain development,GO:0030902,1.9247180847856242,0.0034124250889543085,symptomatic
1994,skeletal muscle organ development,GO:0060538,1.9223300970873785,0.0043413987208572756,symptomatic
936,regulation of establishment of protein localization,GO:0070201,1.9216194390108214,1.8633958796617603e-09,symptomatic
138,regulation of hydrolase activity,GO:0051336,1.921296586282493,5.785032355267873e-13,symptomatic
1020,regulation of T cell activation,GO:0050863,1.9203065917220237,1.2895696039167629e-06,symptomatic
1146,placenta development,GO:0001890,1.919783964508455,0.005414385023673106,symptomatic
2221,positive regulation of leukocyte cell-cell adhesion,GO:1903039,1.9195441114394258,6.616677847025372e-05,symptomatic
2254,negative regulation of neuron projection development,GO:0010977,1.9170634392871393,0.006961438559596906,symptomatic
16,positive regulation of macromolecule biosynthetic process,GO:0010557,1.9170506912442398,0.03353906690732562,asymptomatic
492,regulation of response to stress,GO:0080134,1.9166595068304837,4.790835272133592e-24,symptomatic
385,eye morphogenesis,GO:0048592,1.9128371089536138,0.005049868128755831,symptomatic
64,embryonic morphogenesis,GO:0048598,1.9120088616667752,3.3764021949916063e-10,symptomatic
2211,regulation of T cell differentiation,GO:0045580,1.911825561037721,0.0019509513152746742,symptomatic
533,cellular response to cytokine stimulus,GO:0071345,1.9112244761688546,2.0891065022879737e-12,symptomatic
178,positive regulation of molecular function,GO:0044093,1.9106604968261427,3.589112057586538e-21,symptomatic
1006,mitochondrial transport,GO:0006839,1.9093705683429694,0.002484049199615261,symptomatic
295,regulation of cell-cell adhesion,GO:0022407,1.9089093120153109,2.5735573740190067e-08,symptomatic
1016,regulation of mononuclear cell proliferation,GO:0032944,1.9079724449099624,0.00027752429418746374,symptomatic
614,peptidyl-lysine modification,GO:0018205,1.9076558215370933,0.014406730776426234,symptomatic
2031,sex differentiation,GO:0007548,1.9073861882054273,5.6927802631071895e-05,symptomatic
2271,DNA-templated transcription initiation,GO:0006352,1.907153806847215,0.005824987037136322,symptomatic
1413,positive regulation of cell-cell adhesion,GO:0022409,1.9069514563106795,1.150847186374003e-05,symptomatic
232,regulation of developmental process,GO:0050793,1.9069388920616792,1.5833754339062503e-45,symptomatic
140,regulation of molecular function,GO:0065009,1.9066297915135573,2.04279451382201e-36,symptomatic
2152,vacuole organization,GO:0007033,1.9064758282454208,0.0018046107182451648,symptomatic
261,regulation of organelle organization,GO:0033043,1.9064323460734913,1.910104341650329e-20,symptomatic
19,positive regulation of cellular biosynthetic process,GO:0031328,1.9049888309754281,0.032554448214539525,asymptomatic
2256,neural tube formation,GO:0001841,1.9040221914008322,0.03329246355338601,symptomatic
347,regulation of cell morphogenesis,GO:0022604,1.9020950434338273,0.0002274191081395559,symptomatic
17,positive regulation of macromolecule metabolic process,GO:0010604,1.9014356870788165,0.009116614943385245,asymptomatic
1307,positive regulation of response to external stimulus,GO:0032103,1.9014352047277332,2.8650071221649254e-09,symptomatic
704,protein-containing complex localization,GO:0031503,1.9011019119661683,0.005217764491841847,symptomatic
1810,platelet activation,GO:0030168,1.8992621359223303,0.04278005164371929,symptomatic
171,regulation of cell population proliferation,GO:0042127,1.8966378571263063,3.368559388678151e-29,symptomatic
2220,positive regulation of T cell activation,GO:0050870,1.8964964119881806,0.000190569332002428,symptomatic
624,regulation of protein-containing complex assembly,GO:0043254,1.894998389545852,6.176670866924628e-07,symptomatic
2261,positive regulation of leukocyte migration,GO:0002687,1.8946887492861224,0.006198496658459163,symptomatic
121,regulation of viral process,GO:0050792,1.892755787901419,0.004309403319779991,symptomatic
2266,inner ear development,GO:0048839,1.8924686586860213,0.0011762567754459053,symptomatic
1001,cell morphogenesis involved in neuron differentiation,GO:0048667,1.8923605855514953,1.7640478103991793e-07,symptomatic
1729,protein modification by small protein conjugation or removal,GO:0070647,1.890489277185066,2.533990352729938e-13,symptomatic
2252,establishment of RNA localization,GO:0051236,1.8895098271371065,0.005404468225251235,symptomatic
2265,ear development,GO:0043583,1.8876786532772198,0.0005130175045029464,symptomatic
2222,positive regulation of lymphocyte proliferation,GO:0050671,1.887378640776699,0.009807341087403927,symptomatic
835,regulation of chromosome organization,GO:0033044,1.8868171715990174,0.000261607695427817,symptomatic
4,brain development,GO:0007420,1.8860597178970506,4.021443979315988e-12,symptomatic
1164,negative regulation of immune system process,GO:0002683,1.8841886269070736,3.194760565824927e-08,symptomatic
281,cytoskeleton-dependent intracellular transport,GO:0030705,1.8840847862552734,0.0024936307797764363,symptomatic
1486,protein localization to plasma membrane,GO:0072659,1.8833262980160406,0.0012507750985635828,symptomatic
1243,positive regulation of small molecule metabolic process,GO:0062013,1.8833262980160406,0.012348652139877896,symptomatic
507,multicellular organismal-level homeostasis,GO:0048871,1.8814294567238172,9.312942586561543e-10,symptomatic
59,negative regulation of macromolecule metabolic process,GO:0010605,1.881216252925832,1.4944733437284672e-46,symptomatic
10,head development,GO:0060322,1.8805825242718444,8.877840784273486e-13,symptomatic
2208,regulation of plasma membrane bounded cell projection assembly,GO:0120032,1.8804575603191387,0.0015962885977701623,symptomatic
691,regulation of leukocyte proliferation,GO:0070663,1.8789692678297685,0.00018313969195362238,symptomatic
804,phosphorylation,GO:0016310,1.8784648465498144,6.7302255256673e-12,symptomatic
1190,glycerophospholipid metabolic process,GO:0006650,1.8764041220716392,7.99154823601793e-05,symptomatic
2263,inner ear morphogenesis,GO:0042472,1.8742718446601943,0.02948024348534762,symptomatic
2189,muscle cell differentiation,GO:0042692,1.8720642217571786,0.00013562780554802898,symptomatic
520,response to organic substance,GO:0010033,1.8719926328507168,6.480308626401399e-43,symptomatic
615,peptidyl-amino acid modification,GO:0018193,1.8707287976948632,2.0694143392145724e-08,symptomatic
1437,vacuolar transport,GO:0007034,1.8706182933060806,0.004712046583673593,symptomatic
743,regulation of inflammatory response,GO:0050727,1.8676954522227902,5.169968267441309e-06,symptomatic
1159,Golgi vesicle transport,GO:0048193,1.8654724463284562,0.0001408266480614244,symptomatic
398,cell migration,GO:0016477,1.8638707800394385,4.23596664368116e-14,symptomatic
56,negative regulation of metabolic process,GO:0009892,1.8627840870078687,3.0488703481646538e-49,symptomatic
2209,regulation of cell projection assembly,GO:0060491,1.8620217018846374,0.0017984580042613222,symptomatic
623,regulation of protein polymerization,GO:0032271,1.8620217018846374,0.0017970340470132927,symptomatic
65,embryo development,GO:0009790,1.8595230891938723,1.587730703534606e-16,symptomatic
2157,regulation of interleukin-1 production,GO:0032652,1.8576853681587764,0.04357412912989563,symptomatic
2267,learning or memory,GO:0007611,1.8564216366158113,0.00018827800619885588,symptomatic
1209,response to inorganic substance,GO:0010035,1.8553398058252428,4.514425686689712e-08,symptomatic
44,positive regulation of macromolecule metabolic process,GO:0010604,1.853953046461417,6.916426752056653e-61,symptomatic
2249,RNA transport,GO:0050658,1.8511326860841424,0.008069735389498468,symptomatic
1886,lysosomal transport,GO:0007041,1.8511326860841424,0.017697386856183845,symptomatic
2250,nucleic acid transport,GO:0050657,1.8511326860841424,0.008064802788404643,symptomatic
43,positive regulation of macromolecule biosynthetic process,GO:0010557,1.8502796295467767,1.822273382073025e-43,symptomatic
2177,regulation of chemotaxis,GO:0050920,1.8495017321756981,0.0010478717729768613,symptomatic
1560,macroautophagy,GO:0016236,1.8492815533980584,0.002392903817248775,symptomatic
1902,response to virus,GO:0009615,1.8491475571982616,1.0123148200050403e-05,symptomatic
1742,regulation of G protein-coupled receptor signaling pathway,GO:0008277,1.848596887884027,0.01574586245788147,symptomatic
2223,positive regulation of mononuclear cell proliferation,GO:0032946,1.848596887884027,0.01575415848657372,symptomatic
2269,transcription initiation at RNA polymerase II promoter,GO:0006367,1.8480215387125725,0.03492881905308918,symptomatic
2253,RNA localization,GO:0006403,1.847108484592655,0.004596159942525883,symptomatic
284,organelle localization,GO:0051640,1.8457180383734757,3.5307443413531575e-08,symptomatic
858,mitochondrion organization,GO:0007005,1.844385961032355,1.2143079252782478e-06,symptomatic
1965,organelle fission,GO:0048285,1.8436641392238606,2.544456080949827e-05,symptomatic
596,regulation of MAPK cascade,GO:0043408,1.842602120710483,1.0415157472627667e-09,symptomatic
66,embryonic limb morphogenesis,GO:0030326,1.8392854368932041,0.02836929552624386,symptomatic
71,embryonic appendage morphogenesis,GO:0035113,1.8392854368932041,0.028355863094649995,symptomatic
2272,regulation of leukocyte chemotaxis,GO:0002688,1.8392854368932041,0.02834244337714188,symptomatic
2294,protein-RNA complex organization,GO:0071826,1.8389082249496245,0.002162508686671154,symptomatic
620,regulation of cytoskeleton organization,GO:0051493,1.8383662537663208,9.464389483168996e-08,symptomatic
1892,DNA-templated transcription,GO:0006351,1.8360213988508025,6.565463927203781e-08,symptomatic
222,epithelium development,GO:0060429,1.8354705373449964,2.152756718217101e-16,symptomatic
1893,RNA biosynthetic process,GO:0032774,1.8323189963526159,4.353253027242564e-08,symptomatic
498,negative regulation of response to stimulus,GO:0048585,1.8322208737864076,3.9710516307304903e-25,symptomatic
1017,regulation of lymphocyte activation,GO:0051249,1.8319576064673344,2.728226050232767e-07,symptomatic
68,limb development,GO:0060173,1.8317490977481825,0.0040600000797416085,symptomatic
69,appendage development,GO:0048736,1.8317490977481825,0.004057184545705726,symptomatic
48,positive regulation of biosynthetic process,GO:0009891,1.8315750965673319,1.1198516285172278e-43,symptomatic
1976,regulation of wound healing,GO:0061041,1.8313495886756097,0.023762923796882524,symptomatic
2273,neuron migration,GO:0001764,1.830274853001504,0.020945606007270547,symptomatic
329,positive regulation of cellular component biogenesis,GO:0044089,1.829997706597355,2.1916619214334264e-07,symptomatic
2181,positive regulation of lymphocyte activation,GO:0051251,1.8285578972294578,7.092087665272203e-05,symptomatic
630,positive regulation of supramolecular fiber organization,GO:1902905,1.827861303744799,0.007836656768757664,symptomatic
47,positive regulation of cellular biosynthetic process,GO:0031328,1.827287119837489,6.151525904214404e-43,symptomatic
1542,respiratory electron transport chain,GO:0022904,1.8253777965386238,0.04666660998538083,symptomatic
1208,cellular response to inorganic substance,GO:0071241,1.8253777965386238,0.001683898719855298,symptomatic
2270,transcription by RNA polymerase II,GO:0006366,1.8242912621359224,1.0110211713506216e-05,symptomatic
2116,positive regulation of production of molecular mediator of immune response,GO:0002702,1.8241088512507972,0.026869529259731406,symptomatic
400,cell morphogenesis,GO:0000902,1.8240040174087715,7.362094812627754e-10,symptomatic
223,skin development,GO:0043588,1.8238528359734287,0.00033475041183495094,symptomatic
2274,positive regulation of protein secretion,GO:0050714,1.8236158488585674,0.01704790117378404,symptomatic
45,positive regulation of metabolic process,GO:0009893,1.8223627293066045,4.395078687389238e-63,symptomatic
538,developmental maturation,GO:0021700,1.8205985386848162,0.0002714184159486359,symptomatic
485,regulation of small molecule metabolic process,GO:0062012,1.8202804746494066,9.612736118099167e-05,symptomatic
1308,positive regulation of defense response,GO:0031349,1.8196814025827128,6.445432163497137e-06,symptomatic
447,epithelial cell differentiation,GO:0030855,1.8188890063265337,4.411346563910561e-09,symptomatic
2107,regulation of calcium ion transmembrane transport,GO:1903169,1.81747572815534,0.012587413110150016,symptomatic
67,limb morphogenesis,GO:0035108,1.8174757281553398,0.013941441286435893,symptomatic
70,appendage morphogenesis,GO:0035107,1.8174757281553398,0.013933973990620983,symptomatic
415,positive regulation of signal transduction,GO:0009967,1.8168961759461066,7.551679329528086e-23,symptomatic
2258,morphogenesis of embryonic epithelium,GO:0016331,1.8113768163158923,0.017697621446740763,symptomatic
2278,negative regulation of T cell activation,GO:0050868,1.8103203119027598,0.03147958850791293,symptomatic
1000,axonogenesis,GO:0007409,1.8101075833114668,3.25811781830032e-05,symptomatic
2213,regulation of alpha-beta T cell activation,GO:0046634,1.8096417810512222,0.048746914415019826,symptomatic
243,positive regulation of multicellular organismal process,GO:0051240,1.809224476362867,1.1095788865659733e-23,symptomatic
721,process utilizing autophagic mechanism,GO:0061919,1.8088210818307906,0.00016448493068866823,symptomatic
718,autophagy,GO:0006914,1.8088210818307906,0.00016465662685848938,symptomatic
1599,muscle organ development,GO:0007517,1.8088210818307906,0.00016431359221920087,symptomatic
282,establishment of vesicle localization,GO:0051650,1.8065270791905483,0.012955360281947204,symptomatic
1300,immune response-activating signaling pathway,GO:0002757,1.8061518918428454,0.00013617820099456426,symptomatic
2281,negative regulation of protein-containing complex assembly,GO:0031333,1.8048543689320389,0.022618992529817968,symptomatic
2264,ear morphogenesis,GO:0042471,1.8038104971165778,0.035365898200907034,symptomatic
256,positive regulation of cytokine production,GO:0001819,1.8009197751660706,8.466932772110388e-07,symptomatic
521,response to alcohol,GO:0097305,1.8000669568128558,0.0008633188366503768,symptomatic
416,positive regulation of signaling,GO:0023056,1.7988455669327907,8.130829288007898e-25,symptomatic
2183,positive regulation of cell activation,GO:0050867,1.7982431807674526,2.9440615682988552e-05,symptomatic
49,positive regulation of cellular metabolic process,GO:0031325,1.7981640285595557,5.6279373418612486e-52,symptomatic
326,positive regulation of cellular component organization,GO:0051130,1.7971551140212236,3.9381392527765e-15,symptomatic
367,regulation of lipid localization,GO:1905952,1.7957095517702457,0.013448118939335028,symptomatic
285,establishment of organelle localization,GO:0051656,1.7954189838816101,1.4576744837760163e-05,symptomatic
997,plasma membrane bounded cell projection morphogenesis,GO:0120039,1.7936580018791104,1.2551210047480944e-06,symptomatic
273,positive regulation of hydrolase activity,GO:0051345,1.793117806025423,1.4662685295226862e-06,symptomatic
627,positive regulation of cytoskeleton organization,GO:0051495,1.792781764457577,0.010047449647862841,symptomatic
1489,protein localization to cell periphery,GO:1990778,1.7921324411093489,0.0014235896450291187,symptomatic
989,neuron projection morphogenesis,GO:0048812,1.7915646688944695,1.6370661756956675e-06,symptomatic
2195,regulation of tumor necrosis factor superfamily cytokine production,GO:1903555,1.791211628037488,0.010993149081961568,symptomatic
1311,positive regulation of response to biotic stimulus,GO:0002833,1.7908352044527371,0.00029441903265112847,symptomatic
2282,positive regulation of lymphocyte differentiation,GO:0045621,1.790349224750036,0.0364921293214444,symptomatic
2284,camera-type eye morphogenesis,GO:0048593,1.790349224750036,0.03647575044831987,symptomatic
2283,bone development,GO:0060348,1.790349224750036,0.005279685350441381,symptomatic
1769,response to metal ion,GO:0010038,1.7899382171226832,6.0726129547008924e-05,symptomatic
1163,negative regulation of lymphocyte activation,GO:0051250,1.789428263214671,0.01720028360810683,symptomatic
2285,negative regulation of monoatomic ion transport,GO:0043271,1.7879232772910254,0.04196511602960885,symptomatic
1986,amide biosynthetic process,GO:0043604,1.7876266742257811,3.1766901861104464e-07,symptomatic
2194,regulation of tumor necrosis factor production,GO:0032680,1.7850208044382805,0.013890189470671008,symptomatic
1234,tissue homeostasis,GO:0001894,1.7850208044382803,0.0031724984193085394,symptomatic
1235,anatomical structure homeostasis,GO:0060249,1.7850208044382803,0.0031747906869525485,symptomatic
2268,cognition,GO:0050890,1.7839223300970874,0.0002181069092315035,symptomatic
1458,mRNA metabolic process,GO:0016071,1.7838728810913747,4.329833305928308e-08,symptomatic
978,regulation of cellular component size,GO:0032535,1.7812228878330925,5.7786556228851734e-05,symptomatic
161,anatomical structure formation involved in morphogenesis,GO:0048646,1.7809764730585023,1.0095448501862353e-12,symptomatic
1550,"mRNA splicing, via spliceosome",GO:0000398,1.7806847215125192,0.0018831821579631113,symptomatic
1552,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile",GO:0000377,1.7806847215125192,0.0018817005040229358,symptomatic
1984,peptide metabolic process,GO:0006518,1.779884053921911,2.8385977787989887e-07,symptomatic
2224,positive regulation of leukocyte proliferation,GO:0070665,1.7784501757102864,0.017727189736996916,symptomatic
417,positive regulation of cell communication,GO:0010647,1.7781005413423965,1.6295882504981063e-23,symptomatic
194,DNA metabolic process,GO:0006259,1.777659893904514,6.526104068903798e-10,symptomatic
2182,positive regulation of leukocyte activation,GO:0002696,1.7770873786407768,8.444799841728347e-05,symptomatic
2146,positive regulation of MAPK cascade,GO:0043410,1.7766117128542025,4.296498006289593e-06,symptomatic
998,cell projection morphogenesis,GO:0048858,1.7757572234172434,2.185437289867492e-06,symptomatic
255,regulation of cytokine production,GO:0001817,1.7745340921772121,5.344552091609623e-10,symptomatic
2286,recombinational repair,GO:0000725,1.7735045411838395,0.04425552439197539,symptomatic
207,chromosome organization,GO:0051276,1.7728155339805824,4.516208032449104e-06,symptomatic
557,nucleoside triphosphate metabolic process,GO:0009141,1.769647419519673,0.006363998931493039,symptomatic
1304,immune response-regulating signaling pathway,GO:0002764,1.7689756736118687,0.00011336419723554186,symptomatic
2287,positive regulation of DNA repair,GO:0045739,1.7685436893203883,0.04880226696026469,symptomatic
2289,positive regulation of hormone secretion,GO:0046887,1.7680206063007728,0.026145453886740524,symptomatic
283,vesicle localization,GO:0051648,1.7672692163278443,0.013412540552128776,symptomatic
1018,regulation of leukocyte activation,GO:0002694,1.7660983224124327,3.697069738020792e-07,symptomatic
1375,establishment of protein localization,GO:0045184,1.7653869582546833,1.8672657364137304e-16,symptomatic
5,central nervous system development,GO:0007417,1.7651872399445214,1.1702727724243298e-12,symptomatic
1019,regulation of cell activation,GO:0050865,1.7649643909052657,7.266600138995203e-08,symptomatic
2291,organelle disassembly,GO:1903008,1.7640205596801826,0.039285647631368915,symptomatic
117,cellular response to chemical stimulus,GO:0070887,1.7573750238756112,9.412594759736793e-32,symptomatic
744,regulation of defense response,GO:0031347,1.757279079834271,1.2640038182912494e-09,symptomatic
287,transport along microtubule,GO:0010970,1.7568932038834952,0.019285945302454383,symptomatic
168,animal organ morphogenesis,GO:0009887,1.7563457714352555,2.9377719810700305e-12,symptomatic
1876,skeletal system development,GO:0001501,1.7547423450336073,2.753013239233269e-06,symptomatic
391,protein modification process,GO:0036211,1.753789410953183,1.0448517967011696e-26,symptomatic
987,axon guidance,GO:0007411,1.7537046499744506,0.004978263610907629,symptomatic
988,neuron projection guidance,GO:0097485,1.7537046499744506,0.004974975457928165,symptomatic
1310,regulation of response to biotic stimulus,GO:0002831,1.7526909478646389,2.4230399325412243e-06,symptomatic
1194,regulation of small GTPase mediated signal transduction,GO:0051056,1.7525658807212205,0.0006540619900765463,symptomatic
1553,"RNA splicing, via transesterification reactions",GO:0000375,1.7523072757513634,0.0030018039064790172,symptomatic
2136,regulation of cytokine-mediated signaling pathway,GO:0001959,1.7493203883495145,0.02447136055781203,symptomatic
1002,axon development,GO:0061564,1.7487296013220412,3.135312685470408e-05,symptomatic
745,regulation of response to external stimulus,GO:0032101,1.7479547986630593,2.4323724267911923e-13,symptomatic
265,intracellular transport,GO:0046907,1.7472203638737047,2.0250099945224253e-14,symptomatic
406,regulation of signal transduction,GO:0009966,1.7470868965783208,6.94735252050406e-41,symptomatic
269,vesicle-mediated transport in synapse,GO:0099003,1.7412590040714062,0.030699789650102883,symptomatic
349,myeloid leukocyte activation,GO:0002274,1.7412590040714062,0.030714209466753944,symptomatic
1490,establishment of protein localization to membrane,GO:0090150,1.7403952843273234,0.006459342650259419,symptomatic
366,regulation of lipid transport,GO:0032368,1.7384550443224989,0.04301321735783458,symptomatic
89,regulation of immune system process,GO:0002682,1.733092926490985,2.869261535421194e-18,symptomatic
2293,protein-RNA complex assembly,GO:0022618,1.7320003845044698,0.01098815018256565,symptomatic
2292,cellular response to metal ion,GO:0071248,1.7320003845044698,0.010994292245272506,symptomatic
185,cellular macromolecule localization,GO:0070727,1.7317721059153135,1.3376216885440168e-23,symptomatic
11,multicellular organism development,GO:0007275,1.7315842583249244,0.017576288448335153,asymptomatic
2262,regulation of leukocyte migration,GO:0002685,1.7309292649098476,0.005462317370280106,symptomatic
2049,regulation of cell division,GO:0051302,1.7290579900288636,0.015482508244154737,symptomatic
2288,regulation of DNA repair,GO:0006282,1.728300517194447,0.007836223462987839,symptomatic
2295,response to xenobiotic stimulus,GO:0009410,1.7274394881660775,4.1754561276695064e-05,symptomatic
260,regulation of cellular component organization,GO:0051128,1.727420624508003,3.5302050193680845e-30,symptomatic
1453,nucleobase-containing compound catabolic process,GO:0034655,1.7255201109570044,0.0004616974429696516,symptomatic
10,system development,GO:0048731,1.724534686971235,0.0423462154058966,asymptomatic
1856,regulation of actin cytoskeleton organization,GO:0032956,1.7244762391415431,0.000498620555530419,symptomatic
333,regulation of lipid metabolic process,GO:0019216,1.7234683629059258,0.0008531390413539445,symptomatic
1406,regulation of viral life cycle,GO:1903900,1.7234683629059255,0.049279330267757784,symptomatic
990,neuron projection development,GO:0031175,1.7229773462783173,5.390055138877861e-08,symptomatic
184,protein localization,GO:0008104,1.722581805106077,4.225097284511784e-23,symptomatic
1857,regulation of actin filament-based process,GO:0032970,1.7225683794266013,0.00015972922149850018,symptomatic
732,negative regulation of cytoskeleton organization,GO:0051494,1.7190773607074394,0.03313397081138206,symptomatic
221,tissue development,GO:0009888,1.7178176469619721,1.5062735058755647e-20,symptomatic
1551,mRNA processing,GO:0006397,1.7167243562684675,3.516945415317692e-05,symptomatic
2276,positive regulation of secretion by cell,GO:1903532,1.711663785077803,0.001933270401726739,symptomatic
392,macromolecule modification,GO:0043412,1.7103787297699313,8.23641812764096e-27,symptomatic
125,membrane organization,GO:0061024,1.7098620337250896,2.28558939308044e-08,symptomatic
1951,ribonucleoside triphosphate metabolic process,GO:0009199,1.709180542280799,0.018111043115166668,symptomatic
994,neurogenesis,GO:0022008,1.7081031174714003,6.1521554393419245e-15,symptomatic
753,response to extracellular stimulus,GO:0009991,1.70807427655764,1.0354568357967992e-05,symptomatic
1189,phospholipid metabolic process,GO:0006644,1.7073256840247133,0.00040215101845791473,symptomatic
752,response to nutrient levels,GO:0031667,1.7071556993887094,2.2634833245368117e-05,symptomatic
2296,lipid homeostasis,GO:0055088,1.7066540374141606,0.03739495067645286,symptomatic
477,protein-containing complex organization,GO:0043933,1.7062931971779043,3.928765495698226e-23,symptomatic
723,organonitrogen compound catabolic process,GO:1901565,1.7044887823552743,3.380001978813554e-12,symptomatic
409,regulation of signaling,GO:0023051,1.7028911343447308,1.2810438390191457e-42,symptomatic
2251,nucleobase-containing compound transport,GO:0015931,1.7023953872896087,0.007839759122106684,symptomatic
14,anatomical structure morphogenesis,GO:0009653,1.7009916875165318,1.5425423711961832e-25,symptomatic
694,neuromuscular process,GO:0050905,1.698686464877213,0.04304747044514286,symptomatic
1374,protein transport,GO:0015031,1.696588581099136,1.44881374797526e-11,symptomatic
699,positive regulation of transport,GO:0051050,1.6952478283086356,5.007851757901229e-09,symptomatic
2143,regulation of transcription by RNA polymerase II,GO:0006357,1.6935410597928453,9.35069135011137e-30,symptomatic
495,negative regulation of multicellular organismal process,GO:0051241,1.692890698402756,8.737354937537788e-12,symptomatic
58,negative regulation of cellular process,GO:0048523,1.6928241853311545,1.0032815569720281e-64,symptomatic
2117,regulation of production of molecular mediator of immune response,GO:0002700,1.692464170134073,0.023632270753519438,symptomatic
234,regulation of multicellular organismal process,GO:0051239,1.6918578845033356,1.6292968142564288e-34,symptomatic
408,regulation of cell communication,GO:0010646,1.6912034319259428,2.0388083665258769e-41,symptomatic
2297,regulation of ERK1 and ERK2 cascade,GO:0070372,1.6885331933875625,0.0029510318476887133,symptomatic
2239,negative regulation of response to external stimulus,GO:0032102,1.6863864030194409,0.00020399481699581409,symptomatic
1323,response to temperature stimulus,GO:0009266,1.6860919405778452,0.0396069743539212,symptomatic
1894,nucleobase-containing compound biosynthetic process,GO:0034654,1.683780818514915,1.2263517630747774e-09,symptomatic
993,generation of neurons,GO:0048699,1.6816694717816487,4.743927186605201e-12,symptomatic
1875,skeletal system morphogenesis,GO:0048705,1.6803816538332776,0.010839873294892782,symptomatic
2088,regulation of transporter activity,GO:0032409,1.680019580647793,0.009023052181875227,symptomatic
537,anatomical structure maturation,GO:0071695,1.680019580647793,0.009028301194197433,symptomatic
1554,RNA splicing,GO:0008380,1.679137680605458,0.00044831753732613497,symptomatic
195,nucleic acid metabolic process,GO:0090304,1.6782470829250913,2.5253761946310325e-23,symptomatic
2298,cell-cell junction organization,GO:0045216,1.6753267885230785,0.03680488794022658,symptomatic
32,regulation of nitrogen compound metabolic process,GO:0051171,1.6708890394486202,9.688465588316101e-72,symptomatic
1895,cellular nitrogen compound biosynthetic process,GO:0044271,1.6692670186793845,1.6370807551611998e-15,symptomatic
1188,organophosphate biosynthetic process,GO:0090407,1.669043046182581,1.6281164320994524e-05,symptomatic
1950,purine ribonucleoside triphosphate metabolic process,GO:0009205,1.6660194174757281,0.031258500213861194,symptomatic
399,cell motility,GO:0048870,1.6644782339257969,1.6208762703137916e-10,symptomatic
622,regulation of supramolecular fiber organization,GO:1902903,1.6617584982494475,0.0005456445387087059,symptomatic
1855,regulation of actin filament organization,GO:0110053,1.6598717443485116,0.006629082820094094,symptomatic
361,negative regulation of transport,GO:0051051,1.6581235908526204,0.0003577976530082769,symptomatic
572,cell maturation,GO:0048469,1.6571102227298686,0.032504541126243555,symptomatic
1569,DNA repair,GO:0006281,1.656389247432516,4.6885201428768395e-05,symptomatic
979,regulation of anatomical structure size,GO:0090066,1.6532038834951457,4.852051309954416e-05,symptomatic
300,microtubule cytoskeleton organization,GO:0000226,1.6510641264750483,2.6040811161018598e-05,symptomatic
418,positive regulation of response to stimulus,GO:0048584,1.6496713232810511,3.017129162678761e-22,symptomatic
33,regulation of primary metabolic process,GO:0080090,1.648239060832444,3.0530867342698463e-70,symptomatic
110,response to stress,GO:0006950,1.6460408283805235,4.553572043962298e-36,symptomatic
991,neuron development,GO:0048666,1.6449305640899592,5.560562240390591e-08,symptomatic
560,phosphate-containing compound metabolic process,GO:0006796,1.641676643988356,4.601314664659382e-16,symptomatic
2290,regulation of hormone secretion,GO:0046883,1.6405840065219002,0.010382859371922935,symptomatic
2277,positive regulation of secretion,GO:0051047,1.6397415086827356,0.004458442917859073,symptomatic
1303,positive regulation of immune system process,GO:0002684,1.6393631067961167,4.373978798922423e-09,symptomatic
41,negative regulation of biological process,GO:0048519,1.637228759339627,4.622345555763736e-61,symptomatic
186,cellular localization,GO:0051641,1.6347032630118987,6.921760084094625e-26,symptomatic
1183,glycerolipid metabolic process,GO:0046486,1.633714331818304,0.0020616477502060017,symptomatic
2300,negative regulation of cytokine production,GO:0001818,1.6320190212007133,0.007416890920989706,symptomatic
132,macromolecule localization,GO:0033036,1.6303938450265618,1.6796940901072683e-22,symptomatic
1488,localization within membrane,GO:0051668,1.6301910429063577,5.0464276608407223e-05,symptomatic
1301,activation of immune response,GO:0002253,1.6272747798600138,0.0013266940633001939,symptomatic
190,regulation of DNA-templated transcription,GO:0006355,1.6272747798600136,1.8523913931739883e-34,symptomatic
1896,heterocycle biosynthetic process,GO:0018130,1.626587005227782,7.8912010059427e-09,symptomatic
30,regulation of RNA metabolic process,GO:0051252,1.6252334178994197,3.8197048047495547e-38,symptomatic
992,neuron differentiation,GO:0030182,1.624939486633861,1.3121765710251395e-09,symptomatic
791,regulation of immune response,GO:0050776,1.6242326709087251,5.2190994264437544e-08,symptomatic
191,regulation of RNA biosynthetic process,GO:2001141,1.6241160669928174,2.5466953635908443e-34,symptomatic
561,phosphorus metabolic process,GO:0006793,1.6228582926706576,1.6754462288368168e-15,symptomatic
266,establishment of localization in cell,GO:0051649,1.6221499533290922,2.136271421628346e-14,symptomatic
1024,RNA metabolic process,GO:0016070,1.6202855511136494,2.09254137535352e-13,symptomatic
31,regulation of nucleobase-containing compound metabolic process,GO:0019219,1.619661329769558,1.5256269957122304e-41,symptomatic
707,ribonucleoprotein complex biogenesis,GO:0022613,1.6192413344796495,0.00040967833653953925,symptomatic
5,regulation of nitrogen compound metabolic process,GO:0051171,1.6187066130800145,0.008447948334584452,asymptomatic
22,positive regulation of cellular process,GO:0048522,1.6182232346241459,0.008407682176442818,asymptomatic
1660,modulation of chemical synaptic transmission,GO:0050804,1.617628811988881,0.0003079566267534039,symptomatic
999,cellular anatomical entity morphogenesis,GO:0032989,1.617018846373501,2.737651116708114e-05,symptomatic
1661,regulation of trans-synaptic signaling,GO:0099177,1.614279684013749,0.0003161760400161267,symptomatic
706,ribosome biogenesis,GO:0042254,1.6132972840113062,0.005954681082199814,symptomatic
22,regulation of macromolecule metabolic process,GO:0060255,1.6121699584325047,6.722945060821277e-70,symptomatic
249,cell surface receptor signaling pathway,GO:0007166,1.6107258437355525,3.6277662519248275e-18,symptomatic
1898,aromatic compound biosynthetic process,GO:0019438,1.6107023665048545,1.3506910819976094e-08,symptomatic
1455,heterocycle catabolic process,GO:0046700,1.6088736327074316,0.0021328060632068747,symptomatic
3,regulation of cellular metabolic process,GO:0031323,1.6079286422200199,0.006066336431253163,asymptomatic
212,regulation of localization,GO:0032879,1.606870799103809,1.7084409049610447e-17,symptomatic
2087,regulation of transmembrane transporter activity,GO:0022898,1.6065187239944523,0.033304608956252715,symptomatic
2108,regulation of calcium ion transport,GO:0051924,1.604314994606257,0.0251222223487513,symptomatic
2301,synapse organization,GO:0050808,1.6028758243935577,0.005089437360076149,symptomatic
21,regulation of macromolecule biosynthetic process,GO:0010556,1.6010493009167859,9.106620409192707e-52,symptomatic
1389,immune response-activating cell surface receptor signaling pathway,GO:0002429,1.5993786407766992,0.02126032516777051,symptomatic
27,regulation of cellular metabolic process,GO:0031323,1.5983218990252772,2.5038113801941747e-67,symptomatic
2302,vesicle organization,GO:0016050,1.5982163016482276,0.005190573419674188,symptomatic
133,nitrogen compound transport,GO:0071705,1.5962384994662735,2.121723498673211e-12,symptomatic
9,negative regulation of cellular process,GO:0048523,1.5960396039603961,0.04131227570264935,asymptomatic
20,regulation of gene expression,GO:0010468,1.595950001387529,2.6003478441364988e-49,symptomatic
50,positive regulation of cellular process,GO:0048522,1.5956653471039652,3.411043991295585e-61,symptomatic
2303,negative regulation of protein localization,GO:1903828,1.5956242308218243,0.038608970588149466,symptomatic
386,eye development,GO:0001654,1.5932113709536526,0.002523106721894243,symptomatic
196,nucleobase-containing compound metabolic process,GO:0006139,1.592527492752956,1.34337431004003e-23,symptomatic
393,protein metabolic process,GO:0019538,1.5918280228981732,4.474440282829363e-32,symptomatic
1487,protein localization to membrane,GO:0072657,1.5917382969513325,0.0006602528676785038,symptomatic
2304,anterior/posterior pattern specification,GO:0009952,1.5902912621359224,0.042004088615658304,symptomatic
724,organic substance catabolic process,GO:1901575,1.5895965084172086,4.766989394697113e-13,symptomatic
1390,immune response-regulating cell surface receptor signaling pathway,GO:0002768,1.5894884901711894,0.014785261726246387,symptomatic
0,regulation of macromolecule biosynthetic process,GO:0010556,1.5891762833267011,0.03147543228391076,asymptomatic
220,epidermis development,GO:0008544,1.5889780571300296,0.005401003052192578,symptomatic
362,regulation of transport,GO:0051049,1.5887457895779673,6.776003760729579e-13,symptomatic
4,regulation of biosynthetic process,GO:0009889,1.5870520231213874,0.0294490842703514,asymptomatic
26,regulation of cellular biosynthetic process,GO:0031326,1.5869004492102594,2.2300654594678658e-51,symptomatic
1454,cellular nitrogen compound catabolic process,GO:0044270,1.5866851595006934,0.003744905539910697,symptomatic
165,sensory organ development,GO:0007423,1.585360714459374,0.00010238323829128843,symptomatic
2275,regulation of protein secretion,GO:0050708,1.5842901630335224,0.020484837248120037,symptomatic
1544,energy derivation by oxidation of organic compounds,GO:0015980,1.5842901630335224,0.020474412394558654,symptomatic
29,regulation of biosynthetic process,GO:0009889,1.5831999551041025,3.433003268402975e-51,symptomatic
407,regulation of response to stimulus,GO:0048583,1.5815051225661105,9.115456983678325e-36,symptomatic
208,organelle organization,GO:0006996,1.5805411704997228,3.4315809073448794e-26,symptomatic
23,regulation of metabolic process,GO:0019222,1.58041970049306,1.2760327261409051e-71,symptomatic
7,regulation of gene expression,GO:0010468,1.5797468354430382,0.04390417877116288,asymptomatic
982,organelle assembly,GO:0070925,1.578945231893373,1.3817958604823078e-06,symptomatic
1165,negative regulation of cell activation,GO:0050866,1.5783341849770056,0.04932431009786777,symptomatic
1543,generation of precursor metabolites and energy,GO:0006091,1.5770572155716844,0.0026741648066152266,symptomatic
387,visual system development,GO:0150063,1.5769954791373304,0.003524378628576418,symptomatic
356,cell development,GO:0048468,1.575280859916782,1.0535913593610395e-17,symptomatic
1,regulation of macromolecule metabolic process,GO:0060255,1.5721531576330183,0.008629795341015696,asymptomatic
46,positive regulation of biological process,GO:0048518,1.5710482622766289,5.3253777777068305e-64,symptomatic
2299,cell junction organization,GO:0034330,1.5705543491915368,0.00044008020768337373,symptomatic
737,gene expression,GO:0010467,1.5690411695696742,1.6391486810868007e-19,symptomatic
15,positive regulation of biological process,GO:0048518,1.5675362318840582,0.008898255866041796,asymptomatic
2305,cell junction assembly,GO:0034329,1.5673353404823922,0.020913495867921104,symptomatic
6,nervous system development,GO:0007399,1.567130181549439,6.3242937384043e-17,symptomatic
1535,regionalization,GO:0003002,1.5656568019651422,0.0028626020016082124,symptomatic
204,cellular nitrogen compound metabolic process,GO:0034641,1.5596130678194318,2.872542203443784e-26,symptomatic
7,system development,GO:0048731,1.5588980336109606,9.601871692225129e-29,symptomatic
845,endocytosis,GO:0006897,1.5553729665997311,0.0006617137600444068,symptomatic
6,regulation of primary metabolic process,GO:0080090,1.5538954108858059,0.029613761262222548,asymptomatic
459,camera-type eye development,GO:0043010,1.5536486063263388,0.011391084693193105,symptomatic
388,sensory system development,GO:0048880,1.5532812614059421,0.005066824761854437,symptomatic
819,proteolysis,GO:0006508,1.5505527251754303,1.705064997460959e-08,symptomatic
720,catabolic process,GO:0009056,1.5473864558598092,9.135961917191612e-14,symptomatic
1302,positive regulation of immune response,GO:0050778,1.5461068407202012,0.00013448122905309714,symptomatic
200,heterocycle metabolic process,GO:0046483,1.5449473820194572,9.486740288390544e-22,symptomatic
11,animal organ development,GO:0048513,1.5434923707391024,4.0526055027394865e-21,symptomatic
2,regulation of metabolic process,GO:0019222,1.5412105503887787,0.008796199636521602,asymptomatic
8,multicellular organism development,GO:0007275,1.5407737599561098,4.814823717437866e-31,symptomatic
206,macromolecule metabolic process,GO:0043170,1.5380002200280534,1.854244208163231e-49,symptomatic
363,regulation of transmembrane transport,GO:0034762,1.5378640776699029,0.0025901520667220056,symptomatic
1536,pattern specification process,GO:0007389,1.5328817966407349,0.0031760278698132315,symptomatic
1456,aromatic compound catabolic process,GO:0019439,1.5282283378348787,0.008521576294040333,symptomatic
2082,regulation of monoatomic cation transmembrane transport,GO:1904062,1.5276457117053188,0.02609540044698973,symptomatic
203,cellular aromatic compound metabolic process,GO:0006725,1.5241470133621775,1.655316533403897e-20,symptomatic
508,homeostatic process,GO:0042592,1.5238834951456308,4.2324006287301265e-09,symptomatic
1457,organic cyclic compound catabolic process,GO:1901361,1.521657079193288,0.005747042014383876,symptomatic
2084,regulation of monoatomic ion transport,GO:0043269,1.5145631067961165,0.004199877258403397,symptomatic
738,macromolecule biosynthetic process,GO:0009059,1.510253374378404,2.276305189476605e-19,symptomatic
862,regulation of GTPase activity,GO:0043087,1.5094806802632434,0.03302594756834091,symptomatic
1985,amide metabolic process,GO:0043603,1.509075559307725,4.842796922318533e-05,symptomatic
489,regulation of system process,GO:0044057,1.5067675613934892,0.0018686212536168708,symptomatic
1897,organic cyclic compound biosynthetic process,GO:1901362,1.5037636133389616,7.667244439881229e-07,symptomatic
1676,behavior,GO:0007610,1.5025808037360207,0.0006811180736174573,symptomatic
395,actin cytoskeleton organization,GO:0030036,1.4985037539269803,0.0024303617867262512,symptomatic
126,cellular component organization,GO:0016043,1.4969344091726555,1.68561595273513e-42,symptomatic
788,inflammatory response,GO:0006954,1.4967447173043973,0.0022049381153617514,symptomatic
531,biological process involved in interspecies interaction between organisms,GO:0044419,1.4958864133789773,5.057505144406665e-09,symptomatic
127,cellular component organization or biogenesis,GO:0071840,1.4946346448645886,1.9799972992886931e-44,symptomatic
697,regulation of endocytosis,GO:0030100,1.4924757281553398,0.048574119218794655,symptomatic
2086,regulation of metal ion transport,GO:0010959,1.4876726913229739,0.019324702974032413,symptomatic
205,nitrogen compound metabolic process,GO:0006807,1.487128443610454,1.7922471212175193e-49,symptomatic
79,cellular developmental process,GO:0048869,1.486980415269559,5.349631328561411e-23,symptomatic
80,cell differentiation,GO:0030154,1.4854655889808217,9.239964587340712e-23,symptomatic
1983,organonitrogen compound biosynthetic process,GO:1901566,1.484717304397487,1.529710026151989e-07,symptomatic
1023,RNA processing,GO:0006396,1.4817504511186637,6.784041700452184e-05,symptomatic
877,regulation of secretion by cell,GO:1903530,1.4809061488673139,0.003038307852558184,symptomatic
708,cellular component biogenesis,GO:0044085,1.4802225695888487,1.2425011255982569e-15,symptomatic
1268,protein-containing complex assembly,GO:0065003,1.4797400810335601,6.250209030003403e-07,symptomatic
197,organic cyclic compound metabolic process,GO:1901360,1.4780370653488946,5.186038347540732e-19,symptomatic
983,cellular component assembly,GO:0022607,1.4756365560236422,9.527581110584011e-14,symptomatic
396,actin filament-based process,GO:0030029,1.474305675756479,0.001973925626991561,symptomatic
124,regulation of biological quality,GO:0065008,1.4736289687745998,4.3131506501174464e-16,symptomatic
299,cytoskeleton organization,GO:0007010,1.4735311182454647,1.1539898980050859e-06,symptomatic
118,response to chemical,GO:0042221,1.4703282478039759,2.0019608071415145e-22,symptomatic
394,organonitrogen compound metabolic process,GO:1901564,1.4702059599304116,2.1654445380049227e-29,symptomatic
911,developmental process involved in reproduction,GO:0003006,1.4694291262135923,3.341453886562063e-05,symptomatic
1811,regulation of body fluid levels,GO:0050878,1.4683560967582687,0.036634151201843365,symptomatic
1654,intracellular chemical homeostasis,GO:0055082,1.4679611650485438,0.004058404907223082,symptomatic
562,organophosphate metabolic process,GO:0019637,1.464399233195226,6.483826496507376e-05,symptomatic
2083,regulation of monoatomic ion transmembrane transport,GO:0034765,1.4614205416453756,0.04171985635533812,symptomatic
202,primary metabolic process,GO:0044238,1.4568073016867253,2.013292969220091e-49,symptomatic
741,cellular biosynthetic process,GO:0044249,1.4557200186841723,9.411023005434008e-22,symptomatic
1653,chemical homeostasis,GO:0048878,1.4505050946301614,0.00020306410773680099,symptomatic
739,organic substance biosynthetic process,GO:1901576,1.4499916726264537,7.368966466155551e-22,symptomatic
1387,response to biotic stimulus,GO:0009607,1.4480028806891916,7.099107178248919e-07,symptomatic
878,regulation of secretion,GO:0051046,1.4463834171011145,0.0033764564131724918,symptomatic
1,anatomical structure development,GO:0048856,1.444669102976468,8.602526909877731e-31,symptomatic
267,vesicle-mediated transport,GO:0016192,1.4434546613187391,3.7308703064699235e-06,symptomatic
1793,protein maturation,GO:0051604,1.44252900781435,0.014162032402670145,symptomatic
201,cellular metabolic process,GO:0044237,1.4395903445270322,1.167644691511586e-40,symptomatic
128,organic substance transport,GO:0071702,1.4392314339450007,5.395472690930217e-09,symptomatic
1655,cellular homeostasis,GO:0019725,1.4363921077356718,0.002923224547476747,symptomatic
740,biosynthetic process,GO:0009058,1.4361950257223532,6.87443722000915e-21,symptomatic
754,response to external stimulus,GO:0009605,1.4361232882520032,7.553299306550438e-11,symptomatic
288,microtubule-based process,GO:0007017,1.4314827033650674,0.0008762844242627074,symptomatic
2,developmental process,GO:0032502,1.4300072574464957,6.474903891101784e-33,symptomatic
1214,multicellular organismal reproductive process,GO:0048609,1.4233243654228565,0.0004985763702485127,symptomatic
1903,response to other organism,GO:0051707,1.4104505922189594,1.0218955191621015e-05,symptomatic
1904,response to external biotic stimulus,GO:0043207,1.407395464582384,1.3003664386727668e-05,symptomatic
198,organic substance metabolic process,GO:0071704,1.4019025836443602,3.8717547237007466e-43,symptomatic
1548,supramolecular fiber organization,GO:0097435,1.3971277644056024,0.014756751953506099,symptomatic
698,regulation of vesicle-mediated transport,GO:0060627,1.3956841912438174,0.02443793222284221,symptomatic
199,metabolic process,GO:0008152,1.3956227329750304,4.0148280894589183e-47,symptomatic
995,plasma membrane bounded cell projection organization,GO:0120036,1.3921926966103404,0.00020633014038457743,symptomatic
719,cellular catabolic process,GO:0044248,1.3863871830937595,0.000327155758607582,symptomatic
846,import into cell,GO:0098657,1.3840776699029125,0.008419999843656456,symptomatic
131,localization,GO:0051179,1.3835993295988163,5.899423985359388e-19,symptomatic
1186,lipid biosynthetic process,GO:0008610,1.375916533835676,0.022458441433488647,symptomatic
1215,multicellular organism reproduction,GO:0032504,1.3758992478006014,0.0016844634298250432,symptomatic
1025,ncRNA metabolic process,GO:0034660,1.3665103087160466,0.04426231102566423,symptomatic
103,cellular response to stimulus,GO:0051716,1.3657845286564358,1.4332051167871495e-28,symptomatic
2306,gamete generation,GO:0007276,1.362543761504313,0.007387797490321029,symptomatic
251,endomembrane system organization,GO:0010256,1.361478233636079,0.03572054948247189,symptomatic
996,cell projection organization,GO:0030030,1.3604673085444952,0.0005324965230031037,symptomatic
558,nucleoside phosphate metabolic process,GO:0006753,1.3588761729131638,0.04543742159733705,symptomatic
913,reproduction,GO:0000003,1.3422585590189062,0.0001929455126982136,symptomatic
912,reproductive process,GO:0022414,1.3396156132355854,0.0002195500369730239,symptomatic
130,establishment of localization,GO:0051234,1.3350193754893267,2.403804598729259e-12,symptomatic
559,nucleobase-containing small molecule metabolic process,GO:0055086,1.3317194685743483,0.04858850431702508,symptomatic
102,signal transduction,GO:0007165,1.3150038417327736,4.566991141945195e-14,symptomatic
1184,cellular lipid metabolic process,GO:0044255,1.3141446267157684,0.013755715900267376,symptomatic
771,cell-cell signaling,GO:0007267,1.3070428579091349,0.008026102155222002,symptomatic
129,transport,GO:0006810,1.299331364366652,3.7184447657281285e-09,symptomatic
105,signaling,GO:0023052,1.2874231082783665,6.272539214159444e-13,symptomatic
106,cell communication,GO:0007154,1.2841837243028416,4.0492475200107023e-13,symptomatic
352,immune system process,GO:0002376,1.2818854067105991,6.164104010561898e-05,symptomatic
28,regulation of cellular process,GO:0050794,1.2791663370141393,1.6495989456733122e-46,symptomatic
104,response to stimulus,GO:0050896,1.2608154770239195,1.13882937816757e-21,symptomatic
789,defense response,GO:0006952,1.2598983406395396,0.008213835117321506,symptomatic
24,regulation of biological process,GO:0050789,1.2552707298366856,8.492830547689225e-44,symptomatic
1185,lipid metabolic process,GO:0006629,1.243458757469768,0.028336724227842173,symptomatic
25,biological regulation,GO:0065007,1.2432366297940942,1.5325064815768727e-43,symptomatic
9,multicellular organismal process,GO:0032501,1.2182072300949283,3.352245000788793e-11,symptomatic
76,cellular process,GO:0009987,1.181638872362702,5.271118460584467e-48,symptomatic
